
<html lang="en"     class="pb-page"  data-request-id="f78a382c-8177-46dd-91ae-ff4ae1d16fe9"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm301718c;website:website:acspubs;issue:issue:10.1021/jmcmar.2013.56.issue-11;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Structural Optimization, Biological Evaluation, and Application of Peptidomimetic Prostate Specific Antigen Inhibitors" /></meta><meta name="dc.Creator" content="Maya B.  Kostova" /></meta><meta name="dc.Creator" content="D. Marc  Rosen" /></meta><meta name="dc.Creator" content="Ying  Chen" /></meta><meta name="dc.Creator" content="Ronnie C.  Mease" /></meta><meta name="dc.Creator" content="Samuel R.  Denmeade" /></meta><meta name="dc.Description" content="Prostate-specific antigen (PSA) is a serine protease produced at high levels by normal and malignant prostate epithelial cells that is used extensively as a biomarker in the clinical management of ..." /></meta><meta name="Description" content="Prostate-specific antigen (PSA) is a serine protease produced at high levels by normal and malignant prostate epithelial cells that is used extensively as a biomarker in the clinical management of ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 4, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm301718c" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm301718c" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm301718c" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm301718c" /></link>
        
    
    

<title>Structural Optimization, Biological Evaluation, and Application of Peptidomimetic Prostate Specific Antigen Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm301718c" /></meta><meta property="og:title" content="Structural Optimization, Biological Evaluation, and Application of Peptidomimetic Prostate Specific Antigen Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/large/jm-2012-01718c_0011.jpeg" /></meta><meta property="og:description" content="Prostate-specific antigen (PSA) is a serine protease produced at high levels by normal and malignant prostate epithelial cells that is used extensively as a biomarker in the clinical management of prostate cancer. To better understand PSA’s role in prostate cancer progression, we prepared a library of peptidyl boronic acid-based inhibitors. To enhance selectivity for PSA vs other serine proteases, we modified the P1 site of the inhibitors to incorporate a bromopropylglycine group. This allowed the inhibitors to participate in halogen bond formation with the serine found at the bottom of the specificity pocket. The best of these Ahx-FSQn(boro)Bpg had PSA Ki of 72 nM and chymotrypsin Ki of 580 nM. In vivo studies using PSA-producing xenografts demonstrated that candidate inhibitors had minimal effect on growth but significantly altered serum levels of PSA. Biodistribution of 125I labeled peptides showed low levels of uptake into tumors compared to other normal tissues." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm301718c"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm301718c">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm301718c&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm301718c&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm301718c&amp;href=/doi/10.1021/jm301718c" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 4224-4235</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm301694x" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm400307y" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structural Optimization, Biological Evaluation, and Application of Peptidomimetic Prostate Specific Antigen Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maya+B.++Kostova">Maya B. Kostova</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=D.+Marc++Rosen">D. Marc Rosen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ying++Chen">Ying Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ronnie+C.++Mease">Ronnie C. Mease</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Samuel+R.++Denmeade">Samuel R. Denmeade</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Department of Oncology, <sup>‡</sup>Radiology and Radiological Science, <sup>§</sup>Pharmacology and Molecular Science, <sup>∥</sup>The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University, School of Medicine, Baltimore, Maryland 21231, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: (410) 955-8875. E-mail: <a href="/cdn-cgi/l/email-protection#b8dcddd6d5ddcbd9f8d2d0d5d196dddccd"><span class="__cf_email__" data-cfemail="680c0d06050d1b092802000501460d0c1d">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm301718c&amp;href=/doi/10.1021%2Fjm301718c" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 4224–4235</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 21, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>21 November 2012</li><li><span class="item_label"><b>Published</b> online</span>4 June 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 June 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm301718c" title="DOI URL">https://doi.org/10.1021/jm301718c</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4224%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMaya%2BB.%2BKostova%252C%2BD.%2BMarc%2BRosen%252C%2BYing%2BChen%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D11%26contentID%3Djm301718c%26title%3DStructural%2BOptimization%252C%2BBiological%2BEvaluation%252C%2Band%2BApplication%2Bof%2BPeptidomimetic%2BProstate%2BSpecific%2BAntigen%2BInhibitors%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4235%26publicationDate%3DJune%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm301718c"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1516</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">15</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm301718c" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structural Optimization, Biological Evaluation, and Application of Peptidomimetic Prostate Specific Antigen Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Maya&quot;,&quot;last_name&quot;:&quot;B. Kostova&quot;},{&quot;first_name&quot;:&quot;D.&quot;,&quot;last_name&quot;:&quot;Marc Rosen&quot;},{&quot;first_name&quot;:&quot;Ying&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Ronnie&quot;,&quot;last_name&quot;:&quot;C. Mease&quot;},{&quot;first_name&quot;:&quot;Samuel&quot;,&quot;last_name&quot;:&quot;R. Denmeade&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;04&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;4224-4235&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm301718c&quot;},&quot;abstract&quot;:&quot;Prostate-specific antigen (PSA) is a serine protease produced at high levels by normal and malignant prostate epithelial cells that is used extensively as a biomarker in the clinical management of prostate cancer. To better understand PSA’s role in prostate cancer progression, we prepared a library of peptidyl boronic acid-based inhibitors. To enhance selectivity for PSA vs other serine proteases, we modified the P1 site of the inhibitors to incorporate a bromopropylglycine group. This allowed the inhibitors to participate in halogen bond formation with the serine found at the bottom of the specificity pocket. The best of these Ahx-FSQn(boro)Bpg had PSA Ki of 72 nM and chymotrypsin Ki of 580 nM. In vivo studies using PSA-producing xenografts demonstrated that candidate inhibitors had minimal effect on growth but significantly altered serum levels of PSA. Biodistribution of 125I labeled peptides showed low levels of uptake into tumors compared to other normal tissues.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm301718c&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301718c" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm301718c&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301718c" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm301718c&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301718c" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm301718c&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301718c&amp;href=/doi/10.1021/jm301718c" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm301718c" /></input><a href="/doi/pdf/10.1021/jm301718c" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm301718c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm301718c%26sid%3Dliteratum%253Aachs%26pmid%3D23692593%26genre%3Darticle%26aulast%3DKostova%26date%3D2013%26atitle%3DStructural%2BOptimization%252C%2BBiological%2BEvaluation%252C%2Band%2BApplication%2Bof%2BPeptidomimetic%2BProstate%2BSpecific%2BAntigen%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D11%26spage%3D4224%26epage%3D4235%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/11" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jmcmar.2013.56.issue-11/production/jmcmar.2013.56.issue-11.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/medium/jm-2012-01718c_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/large/jm-2012-01718c_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301718c&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Prostate-specific antigen (PSA) is a serine protease produced at high levels by normal and malignant prostate epithelial cells that is used extensively as a biomarker in the clinical management of prostate cancer. To better understand PSA’s role in prostate cancer progression, we prepared a library of peptidyl boronic acid-based inhibitors. To enhance selectivity for PSA vs other serine proteases, we modified the P1 site of the inhibitors to incorporate a bromopropylglycine group. This allowed the inhibitors to participate in halogen bond formation with the serine found at the bottom of the specificity pocket. The best of these Ahx-FSQn(boro)Bpg had PSA <i>K</i><sub>i</sub> of 72 nM and chymotrypsin <i>K</i><sub>i</sub> of 580 nM. In vivo studies using PSA-producing xenografts demonstrated that candidate inhibitors had minimal effect on growth but significantly altered serum levels of PSA. Biodistribution of <sup>125</sup>I labeled peptides showed low levels of uptake into tumors compared to other normal tissues.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00470" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00470" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A hallmark of prostate cancer is the production of the prostate tissue differentiation protein prostate-specific antigen (PSA).<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> PSA is aptly named in that its expression is highly restricted to normal and malignant prostate cells in men.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Although controversy exists over the use of PSA as a screening tool for prostate cancer, it continues to be a useful biomarker for the detection of cancer recurrence after localized therapy and as a marker of therapeutic response in the metastatic setting.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> PSA is found in high μg/mL to mg/mL amounts in the extracellular fluid where it exists in an enzymatically active state.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Upon entering the circulation, PSA is rapidly inhibited by the protease inhibitors α<sub>2</sub>-macroglobulin and α<sub>1</sub>-antichymotrypsin that are present in molar excess in the serum.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> This functional and quantitative difference in PSA compartmentalization has resulted in strategies to target PSA’s enzymatic activity for prodrug/protoxin activity<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> and to the design of antibodies directed at PSA’s catalytic site for potential use as imaging agents.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p">Because of the presence of the characteristic His-Asp-Ser catalytic triad, PSA is classified as a serine protease. For all serine proteases, substrate and inhibitor recognition is mainly governed by the binding of the P1 residue to the S1 pocket of the enzyme. PSA (i.e., KLK3) is also one of 15 members of the kallikrein family of proteases.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Most of the other kallikreins have trypsin-like proteolytic activity due to the presence of an aspartic acid residue at the bottom of the S1 specificity pocket.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> In contrast, PSA is considered a chymotrypsin-like protease due to the presence of a serine at the bottom of the S1 pocket (i.e., Ser189).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> However, while PSA has some similarity to chymotrypsin in its preference for hydrophobic amino acids at the P1 position, PSA also displays enzymatic properties that differentiate it from chymotrypsin and other serine proteases. In particular, PSA demonstrates preference for glutamine in the P1 position that is a unique characteristic compared to chymotrypsin,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> which has no ability to cleave after glutamine. Chymotrypsin is also not inhibited appreciably by peptide aldehyde inhibitors containing glutamine or glutamine analogues in the P1 position.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">Previously, using docking studies based on crystal structure data, we documented important differences in the physical and electrostatic characteristics of the S1 pocket of these two serine proteases that explain this differential preference for P1 glutamine on the part of PSA.<a onclick="showRef(event, 'ref11 ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13 ref14">(11-14)</a> In the case of PSA, the presence of polar chains provides a noticeable polar character to its shallow bottomed pocket. In contrast, the S1 cavity of chymotrypsin is less polar and more spacious. A comparative analysis of the binding modes of the peptide aldehyde inhibitor SSKLQ-CHO docked in the S1 pocket of PSA and chymotrypsin respectively revealed drastic differences in orientation of the glutamine side chain that underlies the marked difference in <i>K</i><sub>i</sub> values for this inhibitor for these two proteases (PSA <i>K</i><sub>i</sub> = 45 ± 4 μM vs chymotrypsin <i>K</i><sub>i</sub> <1000 μM).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p last">These modeling studies suggested that a P1 glutamine-based PSA inhibitor would be the most selective for PSA vs other chymotrypsin-like proteases. Previously, we generated boronic acid analogues of leucine and norleucine and determined that the substitution of boronic acid for aldehyde as the inhibitory group greatly decreased the <i>K</i><sub>i</sub> for PSA inhibition. Boronic acid was selected as the inhibitory moiety based on selectivity for serine protease inhibition and due to the fact that a boronic acid-based inhibitor bortezomib has achieved FDA approval as cancer therapy. However, while boronic acid analogues of these P1 preferred amino acids can be generated, the synthesis of a boronic acid analogue of glutamine is not feasible.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Previous studies demonstrated that an aldehyde analogue of methionine in the P1 position produced an inhibitor with a <i>K</i><sub>i</sub> of 3.8 μM for PSA inhibition but a <i>K</i><sub>i</sub> of >100 μM for chymotrypsin.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> On the basis of this previous data, in this study we describe our efforts to produce more potent and potentially more selective PSA inhibitors by generating a series of peptidyl-based inhibitors containing a boronic acid analogue of 3-bromopropylglycine (Bpg) in the P1 position. Bpg resembles Met and Gln as they have very similar side chain lengths. Like Met, the side chain of Bpg terminates in a bulky electron-rich atom that can form hydrogen bonds. We compared the ability of Bpg inhibitors vs inhibitors containing a boronic acid analogue of phenylalanine in the P1 position to inhibit both PSA and chymotrypsin. Selective PSA inhibitors were further evaluated in vitro for ability to effect the growth of PSA-producing vs nonproducing prostate cancer cell lines. Further optimization of selected inhibitors was achieved through modification of the P5 position of the peptide to enhance circulating half-life. These inhibitors were labeled with <sup>125</sup>I to assess biodistribution in vivo and to evaluate their potential for imaging of prostate cancers. Finally, we assessed the effect of the lead inhibitor on the in vivo growth and PSA production of human prostate cancer xenografts.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21574" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21574" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">For the synthesis of the (boro)phenylalanine containing peptidomimetics, the building block (<i>R</i>)-borophenylalanine-(1<i>S</i>,2<i>S</i>,3<i>R</i>,5<i>S</i>)-(+)-2,3-pinanediol ester <b>5</b> was synthesized (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) using modified literature precedence originally developed by Matteson and Winssinger.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> The (boro)bromopropylglycine analogues were prepared using commercial (1<i>R</i>)-1-amino-4-bromobutan-1-ylboronic acid (1<i>S</i>,2<i>S</i>,3<i>R</i>,5<i>S</i>)-(+)-2,3-pinanediol ester <b>6</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). All peptides, containing only <span class="smallcaps smallerCapital">l</span>-amino acids, were synthesized using Fmoc solid phase peptide synthesis. All peptidyl boronic acid inhibitors were prepared by amide bond formation between the fully protected peptide and the pinanediol protected boronic acid (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Consequently, the side chains of the peptide were deprotected, and in the majority of the sequences, this was followed by boronic acid deprotection (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). For compounds <b>21</b> and <b>23</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>), the ester protection of the acid was not deprotected and is abbreviated as boro-Pin. Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> lists the inhibitor sequences synthesized for these studies. All final products were purified by HPLC and characterized by MS (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The first set of peptides have their N-terminus capped by Cbz and were prepared to determine whether peptides that included boronic acid analogue of Phe <b>12</b> or Bpg <b>13</b> maintained the ability to inhibit PSA’s enzymatic activity (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). In the subsequent peptide inhibitors, aminohexanoic acid (Ahx) was incorporated at the N-terminus of the peptide to serve as a linker whereby other groups such as chelating groups or radiohalogenated prosthetic groups could be attached.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/medium/jm-2012-01718c_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/large/jm-2012-01718c_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Pinanediol Protected Phenylalanine Boronic Acid,<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> (boro-Pin)Phe<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/large/jm-2012-01718c_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301718c&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) (+)-pinanediol, Et<sub>2</sub>O, MgSO<sub>4</sub>, rt, 85%; (b) LiCHCl<sub>2</sub>, ZnCl<sub>2</sub>, THF, −100 °C, 80%; (c) LiN(SiMe<sub>3</sub>)<sub>2</sub>, THF, −78 °C; (d) TFA, Et<sub>2</sub>O, 0 °C, 73%.</p></p></figure><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/medium/jm-2012-01718c_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/large/jm-2012-01718c_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Schematic Illustration of Solid Phase Peptide Synthesis and Subsequent Conjugation to Boronic Acids ((boro)Phe and (boro)Bpg Are Used As Examples)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/large/jm-2012-01718c_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301718c&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. HPLC (Semi-prep) Retention Times and Observed <i>m</i>/<i>z</i> Ratios by ESI-MS<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="​" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">inhibitor</th><th class="colsep0 rowsep0" align="center" char="​"><i>R</i><sub>t</sub>, min</th><th class="colsep0 rowsep0" align="center">exact mass calcd</th><th class="colsep0 rowsep0" align="center"><i>m</i>/<i>z</i>,[M + H-18]<sup>+</sup></th><th class="colsep0 rowsep0" align="center">[M + H]<sup>+</sup></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">Z-SSKn(boro)F</td><td class="colsep0 rowsep0" align="char" char="​">25.6<a class="ref internalNav" href="#t1fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">714.38</td><td class="colsep0 rowsep0" align="left">697.0</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">Z-SSKn(boro)Bpg</td><td class="colsep0 rowsep0" align="char" char="​">24.2<a class="ref internalNav" href="#t1fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">744.29</td><td class="colsep0 rowsep0" align="left">729.0</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">Ahx-SSQn(boro)L</td><td class="colsep0 rowsep0" align="char" char="​">21.9<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">659.40</td><td class="colsep0 rowsep0" align="left">642.1</td><td class="colsep0 rowsep0" align="left">660.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">Ahx-SQn(boro)F</td><td class="colsep0 rowsep0" align="char" char="​">20.9<a class="ref internalNav" href="#t1fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">606.35</td><td class="colsep0 rowsep0" align="left">589.4</td><td class="colsep0 rowsep0" align="left">607.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">Ahx-SQn(boro)Bpg</td><td class="colsep0 rowsep0" align="char" char="​">19.0<a class="ref internalNav" href="#t1fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">636.27</td><td class="colsep0 rowsep0" align="left">620.9</td><td class="colsep0 rowsep0" align="left">638.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">Ahx-ASQn(boro)F</td><td class="colsep0 rowsep0" align="char" char="​">23.1<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">677.39</td><td class="colsep0 rowsep0" align="left">660.0</td><td class="colsep0 rowsep0" align="left">678.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">Ahx-ASQn(boro)Bpg</td><td class="colsep0 rowsep0" align="char" char="​">20.7<a class="ref internalNav" href="#t1fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">707.30</td><td class="colsep0 rowsep0" align="left">691.9</td><td class="colsep0 rowsep0" align="left">709.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">Ahx-FSQn(boro)F</td><td class="colsep0 rowsep0" align="char" char="​">24.5<a class="ref internalNav" href="#t1fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">753.42</td><td class="colsep0 rowsep0" align="left">736.6</td><td class="colsep0 rowsep0" align="left">754.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">Ahx-FSQn(boro)Bpg</td><td class="colsep0 rowsep0" align="char" char="​">22.9<a class="ref internalNav" href="#t1fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">783.33</td><td class="colsep0 rowsep0" align="left">768.5</td><td class="colsep0 rowsep0" align="left">786.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">Ahx-FSQn(boro-Pin)Bpg</td><td class="colsep0 rowsep0" align="char" char="​">30.2<a class="ref internalNav" href="#t1fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">917.44</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">917.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">SIB-Ahx- FSQn(boro)Bpg</td><td class="colsep0 rowsep0" align="char" char="​">32.4<a class="ref internalNav" href="#t1fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">1013.26</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">1015.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">SIB-Ahx-FSQn(boro- Pin)Bpg</td><td class="colsep0 rowsep0" align="char" char="​">33.5<a class="ref internalNav" href="#t1fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">1147.37</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">1147.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">Ahx-NaphSQn(boro)F</td><td class="colsep0 rowsep0" align="char" char="​">24.6<a class="ref internalNav" href="#t1fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">817.45</td><td class="colsep0 rowsep0" align="left">800.0</td><td class="colsep0 rowsep0" align="left">818.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">Ahx-NaphSQn(boro)Bpg</td><td class="colsep0 rowsep0" align="char" char="​">24.9<a class="ref internalNav" href="#t1fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">847.37</td><td class="colsep0 rowsep0" align="left">831.9</td><td class="colsep0 rowsep0" align="left">849.8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">nd: not detected. Eluent A = 0.1% TFA in 5% MeOH/95% water. Eluent B = 0.1% TFA in MeOH. Note: In some cases molecular ion peaks corresponding to [M – (OH)<sub>2</sub> + H]<sup>+</sup> and/or [M + Na]<sup>+</sup> were detected, as well (data not shown).</p></div><div class="footnote" id="t1fn1"><sup>b</sup><p class="last">HPLC method: 85% A for 5 min; gradient of 15–90% B over 25 min at 5 mL/min; 90% B for 5 min.</p></div><div class="footnote" id="t1fn2"><sup>c</sup><p class="last">HPLC method: 90% A for 5 min; gradient of 10–95% B over 25 min at 5 mL/min; 95% B for 5 min.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Comparison of the Inhibition Constant <i>K</i><sub>i</sub> for PSA vs Chymotrypsin</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">inhibitor</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> (nM) PSA inhibition</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> (nM) chymotrypsin inhibition</th><th class="colsep0 rowsep0" align="center">xspecificity, relative to PSA inhibition</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">Z-SSKn(boro)F</td><td class="colsep0 rowsep0" align="left">164.503</td><td class="colsep0 rowsep0" align="left">18.108</td><td class="colsep0 rowsep0" align="left">0.11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">Z-SSKn(boro)Bpg</td><td class="colsep0 rowsep0" align="left">24.228</td><td class="colsep0 rowsep0" align="left">196.882</td><td class="colsep0 rowsep0" align="left">8.13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">Ahx-SSQn(boro)L</td><td class="colsep0 rowsep0" align="left">43.053</td><td class="colsep0 rowsep0" align="left">137.837</td><td class="colsep0 rowsep0" align="left">3.20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">Ahx-SQn(boro)F</td><td class="colsep0 rowsep0" align="left">22.01</td><td class="colsep0 rowsep0" align="left">3.765</td><td class="colsep0 rowsep0" align="left">0.17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">Ahx-SQn(boro)Bpg</td><td class="colsep0 rowsep0" align="left">302.096</td><td class="colsep0 rowsep0" align="left">250.575</td><td class="colsep0 rowsep0" align="left">0.83</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">Ahx-ASQn(boro)F</td><td class="colsep0 rowsep0" align="left">310.286</td><td class="colsep0 rowsep0" align="left">36.22</td><td class="colsep0 rowsep0" align="left">0.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">Ahx-ASQn(boro)Bpg</td><td class="colsep0 rowsep0" align="left">52.11</td><td class="colsep0 rowsep0" align="left">165.921</td><td class="colsep0 rowsep0" align="left">3.18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">Ahx-FSQn(boro)F</td><td class="colsep0 rowsep0" align="left">61.484</td><td class="colsep0 rowsep0" align="left">0.135</td><td class="colsep0 rowsep0" align="left">0.002</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">Ahx-FSQn(boro)Bpg</td><td class="colsep0 rowsep0" align="left">72.288</td><td class="colsep0 rowsep0" align="left">580.724</td><td class="colsep0 rowsep0" align="left">8.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">Ahx-FSQn(boro-Pin)Bpg</td><td class="colsep0 rowsep0" align="left">73.327</td><td class="colsep0 rowsep0" align="left">496.3</td><td class="colsep0 rowsep0" align="left">6.77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">SIB-Ahx- FSQn(boro)Bpg</td><td class="colsep0 rowsep0" align="left">64.409</td><td class="colsep0 rowsep0" align="left">652.8</td><td class="colsep0 rowsep0" align="left">10.14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">Ahx-NaphSQn(boro)F</td><td class="colsep0 rowsep0" align="left">228.782</td><td class="colsep0 rowsep0" align="left">7.214</td><td class="colsep0 rowsep0" align="left">0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">Ahx-NaphSQn(boro)Bpg</td><td class="colsep0 rowsep0" align="left">102.463</td><td class="colsep0 rowsep0" align="left">505.676</td><td class="colsep0 rowsep0" align="left">4.94</td></tr></tbody></table></div></div><div class="NLM_p">The binding efficiency of protease substrates and inhibitors is highly dependent on the amino acid residues binding to the corresponding pockets within the vicinity of the catalytic site as illustrated in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. The binding specificity is highly dependent on the amino acid residue present at the P1 position. The structural models of the PSA active site suggest a hydrophobic character for the sides of the specificity pocket and a polar character for the bottom of the pocket,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> where the polar hydroxyl of Ser189 is flanked by the polar hydroxyl side chains of Ser226 and Thr190.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> PSA modeling studies suggested that amino acids with medium length hydrophobic side chains such as leucine, norleucine, or phenylalanine or those with hydrophobic side chains terminating in a polar group such as glutamine, methionine, and tyrosine would be preferred by PSA in the P1 position. However, while aldehyde-based peptide inhibitors with hydrophobic aliphatic side chains (Leu, Nle) or aromatic side chains (Phe, Tyr) in the P1 amino acids could inhibit PSA, these compounds were even more potent chymotrypsin inibitors. In contrast, aldehyde inhibitors containing glutamine or methionine in the P1 position were highly specific for PSA and were not effective at inhibiting chymotrypsin.</div><figure id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/medium/jm-2012-01718c_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/large/jm-2012-01718c_0009.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. PSA Active Site Interactions with Amino Acids in P1–P5 Positions of Peptide Boronic Acid <b>20</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/large/jm-2012-01718c_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301718c&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Substrate binding pockets on the protease are labeled as S.</p></p></figure><div class="NLM_p">Thus, to produce a more potent and specific peptidyl PSA inhibitor, we synthesized and evaluated (boro)Bpg-based inhibitors. The bromopropylglycine boronic acid was selected because it possesses a medium length hydrophobic chain such as that found in residues like Leu, Nle, Met, and Gln, but the presence of the bromine also allows for interactions with the polar groups present within of the bottom of the S1 pocket of PSA (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). A similar strategy has been used to prepare thrombin<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and proteasome inhibitors.<a onclick="showRef(event, 'ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20 ref21">(18-21)</a> The presence of bromine at the end of the side chain of P1 allows for halogen bond formation (electrostatic interaction between a halogen and an oxygen), which provides a unique base for inhibitor–enzyme recognition. Also, halogen–oxygen interactions can play significant role in intermolecular binding.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> An example in drug design and halogen bonding is the binding of inhibitor IDD 594 (5-fluoro-2-(4-bromo-2-fluoro-benzylthiocarbamoyl)-phenoxyacetic acid) to human aldose reductase.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> In our case of protease–inhibitor interactions, the polarized bromine can interact with the carbonyl from the peptide backbone and/or hydroxyl groups of the Thr and the two Ser residues located at the bottom of the S1 pocket.</div><div class="NLM_p">In addition, we synthesized (boro)Phe-based inhibitors to compare them with the (boro)Bpg-based inhibitors with respect to the potency and the specificity. The most important differences in the binding modes of (boro)Bpg and (boro)Phe inhibitors lie in their interaction with the S1 specificity pocket. The bromopropyl group is longer and reaches deeper into the S1 pocket compared to phenylalanine. The additional halogen interaction with the enzyme backbone facilitates tighter binding between the enzyme and the inhibitor. Prior modeling studies with aldehyde inhibitors contrasted the differences in the S1 pockets of PSA and chymotrypsin. As we predicted based on the results from these studies, (boro)Phe inhibitor <b>12</b> was 9-fold better at inhibiting chymotrypsin and (boro)Bpg inhibitor <b>13</b> was ∼8-fold better at inhibiting PSA (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div class="NLM_p">Previously, we used an iterative approach that combined analysis of peptidyl aldehyde inhibitor libraries with molecular modeling studies. On the basis of these studies, it was determined that a peptide sequence length of at least four amino acids was required for PSA inhibition. From a series of 27 natural and unnatural amino acids, we determined that hydrophobic amino acids were best in the P2 position, with norleucine being the most preferred. In the P3 position, glutamine and lysine were equally preferred. Because the presence of lysine makes the peptide more susceptible to cleavage by trypsin-like proteases present in the serum, for our extended studies glutamine was selected as a preferred amino acid for the P3 position. In addition, having Lys along with Ahx in the peptide sequence could present more elaborate synthetic routes when it comes to selective radiolabeling or other N-terminal modifications. Finally, modeling studies suggested a preference for serine or alanine in the P4 position. Therefore, on the basis of these studies, we prepared peptide inhibitors <b>15</b>–<b>25</b> with the sequence X-SQn(boro)Bpg or X-SQn(boro)F and characterized their ability to inhibit PSA vs chymotrypsin (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Effects of P5 Modification on PSA Inhibition</h3><div class="NLM_p">Previous modeling studies indicated that amino acids in P5 position and beyond in the PSA inhibitor sequence were outside of PSA’s catalytic site and were solvent exposed. This suggested that hydrophobic amino acids and bulky adducts such as chelating groups could be added to the amino terminus of the peptide without affecting the ability of the compound to act as a PSA inhibitor (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). In addition, preliminary in vivo studies suggested that inhibitors such as <b>14</b> had a remarkably short serum half-life due to rapid renal clearance. Thus, in an attempt to improve the half-life, inhibitors <b>19</b>, <b>20</b>, and <b>24</b>, <b>25</b> were generated that contained bulky hydrophobic amino acids in the P5 position. In addition, an aminohexanoic (Ahx) group was placed at the N-terminus to serve as a linker to chelating groups (e.g., NOTA, DOTA) or radiolabeled prosthetic groups (SIB, SFB, etc). The addition of this Ahx group did not affect PSA inhibition to a significant degree. Analysis of the <i>K</i><sub>i</sub> for the (boro)Bpg inhibitors demonstrated that in some cases deletion as in <b>16</b> or substitution as in <b>25</b> of P5 Ser had a deleterious effect on PSA inhibition, whereas in other cases the effect on <i>K</i><sub>i</sub> was minimal as in <b>18</b> and <b>20</b>. From this entire group, <b>20</b> was the most selective PSA inhibitor with an 8-fold lower <i>K</i><sub>i</sub> for PSA vs chymotrypsin. In contrast to the specificity conveyed by the (boro)Bpg, all of the (boro)Phe inhibitors were much better (i.e., <b>19</b>, 450-fold) chymotrypsin inhibitors. In fact, the inhibitor <b>19</b> with a <i>K</i><sub>i</sub> of 135 picomolar, is one of the most potent chymotrypsin inhibitors ever described (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><figure id="fig1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/medium/jm-2012-01718c_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/large/jm-2012-01718c_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of peptide boronic acids with hydrophobic amino acid substituents in the P5 position.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/large/jm-2012-01718c_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301718c&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> PSA Inhibitors Affect PSA Blood Levels</h3><div class="NLM_p">PSA is secreted in an enzymatically active form and accumulates to high levels in the extracellular fluid surrounding prostate cancer cells. A fraction of this PSA enters the circulation where it is rapidly inactivated due to the formation of covalent complexes with the serum protease inhibitors α-2-macroglobulin (A<sub>2</sub>M) and α-1-antichymotrypsin (ACT).<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> To assess whether the formation of these complexes could be inhibited, PSA was incubated with either A<sub>2</sub>M or ACT in aqueous buffer in the presence or absence of <b>20</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A). Western blot analysis demonstrated that <b>20</b> completely blocked the ability of PSA to bind to both of these serum protease inhibitors. Subsequently, we evaluated the effect of the PSA inhibitor <b>20</b> on serum PSA levels generated by PSA-producing human prostate cancer xenografts in nude mice. First, we determined that the PSA inhibitor <b>20</b> had no effect on the standard ELISA used to measure PSA levels in humans (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B). Using different antibodies, this assay can measure free PSA, which corresponds to the fraction of PSA in the blood that is unbound to protease inhibitors because it lacks enzymatic activity and total PSA, which corresponds to the sum of the free PSA plus the amount of PSA bound to ACT. The fraction of PSA bound to A<sub>2</sub>M cannot be measured due to lack of antibody that specifically recognizes this complex. In this experiment, mice received three 5-day courses of <b>20</b> at 10 mg/kg and then blood was obtained for free and total PSA measurement. Mice treated with <b>20</b> had an approximately 40% lower level of total PSA/g of tumor and a 23% lower level of free PSA/g of tumor compared to control mice (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>C,D). These results suggest that the inhibitor is able to block PSA complex formation with ACT and alter PSA clearance in treated animals.</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/medium/jm-2012-01718c_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/large/jm-2012-01718c_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. PSA inhibitor blocks PSA binding to serum protease inhibitors and alters PSA blood levels. (A) Western blot analysis of inhibition of PSA complex formation with A<sub>2</sub>M and ACT. FP = control non-PSA containing female plasma; all mixtures were incubated for overnight at room temperature. (B) PSA measurements using Hybritech assay of 100 ng/mL PSA in RPMI + 1% bovine serum albumin + 1 μM <b>6</b> or 1 μM Z-SSKn-OH peptide + <b>6</b> or 1 μM <b>20</b>. (C) Free and total PSA levels in serum of mice bearing PSA-producing LNCaP prostate cancer xenografts either untreated or receiving three courses of <b>20</b> at dose of 10 mg/kg for five consecutive days/week. (D) Free and total PSA levels per g of tumor and ratio of free/total PSA in mice treated as in (C).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/large/jm-2012-01718c_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301718c&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To be able to predict the inhibitor’s behavior in vivo, we next assessed whether <b>20</b> maintained the ability to inhibit PSA in buffer, cell culture media, and plasma (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Enzyme–inhibitor interactions are generally measured in buffer, where we observed the lowest <i>K</i><sub>i</sub> value for Ahx-FSQn(boro)Bpg. When the assay was performed in RPMI with no additives, there was no change in the <i>K</i><sub>i</sub> value. However, when the assay was performed in serum containing media, we saw a linear decrease in the inhibition potential of the agent (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). The study demonstrated that in the presence of serum containing RPMI the <i>K</i><sub>i</sub> for PSA inhibition increased ∼10-fold. These results suggest that the inhibitor may not bind PSA efficiently in plasma due to nonspecific protein binding.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/medium/jm-2012-01718c_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/large/jm-2012-01718c_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Evaluation of the activity of inhibitor <b>20</b> in the presence of bovine serum in the media.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/large/jm-2012-01718c_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301718c&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Comparison of the PSA Inhibition Constant of <b>20</b> in Different Media</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">inhibitor Ahx-FSQn(boro)Bpg screened in different media</th><th class="colsep0 rowsep0" align="center" char="."><i>K</i><sub>i</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PSA buffer (pH 7.8)<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char=".">72</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RPMI<a class="ref internalNav" href="#tbl3-fn2" aria-label="b">b</a> (no additives)</td><td class="colsep0 rowsep0" align="char" char=".">75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RPMI<a class="ref internalNav" href="#tbl3-fn2" aria-label="b">b</a> (+1% FBS<a class="ref internalNav" href="#tbl3-fn3" aria-label="c">c</a>)</td><td class="colsep0 rowsep0" align="char" char=".">142</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RPMI<a class="ref internalNav" href="#tbl3-fn2" aria-label="b">b</a> (+10% FBS<a class="ref internalNav" href="#tbl3-fn3" aria-label="c">c</a> +1% Pen/Strep<a class="ref internalNav" href="#tbl3-fn4" aria-label="d">d</a> +1% Gln<a class="ref internalNav" href="#tbl3-fn5" aria-label="e">e</a>)</td><td class="colsep0 rowsep0" align="char" char=".">699</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">female plasma</td><td class="colsep0 rowsep0" align="char" char=".">604</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">PSA buffer: 50 mM TRIS·HCl, 100 mM NaCl.</p></div><div class="footnote" id="tbl3-fn2"><sup>b</sup><p class="last">RPMI: RPMI-1640 medium, cell culture media (Gibco: Invitrogen, Grand Island, NY).</p></div><div class="footnote" id="tbl3-fn3"><sup>c</sup><p class="last">FBS: fetal bovine serum.</p></div><div class="footnote" id="tbl3-fn4"><sup>d</sup><p class="last">Pen/Strep: penicillin/streptomycin.</p></div><div class="footnote" id="tbl3-fn5"><sup>e</sup><p class="last">Gln: <span class="smallcaps smallerCapital">l</span>-glutamine.</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> In Vivo Study</h3><div class="NLM_p">On the basis of these results suggesting <b>20</b> can bind to PSA in vivo, we next evaluated whether this inhibitor could affect the growth of PSA-producing LNCaP human prostate cancer xenografts growing subcutaneously in nude mice. On the basis of prior studies with peptidyl boronic acid inhibitors in this setting, we selected a daily dose of 10 mg/kg administered intravenously for five consecutive days. This regimen was well tolerated and induced no significant weight loss in treated animals. PSA inhibitor treated animals experienced a delay in tumor growth over the first two cycles of therapy and had smaller tumors at the end of the treatment period, although the difference did not achieve statistical significance (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/medium/jm-2012-01718c_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/large/jm-2012-01718c_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In vivo evaluation of <b>20</b>, Ahx-FSQn(boro)Bpg. Mice bearing subcutaneous PSA-producing LNCaP prostate cancer xenografts were either untreated (tumor control) or received three courses of <b>20</b> at dose of 10 mg/kg for five consecutive days/week (treatment interval indicated by gray bars).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/large/jm-2012-01718c_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301718c&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Addition of 4-Iodobenzoate and <sup>125</sup>I Labeling</h3><div class="NLM_p">An important advantage of our peptide-based inhibitors is that they can be readily modified to incorporate imaging moieties such as radionuclide-bearing groups. To assess circulating half-life and biodistribution, select inhibitors were radiolabeled via the addition of 4-[<sup>125</sup>I]iodobenzoate to the Ahx linker. To introduce this label containing <i>N</i>-hydroxysuccinimidyl-4-[<sup>125</sup>I]iodobenzoate (SIB) was prepared as previously described by Dekker et al.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). This [<sup>125</sup>I]SIB prosthetic group was previously developed for radioiodination of proteins and peptides.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a> Unlabeled SIB-peptides were prepared as chromatographic references and also as a comparison with the noniodinated analogues in the enzyme kinetic studies. The coupling of SIB to Ahx as in <b>22</b>, slightly decreased the <i>K</i><sub>i</sub> for PSA and increased the <i>K</i><sub>i</sub> for chymotrypsin (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><figure id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/medium/jm-2012-01718c_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/large/jm-2012-01718c_0010.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Peptide Radiolabeling with [<sup>125</sup>I]SIB and Preparation of Cold Reference<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/large/jm-2012-01718c_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301718c&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) <i>N</i>-Hydroxysuccinimidyl-4-iodobenzoate, triethylamine, MeOH, rt, 30 min; (b) [125I]<i>N</i>-hydroxysuccinimidyl-4-iodobenzoate, triethylamine, DMF, rt, 40 min.</p></p></figure><div class="NLM_p">In initial studies, we generated [<sup>125</sup>I]SIB-Ahx-SSQn(boro)Bpg, which when injected intraperitoneally (ip) into mice had an extremely short circulating half-life of 12 min (data not shown). Subsequently, in an effort to improve circulating half-life, we generated the <sup>125</sup>I labeled version of Ahx-NaphSQn(boro)F. This compound had a longer circulating half-life of ∼2.7 h following ip injection (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A). Further, we performed a biodistribution study in mice bearing PSA-producing LNCaP tumors. Mice were injected with [<sup>125</sup>I]SIB-Ahx-NaphSQn(boro)F, and at 2, 4, and 6 h, individual mice were sacrificed and their tissues (liver, kidney, heart, brain, skeletal muscle, and tumor) were collected, weighed, and analyzed using a gamma counter (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>B). [<sup>125</sup>I]SIB-Ahx-FSQn(boro)Bpg <b>26</b> and [<sup>125</sup>I]SIB-Ahx-FSQn(boro-Pin)Bpg <b>27</b> were also used for biodistribution studies (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>C). For these three inhibitors, the majority of activity was detected within the liver and kidney by 2 h. Tumor levels at each time point and dose were very similar to those in the heart and skeletal muscle. Highest amount of activity detected in the tumors was around 3–4 h postinjection.</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/medium/jm-2012-01718c_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/large/jm-2012-01718c_0006.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Evaluation of <sup>125</sup>I labeled PSA inhibitor in vivo. (A) Blood clearance of [<sup>125</sup>I]SIB-Ahx-NaphSQn(boro)F from mice blood measured over time. Data shows counts per second normalized to starting counts obtained in plasma as 2 h. Four animals were sacrificed at each time point. (B) Biodistribution of [<sup>125</sup>I]SIB-Ahx-NaphSQn(boro)F, shown as percent of injected dose per gram (%ID/gram). Two mice were sacrificed per time point. Tissues were harvested at 2, 4, and 6 h, weighed, and counted in a gamma counter. Mice had PSA expressing LNCaP xenografts in bilateral flanks. (C) Biodistribution of [<sup>125</sup>I]SIB-Ahx-FSQn(boro)Bpg <b>26</b> and [<sup>125</sup>I]SIB-Ahx-FSQn(boro-Pin)Bpg <b>27</b>, shown as percent of injected dose per gram (%ID/gram). Each drug was injected into two mice, and one animal was sacrificed per time point. Tissues were harvested at 2 and 4 h, weighed, and counted in gamma counter. Mice had single PSA expressing LNCaP xenografts.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/large/jm-2012-01718c_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301718c&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75236" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75236" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The goal of these studies was to identify a specific and potent PSA inhibitor that could be used to investigate the role of PSA in the pathobiology of prostate cancer.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Such a role is suggested by the continued production of PSA throughout the course of the disease, including production by men with poorly differentiated cancers that have become highly resistant to multiple forms of androgen ablative therapy. PSA is able to proteolytically modify growth regulatory proteins that are important in cancer growth and survival. These include insulin growth factor binding proteins (IGFBP) 2, 3, and 5,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> PTH-related protein,<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a> latent TGF-β2,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and extracellular matrix components fibronectin, and laminin.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Using siRNA to knockdown PSA production, Williams et al.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> demonstrated the importance of PSA production in the in vitro and in vivo growth of human prostate cancer cell lines. These combined results suggest that the enzymatic activity of PSA may also represent a potential therapeutic target in prostate cancer and further support the development of selective PSA inhibitors to determine the significance of PSA’s enzymatic activity in the progression and growth of prostate cancer.</div><div class="NLM_p">A further goal of these studies would be to identify a peptidyl PSA inhibitor as an imaging agent in patients with prostate cancer. The potential use of a PSA inhibitor for imaging prostate cancer is particularly attractive because prostate cancer preferentially metastasizes to the bone, resulting in the formation of predominantly osteoblastic lesions.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a> Therapeutic response in the bone is difficult to evaluate with current bone scan imaging modalities. Thus, there is a compelling need for better imaging modalities for prostate cancer that can be used to detect disease recurrence at an earlier time point and to better evaluate the therapeutic efficacy of new treatments. In this regard, Ulmert et al.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> recently reported on the development of <sup>89</sup>Zr labeled monoclonal anti-PSA antibody that selectively binds to the catalytic site of PSA. Positron emission tomography (PET) imaging demonstrated that this <sup>89</sup>Zr antibody accumulated in tumors with a peak activity of 19.6% %ID/g at 24 h postinjection.</div><div class="NLM_p">In our studies, we have focused on peptidyl boronic acid-based approach to PSA inhibition. We have pursued this strategy because peptides provide a platform for easy introduction of imaging moieties and therapeutic agents. Other strategies for PSA inhibition have also been described; the first PSA inhibitors reported in the literature used a homology model derived from porcine kallikrein to design and characterize a series of monocyclic β-lactam compounds.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36, 37)</a> Prior to this study, it had been shown that β-lactams were efficient and specific inhibitors of several serine proteases, especially human leukocyte elastase.<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38, 39)</a> The best inhibitor from the studies of Adlington et al. had an IC<sub>50</sub> value of 226 nM for PSA.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36, 37)</a> However, the specificity and stability of this compound and others in the class versus chymotrypsin and other proteases was not reported. Other attempts have been made to find small-molecule inhibitors for PSA using compounds other than β-lactams. Azapeptides, which can inhibit both cysteine and serine proteases, have been developed and used to effectively inhibit PSA with <i>K</i><sub>i</sub> as low as 500 nM.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> To elucidate the role of PSA in angiogenesis, Koistinen et al. screened a library of nearly 50000 compounds to discover inhibitors of PSA.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Out of the compounds screened, only three were identified that inhibited PSA at sub μM concentrations. The active compounds were either benzoxazinone or triazole derivatives, which inhibited PSA with IC<sub>50</sub> values of 300–900 nM and had 10–30-fold specificity vs chymotrypsin.</div><div class="NLM_p last">In this work, we have developed a small library of peptidomimetics containing peptidyl boronic acid, which shows an improved potency for PSA (<100 nM) and specificity over chymotrypsin (up to 10-fold). These results suggest a potential use of these inhibitors as targeted therapeutics or imaging agents. Systemic administration of inhibitors at doses of 10 mg/kg for five consecutive days/week ×3 resulted in tumor growth changes. PSA inhibitor <b>20</b> was able to block complex formation between PSA and serum protease inhibitors A<sub>2</sub>M and ACT and did not affect measurement of PSA by ELISA assay. PSA inhibitor treatment altered PSA blood levels, reducing the total PSA/g by 40% and the free PSA/g by 23% while increasing the free/total PSA ratio by ∼25%. These lowering of the total PSA levels appear consistent with the PSA inhibitor disrupting PSA binding to ACT, thus decreasing the amount of PSA-ACT complex that typically makes up about 75% of the total PSA measured in men with prostate cancer. The reasons for the reduction in free PSA levels in this model is less clear, as free PSA in the circulation has been demonstrated to be enzymatically inactive due to a combination of incomplete processing of the proPSA zymogen and proteolytic processing.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Potential explanation for this observed decrease in free PSA may be that the inhibitor changes the kinetics of PSA clearance upon binding to PSA or may decrease production of PSA by prostate cancers by some undefined mechanism. While these changes in serum PSA levels suggest that the inhibitor is reaching the target intratumorally, in vivo tumor growth assays demonstrated that the PSA inhibitor has a nonsignificant, minimal effect on the inhibition of growth of subcutaneously implanted human prostate cancer xenografts. This lack of effect may be due to the short biological half-life of the drug as there is insufficient exposure to completely inhibit PSA, which is continuously being secreted into the tumor microenvironment by prostate cancer cells. Alternatively, the lack of effect may be a contextual one: PSA may play no role in the growth of subcutaneously implanted prostate cancer xenografts, as prostate cancer typically forms osteoblastic bone metastases. The mechanism whereby PSA may stimulate bone adhesion or osteoblast growth and/or differentiation has not been clearly defined. However, PSA can release cytokines involved in bone turnover such as IGF-1 and TGF-β2.<a onclick="showRef(event, 'ref27 ref30'); return false;" href="javascript:void(0);" class="ref ref27 ref30">(27, 30)</a> PSA also hydrolyzes PTHrP, an important mediator of osteolytic bone metastases, and inactivates PTHrP-stimulated cAMP accumulation in mouse osteoblasts.<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a> This suggests PSA could alter the bone metastatic phenotype from osteoclastic to osteoblastic through PTHrP degradation. Therefore, in future studies, we plan to assess the effect of PSA inhibitors on growth in potentially more relevant models of prostate cancer bone metastases.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86438" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86438" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">One of our strategies in validating PSA as a “druggable” target is to inhibit its protease activity by creating PSA specific enzyme inhibitors. By introducing new structural differences at P5 and P1, we prepared boronic acid peptidates for targeted inhibition of PSA. These boronic acid peptidates have <i>K</i><sub>i</sub> values in the nanomolar range and rank among the best inhibitors of PSA reported so far. The best of these inhibitors achieved 8-fold selectivity vs chymotrypsin. In addition, we demonstrated that the inhibitors could block PSA complex formation with serum protease inhibitors. In vivo studies showed that inhibition of PSA resulted in decrease of the total PSA as well as the free PSA. The inhibitors did not significantly inhibit the growth of subcutaneous PSA-producing xenografts, and further study is needed to determine the microenvironmental context in which PSA activity is most relevant. In addition, these studies suggest that, while these PSA inhibitors will not be useful as imaging agents without further optimization, the inhibitors are useful research tools to help in the elucidation of PSA’s role in the growth and progression of prostate cancer.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53737" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53737" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Chemistry</h3><div class="NLM_p">All amino acids used in this study are of <span class="smallcaps smallerCapital">l</span>-form. All Fmoc-amino acids and 2-chlorotrityl chloride resin used were purchased from AnaSpec (Fremont, CA). Benzylboronic acid was purchased from Alfa Aesar (Ward Hill, MA), and (1<i>R</i>)-1-amino-4-bromobutan-1-ylboronic acid (1<i>S</i>,2<i>S</i>,3<i>R</i>,5<i>S</i>)-(+)-2,3-pinanediol ester was purchased from BoroChem SAS (Caen, France). Fmoc-(<i>R</i>)-3-amino-4-(2-naphthyl)-butyric acid was used for the synthesis of Naph-containing analogues and was purchased from PepTech Corp. (Burlington, MA). All other reagents and solvents were purchased from Sigma-Aldrich (USA) and used as received. All reactions were carried out under anhydrous conditions, nitrogen atmosphere and dry solvents, unless otherwise noted. Reactions were monitored by thin layer chromatography (TLC) carried out on 250 μm silica gel plates (60 F<sub>254</sub>). All organic extracts were dried over MgSO<sub>4</sub>, and solvents were removed with a rotary evaporator, followed by high vacuum oil pump pressure. The products were characterized by <sup>1</sup>H and <sup>13</sup>C NMR on a 400 MHz Bruker Avance NMR spectrometer. Mass spectra were measured on a Bruker 3000 Esquire mass spectrometer equipped with ESI. The HPLC used for the analysis and purification was equipped with photodiode array detector and purchased from Waters (Milford, MA). The final products were purified on a semiprep HPLC column from Phenomenex: Luna C18, particle size 10 μm, 250 mm × 10 mm. The purity of all synthesized peptides was determined by analytical HPLC to be >95%.</div><div class="NLM_p last">[<sup>125</sup>I]NaI was purchased from MP Biomedicals (Solon, OH). All radiolabeled products were purified on reverse phase radio-HPLC using Waters Delta 600 pump, Waters 2487 UV/vis dual wavelength absorbance detector, and Beta-RAM radio HPLC detector, equipped with sodium iodide cell for soft gammas (I-125) from IN/US Systems (Brandon, FL). The HPLC column was purchased from Phenomenex: Luna C18, particle size 5 μm, 150 mm × 4.60 mm. Solid-phase C18 extraction cartridges (Sep-Pak Plus) were purchased from Waters. Radioactivity was measured in CRC-10R Capintec dose calibrator (Ramsey, NJ). The CT/SPECT scanning was performed in our small animal imaging center using X-SPECT imager (Gamma Medica, Northridge, CA). All animal studies performed were in full compliance with our institutional guidelines related to conducting experiments using animals. The radioactivity of the harvested tissue was measured with automated Gamma 5500 counter (Beckman, Irvine, CA). The percent injected dose per gram of tissue (%ID/g) was calculated based on the number of counts measured for 0.01 mL of the dosing solution.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Biology</h3><div class="NLM_p last">Chymotrypsin (from bovine pancreas) and PSA (from human seminal fluid) were purchased from CalBiochem (San Diego, CA). The fluorescent PSA substrate, Mu-SRKSQQY-AMC (morpholinocarbonyl-Ser-Arg-Lys-Gln-Gln-Tyr-aminomethylcoumarin), was selected as the PSA substrate based on a previous study<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and was custom synthesized by California Peptides (Napa Valley, CA). The chymotrypsin substrate Suc-AAPF-AMC was purchased from Sigma-Aldrich. All kinetic assays were performed on a Beckman DTX-880 multimode detector plate reader.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Enzyme Assays</h3><div class="NLM_p">Peptidyl boronic acids were dissolved in DMSO at 20 mM. Stock solutions could be stored at −20 °C and were stable for one year. More diluted solutions were prepared as necessary. The activity of the inhibitors was determined by monitoring the change of fluorescence of AMC substrate (ex 370 nm; em 465 nm) due to hydrolysis by PSA. Product formation was followed over 30 min. The <i>K</i><sub>m</sub> for the substrate Mu-SRKSQQY-AMC was previously determined to be 140 μM.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Kinetic measurements were done in triplicate and run at 37 °C in PSA buffer (50 mM TRIS, 100 mM NaCl, pH 7.8). Reactions were performed on 96-well plate where the final concentration of PSA was 2.5 μg/mL (2 nM active PSA) and the substrate was 300 μM. The assay mixture contained 100 μL of buffer, peptidyl boronic acid in DMSO (20 μL), PSA solution (20 μL), and Mu-SRKSQQY-AMC in buffer (60 μL). The following concentrations of inhibitors were employed for the assay: 25, 12.5, 6.25, 3.1, 1.56, 0.78, 0.39, 0.19, 0.098, and 0.049 μM.</div><div class="NLM_p">Selectivity of the compounds was determined by screening the products against chymotrypsin. Chymotrypsin assays were performed by monitoring the fluorescence of Suc-AAPF-AMC substrate at the above-described conditions. The <i>K</i><sub>m</sub> value of chymotrypsin for the substrate Suc-AAPF-AMC was determined to be 14 μM. Reactions were performed on 96-well plate where the final concentration of chymotrypsin was 2 nM and the substrate was 25 μM. The assay mixture contained peptidyl boronic acid in DMSO (20 μL), Suc-AAPF-AMC in PSA buffer (90 μL), and chymotrypsin solution (90 μL). The chymotrypsin substrate solution was added last to each assay solution, and the kinetic data was collected immediately.</div><div class="NLM_p last">The inhibition constant (<i>K</i><sub>i</sub>) of each compound was determined by solving the equation: <i>K</i><sub>i</sub> = 1/slope × 1/(1 + [S]/<i>K</i><sub>m</sub>), where the slope is obtained from a linear plot of <i>V</i><sub>0</sub>/<i>V</i><sub>i</sub> −1 vs [I]. The reciprocal of the slope is also equal to the <i>K</i><sub>i(app)</sub>, apparent inhibition constant. [S] = substrate concentration, [I] = inhibitor concentration, <i>K</i><sub>m</sub> = Michaelis constant, <i>V</i><sub>0</sub> = rate of substrate hydrolysis in the absence of inhibitor, and <i>V</i><sub>i</sub> = rate in the presence of inhibitor. The <i>K</i><sub>i</sub> values are reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Biodistribution Studies</h3><div class="NLM_p last">Biodistribution studies were conducted to evaluate the uptake of [<sup>125</sup>I]SIB-Ahx-NaphSQn(boro)F, [<sup>125</sup>I]SIB-Ahx-FSQn(boro)Bpg, and [<sup>125</sup>I]SIB-Ahx-FSQn(boro-Pin)Bpg in LNCaP human prostate cancer xenograft models. Mice received between 230 and 580 μCi of the selected radiolabeled inhibitor in 200 μL of sterile saline through intravenous tail-vein injection. The animals (<i>n</i> = 2 per group) were euthanized between 2 and 6 h postinjection, and blood was immediately harvested by cardiac puncture. These time points were selected based on biodistribution assays previously performed in our lab. The tumors along with liver, kidney, spleen, heart, lung, and skeletal muscle were harvested, weighed, and analyzed using gamma counter for accumulation of <sup>125</sup>I radioactivity. Count data were background and decay corrected, and the tissue uptake for each sample was calculated as counts/mass.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> In Vivo Assay</h3><div class="NLM_p last">In vivo studies were performed by using PSA-producing LNCaP human prostate cancer xenografts as previously described.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Nude male mice (<i>n</i> = 10 per group) bearing subcutaneous tumors were treated once daily for three cycles of five days with doses of 10 mg/kg. The compound of interest was reconstituted in sterile saline and given by intravenous injections. Tumors were measured by caliper, and their volume was determined by the formula: Vol(cc) = <i>L</i> × <i>W</i> × <i>H</i> × 0.5326. Body weight and tumor sizes were measured twice per week. Serum levels of free and total PSA were measured 24 h after the last dose of the inhibitor.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Synthesis</h3><div id="sec5_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Peptide Synthesis</h4><div class="NLM_p last">All peptides were individually prepared by solid-phase synthesis using AAPPTec Apex 396 40-well peptide synthesizer. The products were obtained using standard Fmoc protocol, starting with preloaded Fmoc-Nle-OH onto a 2-ClTrt resin. The amino acids (0.1 mmol) were coupled for 1 h using double coupling conditions. HOBt (5 equiv) served as activating reagent; 5 equiv of Fmoc-protected amino acids were used with 0.5 M DIC in NMP. Once completed, the peptide on the resin was washed consecutively with NMP, methanol, and DCM. When necessary the peptides were capped with Cbz (0.4 M) in the presence of DIEA (4 equiv). In other instances, Ahx was added to the N-terminus of the sequence to serve as a handle containing free amino group. The final sequences were washed with DCM and cleaved from the resin with 1% TFA in DCM. On cleavage, the peptides were diluted with ethyl acetate and after removal of the solvent the peptides were purified by semiprep RP-HPLC using a Phenomenex Luna 250 mm × 10 mm, C18 column, followed by lyophilization for 24 h. The purity of all synthesized peptides was determined by HPLC to be >95%. The peptides masses were confirmed by mass spectrometry and were used for further coupling.</div></div><div id="sec5_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Pinanediol Boronic Acid Ester</h4><div class="NLM_p last">The synthesis of (+)-pinanediol protected benzyl boronic acid (boro-Pin)Phe (<b>5</b>) was performed as described<a onclick="showRef(event, 'ref43 ref44 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref43 ref44 ref45 ref46">(43-46)</a> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). The synthesis of (+)-pinanediol protected bromopropylglycine boronic acid, (boro-Pin)Bpg, or (1<i>R</i>)-1-amino-4-bromobutan-1-ylboronic acid (1<i>S</i>,2<i>S</i>,3<i>R</i>,5<i>S</i>)-(+)-2,3-pinanediol ester <b>6</b> has been previously described as well.<a onclick="showRef(event, 'ref16 ref47'); return false;" href="javascript:void(0);" class="ref ref16 ref47">(16, 47)</a> However, both starting materials are now commercially available and can be purchased from BoroChem SAS, France. For preparation of (boro)Phe analogues, the following procedure modifications were performed and the products were obtained as TFA salts.</div></div><div id="sec5_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (+)-Pinanediol Phenylmethyl-1-boronate (<b>2</b>)</h4><div class="NLM_p last">To a solution of 1.0 g (7.36 mmol) of benzyl boronic acid <b>1</b> in 80 mL of diethyl ether were added 1 equiv of (+)-pinanediol (1.25 g) and 3.0 g of MgSO<sub>4</sub>. The solution was stirred for 2–3 days, and the product formation was followed by NMR. The reaction mixture was filtered out, and the organic layer was washed with saturated solution of NaHCO<sub>3</sub> (20 mL × 2) and brine (20 mL × 2). After drying, the organic layer was concentrated under low pressure and kept under high vacuum overnight to yield 85% colorless oil. The product was used for the next step without purification. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.85 (s, 3H), 1.07 (d, <i>J</i> = 11.0 Hz, 1H), 1.28 (s, 3H), 1.39 (s, 3H), 1.9 (m, 2H), 2.05 (m, 1H), 2.2 (m, 1H), 2.28 (m, 1H), 2.35 (s, 2H), 4.29 (dd, <i>J</i> = 8.9, 2.1 Hz, 1H), 7.16–7.34 (m, 5H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 23.95, 26.50, 28.31, 28.68, 36.22, 38.36, 39.48, 51.31, 78.34, 85.89, 110.64, 124.84, 128.47, 129.13, 138.86. MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>23</sub>BO<sub>2</sub> 270.18, found 288.0 [M + H + H<sub>2</sub>O]<sup>+</sup>, 293.1 [M + Na]<sup>+</sup>.</div></div><div id="sec5_6_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> (+)-Pinanediol (<i>S</i>)-1-Chloro-2-phenylethaneboronate (<b>3</b>)</h4><div class="NLM_p last">In a three-neck flask equipped with thermometer, a solution of 10 mL of freshly distilled THF and 1.3 mL of DCM was cooled to −100 °C (in ethanol/liquid nitrogen bath) under argon atmosphere and chilled at −78 °C. <i>n</i>-BuLi (8.6 mmol; 2.5 M in hexane) was added via syringe by running it down the cold wall of the reaction flask over a period of 15 min. White precipitate of LiCHCl<sub>2</sub> was formed, and after 10 min of stirring, cold solution of <b>2</b> (0.38 g, 1.4 mmol) in 2 mL of dry THF was added. After 10 min of stirring at −100 °C, 8 mL of ZnCl<sub>2</sub> solution (0.5 M in THF) were added. The solution was stirred overnight, and the temperature was allowed to rise to room temperature. The reaction mixture was evaporated and redissolved in hexane. The organic phase was washed with satd NH<sub>4</sub>Cl, water, and brine, then dried and concentrated to give about 80% crude product as colorless oil. The product was used for the next step without purification. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.84 (s, 3H), 1.08 (d, <i>J</i> = 11.2 Hz, 1H), 1.28 (s, 3H), 1.36 (s, 3H), 1.90 (m, 2H), 2.08 (m, 1H), 2.19 (m, 1H), 2.35 (m, 1H), 3.11 (dd, <i>J</i> = 13.7, 8.6 Hz, 1H), 3.23 (dd, <i>J</i> = 13.9, 7.9 Hz, 1H), 3.68 (dd, <i>J</i> = 8.5, 7.8 Hz, 1H), 4.46 (dd, <i>J</i> = 11.3, 2.0 Hz, 1H), 7.20–7.35 (m, 5H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 23.95, 26.22, 27.02, 28.33, 29.71, 35.15, 38.24, 39.35, 40.45, 51.22, 78.56, 86.79, 126.72, 126.75, 128.35, 129.20, 129.24, 138.42. MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>24</sub>BClO<sub>2</sub> 318.16, found 283.0 [M – Cl + H]<sup>+</sup>.</div></div><div id="sec5_6_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> (+)-Pinanediol (<i>R</i>)-1-(<i>N</i>-Bis(trimethylsilyl)amino)-2-phenylethane-1-boronate (<b>4</b>)</h4><div class="NLM_p last">An oven-dried flask containing 5 mL of freshly distilled THF was cooled to −78 °C and flushed with argon. After addition of 7.2 mL (1.25 equiv) of lithium bis(trimethylsilyl)amide and LiN(SiMe<sub>3</sub>)<sub>2</sub> (1 M solution in THF), the contents of the flask were stirred for 10 min. Crude boronic ester <b>3</b> (1.8 g, 5.6 mmol) was dissolved in 10 mL of THF and added dropwise. The reaction mixture was stirred overnight and allowed to warm to room temperature. The resulting solution was concentrated under reduced pressure, reconstituted in 25 mL of DCM, and filtered through Celite. The organic layer was dried with MgSO<sub>4</sub> and evaporated to give 2.5 g of crude product as light-brown oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 0.09 (s, 18H), 0.83 (s, 3H), 0.97 (d, <i>J</i> = 10.6 Hz, 1H), 1.27 (s, 3H), 1.38 (s, 3H), 1.82 (m, 2H), 2.01 (m, 1H), 2.12 (m, 1H), 2.30 (m, 1H), 2.67 (m,1H), 2.74 (dd, <i>J</i> = 13.2, 7.2 Hz, 1H), 3.05 (m, 1H), 4.30 (dd, <i>J</i> = 8.6, 2.1 Hz, 1H), 7.20–7.32 (m, 5H). MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>43</sub>BNO<sub>2</sub>Si<sub>2</sub> 444.29, found 444.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_6_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> (+)-Pinanediol (<i>R</i>)-1-Amino-2-phenylethane-1-boronate Trifluoroacetate Salt (<b>5</b>)</h4><div class="NLM_p last">The crude <b>4</b> (1.1 mmol, 0.5 g) was dissolved in 10 mL of ethyl ether and cooled down to 0 °C. To the mixture was added TFA (0.25 mL, 3.3 mmol), and the reaction was allowed to stir for 3 h. The TFA salt crashed out of solution and was filtered. The final product was washed three times with cold ethyl ether, resulting in white powder with 73% yield (0.34 g). <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>): δ 0.89 (s, 3H), 1.11 (d, <i>J</i> = 10.8 Hz, 1H), 1.34 (s, 3H), 1.42 (s, 3H), 1.93 (m, 2H), 2.06 (m, 1H), 2.26 (m, 1H), 2.43 (m, 1H), 3.03 (dd, <i>J</i> = 14.0, 8.1 Hz, 1H), 3.11 (dd, <i>J</i> = 14.2, 6.4 Hz, 1H), 3.25 (dd, <i>J</i> = 8.0, 6.5 Hz, 1H), 4.50 (d, <i>J</i> = 8.2 Hz, 1H), 7.30–7.37 (m, 5H). <sup>13</sup>C NMR (methanol-<i>d</i><sub>4</sub>): δ 24.25, 27.37, 27.49, 28.81, 35.92, 36.46, 39.38, 40.77, 52.40, 80.33, 89.14, 128.58, 130.00, 130.35, 137.88. MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>27</sub>BNO<sub>2</sub><sup>+</sup> 300.21, found 300.1 [M]<sup>+</sup>.</div></div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> General Method for Synthesis of Peptidyl Boronic Acids (<b>12</b>–<b>25</b>)</h3><div class="NLM_p">The desired N-terminus protected peptide Boc-Ahx- or Z- (1 mmol) was dissolved in 50 mL of CH<sub>2</sub>Cl<sub>2</sub>, and the solution was cooled in an ice bath. HOBt (1.5 mmol, 0.229 g) and EDC (1.5 mmol, 0.288 g) were added to the mixture and stirred for 15 min. Boronic acid pinanediol ester (1 equiv) was added, and after 10 min of stirring at 0 °C, <i>N</i>-methylmorpholine (2 mmol, 0.23 mL) was added. The solution was stirred overnight, and the temperature was allowed to warm slowly to room temperature. The reaction mixture was washed with water ×2 and brine ×2. The organic layer was dried with MgSO<sub>4</sub> and evaporated to dryness to yield crude protected peptide in 95–97% yield. The resulting white powder was then stirred with 95% TFA in water to remove all of the peptide side chain protecting groups. After 1 h of stirring at room temperature, the reaction was concentrated in vacuo and resulting residue was resuspended in a 1:1 mixture of ethyl ether/water (40 mL). Phenyl boronic acid (0.305 g, 2.5 mmol) was then added to remove the (+)-pinanediol protecting group. The deprotection was allowed to go overnight at room temperature. The aqueous layer containing the fully deprotected peptidyl boronic acid was washed with ethyl ether (30 mL, 3×) and lyophilized. The product was purified by HPLC, and the resulting white powder was characterized by MS. The purity of the product was determined by HPLC to be >95%.</div><div id="sec5_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (4-Iodo-benzoylamino)-Ahx-FSQn(boro)Bpg (<b>22</b>)</h4><div class="NLM_p last">To a solution of <b>20</b> (0.0047 g, 0.006 mmol) in 0.3 mL of dry methanol was added 1.2 equiv of <i>N</i>-hydroxysuccinimidyl-4-iodobenzoate<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> (0.0025g, 0.007 mmol), followed by 3 equiv of triethylamine (0.0025 mL, 0.018 mmol). The mixture was stirred for 30 min at room temperature and purified on an analytical RP-HPLC column (Phenomenex: Luna C18, particle size 5 μm, 150 mm × 4.60 mm), using a gradient of 30–100% eluent B over 16 min at 1.25 mL/min, then gradient of 0–70% eluent A over 12 min (buffer A, 0.1% TFA in 5% acetonitrile; eluent B, 0.1% TFA in acetonitrile), product eluted at 16 min. The purity of the product was determined by HPLC to be >95%. MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>40</sub>H<sub>58</sub>BBrIN<sub>7</sub>O<sub>10</sub> 1013.26, found 1037.8 [M + Na]<sup>+</sup>.</div></div><div id="sec5_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (4-Iodo-benzoylamino)-Ahx-FSQn(boro-Pin)Bpg (<b>23</b>)</h4><div class="NLM_p last"><b>23</b> was prepared from <b>21</b> using the same procedure as in <b>22</b>. The product eluted at 18 min. The purity of the product was determined by HPLC to be >95%. MS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>50</sub>H<sub>72</sub>BBrIN<sub>7</sub>O<sub>10</sub> 1147.37, found 1147.8 [M + H]<sup>+</sup>, 1171.7 [M + Na]<sup>+</sup>.</div></div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> General Method for Preparation of Radiolabeled Peptidyl Boronic Acids Such As <b>26</b> and <b>27</b></h3><div class="NLM_p last">[<sup>125</sup>I]SIB was prepared according to a procedure suggested by Dekker et al. and purified by radio-HPLC (retention time: iodobenzoic acid, 10.57 min; SIB, 12.54 min; Sn-precursor, 24.40 min). Radiolabeling of the peptidyl boronic acids using [<sup>125</sup>I]SIB was performed as suggested by Chen et al.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> To a solution of 0.005 g (or about 0.007 mmol) of peptidyl boronic acid (<b>20</b>) or peptidyl boronic pinanediol ester (<b>21</b>) in 0.1 mL of DMF was added 0.002 mL of triethylamine, followed by [<sup>125</sup>I]<i>N</i>-hydroxysuccinimidyl-4-iodobenzoate (0.100 mL, 0.5–5 μCi). After stirring at room temperature for 40 min, 0.005 mL of TFA was added, the mixture was subjected to HPLC purification (Phenomenex: Luna C18, 5 μm, 150 mm × 4.60 mm), using gradient of 30–100% eluent B over 16 min at 1.25 mL/min, then gradient of 0–70% eluent A over 12 min (buffer A, 0.1% TFA in 5% acetonitrile; eluent B: 0.1% TFA in acetonitrile). The purity of the product was determined by HPLC to be >95%. The [<sup>125</sup>I]-peptidyl boronic acid containing fraction was neutralized with 1 M NaHCO<sub>3</sub>, concentrated under vacuum, and reconstituted in PBS (pH 7.4). The solution was passed through a 0.22 μm syringe filter into a sterile vial.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm301718c" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41444" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41444" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Samuel R. Denmeade</span> - <span class="hlFld-Affiliation affiliation">†Department of Oncology, ‡Radiology and Radiological Science, §Pharmacology and Molecular
Science, ∥The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University, School of Medicine, Baltimore,
Maryland 21231, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#395d5c57545c4a587953515450175c5d4c"><span class="__cf_email__" data-cfemail="4226272c2f27312302282a2f2b6c272637">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maya B. Kostova</span> - <span class="hlFld-Affiliation affiliation">†Department of Oncology, ‡Radiology and Radiological Science, §Pharmacology and Molecular
Science, ∥The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University, School of Medicine, Baltimore,
Maryland 21231, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">D. Marc Rosen</span> - <span class="hlFld-Affiliation affiliation">†Department of Oncology, ‡Radiology and Radiological Science, §Pharmacology and Molecular
Science, ∥The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University, School of Medicine, Baltimore,
Maryland 21231, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ying Chen</span> - <span class="hlFld-Affiliation affiliation">†Department of Oncology, ‡Radiology and Radiological Science, §Pharmacology and Molecular
Science, ∥The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University, School of Medicine, Baltimore,
Maryland 21231, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ronnie C. Mease</span> - <span class="hlFld-Affiliation affiliation">†Department of Oncology, ‡Radiology and Radiological Science, §Pharmacology and Molecular
Science, ∥The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University, School of Medicine, Baltimore,
Maryland 21231, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br><p class="inlineNote">Abbreviations for common amino acids are in accordance with the recommendations of IUPAC.</p></div></li></ul></div><div class="ack" id="ACK-d46e2126-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03101" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03101" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Financial assistance for this work provided by Department of Defense Prostate Cancer Training Award (W81XWH-10-1-0420) to M.B.K. and NCI Prostate SPORE Award (2P50CA58236) to S.R.D. We are grateful to W. N. Brennen for his help during the course of this work. We thank G. Green and J. Fox for technical assistance.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i36" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i36"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i37" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i37"> Abbreviations Used</h2><tr><td class="NLM_term">Ahx</td><td class="NLM_def"><p class="first last">6-aminohexanoic acid</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>tert</i>-butoxycarbonyl</p></td></tr><tr><td class="NLM_term">DIC</td><td class="NLM_def"><p class="first last">diisopropylcarbodiimide</p></td></tr><tr><td class="NLM_term">DIEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">4-(dimethylamino)pyridine</p></td></tr><tr><td class="NLM_term">EDC</td><td class="NLM_def"><p class="first last"><i>N</i>-ethyl-<i>N</i>′-(3-dimethylaminopropyl)carbodiimide</p></td></tr><tr><td class="NLM_term">Fmoc</td><td class="NLM_def"><p class="first last">fluorenylmethoxycarbonyl</p></td></tr><tr><td class="NLM_term">Z or Cbz</td><td class="NLM_def"><p class="first last">benzyloxycarbonyl protecting group for N-terminus</p></td></tr><tr><td class="NLM_term">HBTU</td><td class="NLM_def"><p class="first last"><i>O</i>-benzotriazole, <i>N</i>′,<i>N</i>′,<i>N</i>′,<i>N</i>′-tetramethyluronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last"><i>N</i>-hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">Mu</td><td class="NLM_def"><p class="first last">morpholinocarbonyl</p></td></tr><tr><td class="NLM_term">NMP</td><td class="NLM_def"><p class="first last"><i>N</i>-methylpyrrolidone</p></td></tr><tr><td class="NLM_term">Bpg</td><td class="NLM_def"><p class="first last">3-bromopropylglycine</p></td></tr><tr><td class="NLM_term">Naph</td><td class="NLM_def"><p class="first last">(2-naphthyl)-β-homoalanine</p></td></tr><tr><td class="NLM_term">aminoboronic acid or (boro)aa</td><td class="NLM_def"><p class="first last">CO<sub>2</sub>H of the equivalent amino acid is replaced by B(OH)<sub>2</sub>, H is used to designate an unprotected amino function</p></td></tr><tr><td class="NLM_term">Pin</td><td class="NLM_def"><p class="first last">pinanediol protecting group</p></td></tr><tr><td class="NLM_term">PSA</td><td class="NLM_def"><p class="first last">prostate-specific antigen</p></td></tr><tr><td class="NLM_term">KLK3</td><td class="NLM_def"><p class="first last">kallikrein-related peptidase 3</p></td></tr><tr><td class="NLM_term">IGFBP</td><td class="NLM_def"><p class="first last">insulin-like growth factor binding protein</p></td></tr><tr><td class="NLM_term">TGF-β2</td><td class="NLM_def"><p class="first last">transforming growth factor-beta 2</p></td></tr><tr><td class="NLM_term">PTHrP</td><td class="NLM_def"><p class="first last">parathyroid hormone-related protein</p></td></tr><tr><td class="NLM_term">A2M</td><td class="NLM_def"><p class="first last">α-2-macroglobulin</p></td></tr><tr><td class="NLM_term">ACT</td><td class="NLM_def"><p class="first last">α-1-antichymotrypsin</p></td></tr><tr><td class="NLM_term">cAMP</td><td class="NLM_def"><p class="first last">cyclic adenosine monophosphate</p></td></tr><tr><td class="NLM_term">IDD</td><td class="NLM_def"><p class="first last">Institute for Diabetes Discovery</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i38">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51805" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51805" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 48 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Watt, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">M’Timkulu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loor, R.</span><span> </span><span class="NLM_article-title">Human prostate-specific antigen: structural and functional similarity with serine proteases</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">3166</span><span class="NLM_x">–</span> <span class="NLM_lpage">3170</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1986&pages=3166-3170&author=K.+W.+Wattauthor=P.+J.+Leeauthor=T.+M%E2%80%99Timkuluauthor=W.+P.+Chanauthor=R.+Loor&title=Human+prostate-specific+antigen%3A+structural+and+functional+similarity+with+serine+proteases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWatt%26aufirst%3DK.%2BW.%26aulast%3DLee%26aufirst%3DP.%2BJ.%26aulast%3DM%25E2%2580%2599Timkulu%26aufirst%3DT.%26aulast%3DChan%26aufirst%3DW.%2BP.%26aulast%3DLoor%26aufirst%3DR.%26atitle%3DHuman%2520prostate-specific%2520antigen%253A%2520structural%2520and%2520functional%2520similarity%2520with%2520serine%2520proteases%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1986%26volume%3D83%26spage%3D3166%26epage%3D3170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Lilja, H.</span><span> </span><span class="NLM_article-title">A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">1899</span><span class="NLM_x">–</span> <span class="NLM_lpage">1903</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=1985&pages=1899-1903&author=H.+Lilja&title=A+kallikrein-like+serine+protease+in+prostatic+fluid+cleaves+the+predominant+seminal+vesicle+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLilja%26aufirst%3DH.%26atitle%3DA%2520kallikrein-like%2520serine%2520protease%2520in%2520prostatic%2520fluid%2520cleaves%2520the%2520predominant%2520seminal%2520vesicle%2520protein%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1985%26volume%3D76%26spage%3D1899%26epage%3D1903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Yousef, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span> </span><span class="NLM_article-title">An overview of the kallikrein gene families in humans and other species: emerging candidate tumor markers</span> <span class="citation_source-journal">Clin. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">443</span><span class="NLM_x">–</span> <span class="NLM_lpage">452</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm301718c&amp;key=10.1016%2FS0009-9120%2803%2900055-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm301718c&amp;key=12951170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm301718c&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvVygtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2003&pages=443-452&author=G.+M.+Yousefauthor=E.+P.+Diamandis&title=An+overview+of+the+kallikrein+gene+families+in+humans+and+other+species%3A+emerging+candidate+tumor+markers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">An overview of the kallikrein gene families in humans and other species: emerging candidate tumour markers</span></div><div class="casAuthors">Yousef, George M.; Diamandis, Eleftherios P.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Biochemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">443-452</span>CODEN:
                <span class="NLM_cas:coden">CLBIAS</span>;
        ISSN:<span class="NLM_cas:issn">0009-9120</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review.  Kallikreins are serine proteases with diverse physiol. functions.  They are represented by multigene families in many animal species, esp. in rat and mouse.  Recently, the human kallikrein gene family has been fully characterized and includes 15 members, tandemly localized on chromosome 19q13.4.  A new definition has now been proposed for kallikreins, which is not based on function but, rather, on close proximity and structural similarities.  In this review, we summarize available information about kallikreins in many animal species with special emphasis on human kallikreins.  We discuss the common structural features of kallikreins at the DNA, mRNA and protein levels and overview their evolutionary history.  Kallikreins are expressed in a wide range of tissues including the salivary gland, endocrine or endocrine-related tissues such as testis, prostate, breast and endometrium and in the central nervous system.  Most, if not all, genes are under steroid hormone regulation.  Accumulating evidence indicates that kallikreins are involved in many pathol. conditions.  Of special interest is the potential role of kallikreins in the central nervous system.  In addn., many kallikreins seem to be candidate tumor markers for many malignancies, esp. those of endocrine-related organs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp18_jEx9bSzrVg90H21EOLACvtfcHk0liUdBDZuTieKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvVygtrw%253D&md5=090376727b5132f7882f5de06a1ab127</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0009-9120%2803%2900055-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0009-9120%252803%252900055-9%26sid%3Dliteratum%253Aachs%26aulast%3DYousef%26aufirst%3DG.%2BM.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DAn%2520overview%2520of%2520the%2520kallikrein%2520gene%2520families%2520in%2520humans%2520and%2520other%2520species%253A%2520emerging%2520candidate%2520tumor%2520markers%26jtitle%3DClin.%2520Biochem.%26date%3D2003%26volume%3D36%26spage%3D443%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Williams, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denmeade, S. R.</span><span> </span><span class="NLM_article-title">Does PSA play a role as a promoting agent during the initiation and/or progression of prostate cancer?</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">312</span><span class="NLM_x">–</span> <span class="NLM_lpage">329</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=312-329&author=S.+A.+Williamsauthor=P.+Singhauthor=J.+T.+Isaacsauthor=S.+R.+Denmeade&title=Does+PSA+play+a+role+as+a+promoting+agent+during+the+initiation+and%2For+progression+of+prostate+cancer%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DS.%2BA.%26aulast%3DSingh%26aufirst%3DP.%26aulast%3DIsaacs%26aufirst%3DJ.%2BT.%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26atitle%3DDoes%2520PSA%2520play%2520a%2520role%2520as%2520a%2520promoting%2520agent%2520during%2520the%2520initiation%2520and%252For%2520progression%2520of%2520prostate%2520cancer%253F%26jtitle%3DProstate%26date%3D2007%26volume%3D67%26spage%3D312%26epage%3D329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Denmeade, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sokoll, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, J. T.</span><span> </span><span class="NLM_article-title">Concentration of enzymatically active prostate-specific antigen (PSA) in the extracellular fluid of primary human prostate cancers and human prostatic cancer xenograft models</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2001&pages=1-6&author=S.+R.+Denmeadeauthor=L.+J.+Sokollauthor=D.+W.+Chanauthor=S.+R.+Khanauthor=J.+T.+Isaacs&title=Concentration+of+enzymatically+active+prostate-specific+antigen+%28PSA%29+in+the+extracellular+fluid+of+primary+human+prostate+cancers+and+human+prostatic+cancer+xenograft+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26aulast%3DSokoll%26aufirst%3DL.%2BJ.%26aulast%3DChan%26aufirst%3DD.%2BW.%26aulast%3DKhan%26aufirst%3DS.%2BR.%26aulast%3DIsaacs%26aufirst%3DJ.%2BT.%26atitle%3DConcentration%2520of%2520enzymatically%2520active%2520prostate-specific%2520antigen%2520%2528PSA%2529%2520in%2520the%2520extracellular%2520fluid%2520of%2520primary%2520human%2520prostate%2520cancers%2520and%2520human%2520prostatic%2520cancer%2520xenograft%2520models%26jtitle%3DProstate%26date%3D2001%26volume%3D48%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Lilja, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlen, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matikainen, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovgren, T.</span><span> </span><span class="NLM_article-title">Prostate-specific antigen in serum occurs predominantly in complex with a1-antichymotrypsin</span> <span class="citation_source-journal">Clin. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1618</span><span class="NLM_x">–</span> <span class="NLM_lpage">1625</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm301718c&amp;key=1716536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm301718c&amp;key=1%3ACAS%3A528%3ADyaK3MXmtVGntL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1991&pages=1618-1625&author=H.+Liljaauthor=A.+Christenssonauthor=U.+Dahlenauthor=M.+T.+Matikainenauthor=O.+Nilssonauthor=K.+Petterssonauthor=T.+Lovgren&title=Prostate-specific+antigen+in+serum+occurs+predominantly+in+complex+with+a1-antichymotrypsin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Prostate-specific antigen in serum occurs predominantly in complex with α1-antichymotrypsin</span></div><div class="casAuthors">Lilja, Hans; Christensson, Anders; Dahlen, Ulrika; Matikainen, Marja Terttu; Nilsson, Olle; Pettersson, Kim; Lovgren, Timo</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Chemistry (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1618-25</span>CODEN:
                <span class="NLM_cas:coden">CLCHAU</span>;
        ISSN:<span class="NLM_cas:issn">0009-9147</span>.
    </div><div class="casAbstract">Immunol. measurements of the serum concn. of prostate-specific antigen (PSA), an abundant prostatic-secreted serine proteinase, are frequently used to monitor patients with prostate cancer, though it has not been ascertained whether this immunoreactivity represents a PSA zymogen, the active proteinase, or PSA complexed to extracellular proteinase inhibitors.  To characterize the PSA immunoreactivity in serum, the present study used monoclonal antibodies produced against PSA and a polyclonal rabbit IgG against α1-antichymotrypsin in the design of three noncompetitive PSA assays: assay T, which detected PSA both when present as the active proteinase and when complexed to α1-antichymotrypsin; assay F, which recognized the active proteinase but most poorly detected PSA complexed to α1-antichymotrypsin; and assay C, which was specific for PSA complexed to α1-antichymotrypsin.  The three assays were used to measure PSA immunoreactivity in 64 patients' sera and in the effluent after gel chromatog. of sera from four patients.  This identified an 80- to 90-kDa complex between PSA and α1-antichymotrypsin as the predominant fraction of the PSA immunoreactivity in blood plasma; an immunoreactive 25- to 40-kDa compd. was the minor fraction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq58I-zBax5c7Vg90H21EOLACvtfcHk0liitGXOoHfNXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXmtVGntL4%253D&md5=998ce91567f588d2c044308ad8ffaa47</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLilja%26aufirst%3DH.%26aulast%3DChristensson%26aufirst%3DA.%26aulast%3DDahlen%26aufirst%3DU.%26aulast%3DMatikainen%26aufirst%3DM.%2BT.%26aulast%3DNilsson%26aufirst%3DO.%26aulast%3DPettersson%26aufirst%3DK.%26aulast%3DLovgren%26aufirst%3DT.%26atitle%3DProstate-specific%2520antigen%2520in%2520serum%2520occurs%2520predominantly%2520in%2520complex%2520with%2520a1-antichymotrypsin%26jtitle%3DClin.%2520Chem.%26date%3D1991%26volume%3D37%26spage%3D1618%26epage%3D1625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Stenman, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leinonen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfthan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rannikko, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuhkanen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfthan, O.</span><span> </span><span class="NLM_article-title">A complex between prostate specific antigen and a1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1991&pages=222-226&author=U.+H.+Stenmanauthor=J.+Leinonenauthor=H.+Alfthanauthor=S.+Rannikkoauthor=K.+Tuhkanenauthor=O.+Alfthan&title=A+complex+between+prostate+specific+antigen+and+a1-antichymotrypsin+is+the+major+form+of+prostate-specific+antigen+in+serum+of+patients+with+prostatic+cancer%3A+assay+of+the+complex+improves+clinical+sensitivity+for+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStenman%26aufirst%3DU.%2BH.%26aulast%3DLeinonen%26aufirst%3DJ.%26aulast%3DAlfthan%26aufirst%3DH.%26aulast%3DRannikko%26aufirst%3DS.%26aulast%3DTuhkanen%26aufirst%3DK.%26aulast%3DAlfthan%26aufirst%3DO.%26atitle%3DA%2520complex%2520between%2520prostate%2520specific%2520antigen%2520and%2520a1-antichymotrypsin%2520is%2520the%2520major%2520form%2520of%2520prostate-specific%2520antigen%2520in%2520serum%2520of%2520patients%2520with%2520prostatic%2520cancer%253A%2520assay%2520of%2520the%2520complex%2520improves%2520clinical%2520sensitivity%2520for%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D1991%26volume%3D51%26spage%3D222%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Denmeade, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakobsen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lilja, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, J. T.</span><span> </span><span class="NLM_article-title">Prostate-specific antigen (PSA) activated thapsigargin prodrug as targeted therapy for prostate cancer</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">990</span><span class="NLM_x">–</span> <span class="NLM_lpage">1000</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm301718c&amp;key=10.1093%2Fjnci%2F95.13.990" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm301718c&amp;key=12837835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm301718c&amp;key=1%3ACAS%3A528%3ADC%252BD3sXltFygtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2003&pages=990-1000&author=S.+R.+Denmeadeauthor=C.+Jakobsenauthor=S.+Janssenauthor=S.+R.+Khanauthor=H.+Liljaauthor=S.+B.+Christensenauthor=J.+T.+Isaacs&title=Prostate-specific+antigen+%28PSA%29+activated+thapsigargin+prodrug+as+targeted+therapy+for+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer</span></div><div class="casAuthors">Denmeade, Samuel R.; Jakobsen, Carsten M.; Janssen, Samuel; Khan, Saeed R.; Garrett, Elizabeth S.; Lilja, Hans; Christensen, S. Brogger; Isaacs, John T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">990-1000</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Std. anti-proliferative chemotherapy is relatively ineffective against slowly proliferating androgen-independent prostate cancer cells within metastatic sites.  In contrast, the lipophilic cytotoxin thapsigargin, which causes apoptosis by disrupting intracellular free Ca2+ levels, is effective against both proliferative and quiescent (i.e., G0-arrested) cells.  However, thapsigargin's mechanism of action indicates that it is unlikely to be selective for cancer cells or prostate cells.  We coupled a chem. modified form of thapsigargin, L12ADT, to a peptide carrier that is a substrate for the prostate-specific antigen (PSA) protease to produce a sol., cell-impermeant latent prodrug that is specifically activated extracellularly within metastatic prostate cancer sites by PSA.  We analyzed the kinetics of PSA hydrolysis of the prodrug, the in vitro cytotoxicity of the prodrug against PSA-producing LNCaP human prostate cancer and PSA non-producing HCT-116 human colon cancer cells, and the in vivo pharmacokinetics of the prodrug in mice.  We also analyzed antitumor efficacy of the prodrug in nude mice xenograft models of prostate cancer (using LNCaP cells) and renal carcinoma (using human SN12C cells).  The L12ADT peptide prodrug was hydrolyzed efficiently by PSA, was selectively toxic to PSA-producing prostate cancer cells in vitro, and was stable in human plasma.  A single dose of 7 mg/kg resulted in a peak serum prodrug concn. of 15.4±1.1 μM and a half-life of approx. 2.8 h.  Over 24 h, less than 0.5% of free L12ADT was obsd. in plasma.  Levels of prodrug and liberated L12ADT in prostate cancer xenograft tumors were approx. eightfold and sixfold, resp., higher than the in vitro LD50s.  Prostate cancer xenograft tumors in mice treated with prodrug by i.v. administration were growth-inhibited without substantial host toxicity.  Continuous s.c. prodrug administration in mice produced complete growth inhibition of established PSA-producing prostate cancer xenograft tumors but had no effect on PSA non-producing renal carcinoma xenograft tumors.  Further development of PSA-activated thapsigargin prodrugs as therapy for metastatic prostate cancer is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF5KzcmdurTrVg90H21EOLACvtfcHk0ljhtIrQJGyQ5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXltFygtb4%253D&md5=1d4d04fa16cf7ce8989727164379d5cc</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F95.13.990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F95.13.990%26sid%3Dliteratum%253Aachs%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26aulast%3DJakobsen%26aufirst%3DC.%26aulast%3DJanssen%26aufirst%3DS.%26aulast%3DKhan%26aufirst%3DS.%2BR.%26aulast%3DLilja%26aufirst%3DH.%26aulast%3DChristensen%26aufirst%3DS.%2BB.%26aulast%3DIsaacs%26aufirst%3DJ.%2BT.%26atitle%3DProstate-specific%2520antigen%2520%2528PSA%2529%2520activated%2520thapsigargin%2520prodrug%2520as%2520targeted%2520therapy%2520for%2520prostate%2520cancer%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2003%26volume%3D95%26spage%3D990%26epage%3D1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Williams, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merchant, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett-Mayer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckley, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denmeade, S. R.</span><span> </span><span class="NLM_article-title">A prostate-specific antigen-activated channel-forming toxin as therapy for prostatic disease</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">376</span><span class="NLM_x">–</span> <span class="NLM_lpage">385</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm301718c&amp;key=10.1093%2Fjnci%2Fdjk065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm301718c&amp;key=17341729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm301718c&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvVOksLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2007&pages=376-385&author=S.+A.+Williamsauthor=R.+F.+Merchantauthor=E.+Garrett-Mayerauthor=J.+T.+Isaacsauthor=J.+T.+Buckleyauthor=S.+R.+Denmeade&title=A+prostate-specific+antigen-activated+channel-forming+toxin+as+therapy+for+prostatic+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A prostate-specific antigen-activated channel-forming toxin as therapy for prostatic disease</span></div><div class="casAuthors">Williams, Simon A.; Merchant, Rosemina F.; Garrett-Mayer, Elizabeth; Isaacs, John T.; Buckley, J. Thomas; Denmeade, Samuel R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">376-385</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Most men will develop prostatic abnormalities, such as benign prostatic hyperplasia (BPH) or prostate cancer, as they age.  Prostate-specific antigen (PSA) is a serine protease that is secreted at high levels by the normal and diseased prostate.  Therapies that are activated by PSA may prove effective in treating prostatic malignancies.  We modified proaerolysin (PA), the inactive precursor of a bacterial cytolytic pore-forming protein, to produce a PSA-activated protoxin (PRX302).  The viability of the prostate adenocarcinoma cell lines LNCaP, PC-3, CWR22H, and DU145 and the bladder cancer cell line TSU after treatment with PA or PRX302 in the presence or absence of purified PSA was assayed.  Mice carrying xenograft tumors derived from LNCaP, CWR22H, or TSU cells were treated with intratumoral injection of PA or PRX302, and tumor size was monitored.  To test the safety of PRX302, we administered it into the PSA-secreting prostate glands of cynomolgus monkeys.  All statistical tests were two-sided.  Native PA was highly toxic in vitro but had no tumor-specific effects in vitro or in vivo.  Picomolar concns. of PRX302 led to PSA-dependent decreases in cell viability in vitro (PRX302 vs. PRX302 + PSA: DU145 cells, mean viability = 78.7% vs. mean = 1.6%, difference = 77.1%, 95% confidence interval [CI] = 70.6% to 86.1%; P<.001; TSU cells, mean = 100.2% vs. mean = 1.4%, difference = 98.8%, 95% CI = 96.4% to 104.0%; P < .001).  Single intratumoral injections of PRX302 produced substantial and often complete regression of PSA-secreting human prostate cancer xenografts (5 μg dose, complete regression in 6 of 26 mice bearing LNCaP or CWR22H xenografts [23%]; 10 μg dose, complete regression in 10 of 26 mice [38.5%]) but not PSA-null bladder cancer xenografts.  The prostates of cynomolgus monkeys injected with a single dose of PRX302 displayed extensive but organ-confined damage, with no toxicity to neighboring organs or general morbidity.  Our observations demonstrate the potential safe and effective intraprostatic application of this engineered protoxin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGXBHWqz3hS7Vg90H21EOLACvtfcHk0ljhtIrQJGyQ5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvVOksLc%253D&md5=71e66b054765e4db7ebd96bcb08d4a24</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjk065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjk065%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DS.%2BA.%26aulast%3DMerchant%26aufirst%3DR.%2BF.%26aulast%3DGarrett-Mayer%26aufirst%3DE.%26aulast%3DIsaacs%26aufirst%3DJ.%2BT.%26aulast%3DBuckley%26aufirst%3DJ.%2BT.%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26atitle%3DA%2520prostate-specific%2520antigen-activated%2520channel-forming%2520toxin%2520as%2520therapy%2520for%2520prostatic%2520disease%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2007%26volume%3D99%26spage%3D376%26epage%3D385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Ulmert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wongvipat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahamsson, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scardino, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lilja, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyers, C. L.</span><span> </span><span class="NLM_article-title">Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen</span> <span class="citation_source-journal">Cancer Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">320</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=320-327&author=D.+Ulmertauthor=M.+J.+Evansauthor=J.+P.+Hollandauthor=S.+L.+Riceauthor=J.+Wongvipatauthor=K.+Petterssonauthor=P.+A.+Abrahamssonauthor=P.+T.+Scardinoauthor=S.+M.+Larsonauthor=H.+Liljaauthor=J.+S.+Lewisauthor=C.+L.+Sawyers&title=Imaging+androgen+receptor+signaling+with+a+radiotracer+targeting+free+prostate-specific+antigen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUlmert%26aufirst%3DD.%26aulast%3DEvans%26aufirst%3DM.%2BJ.%26aulast%3DHolland%26aufirst%3DJ.%2BP.%26aulast%3DRice%26aufirst%3DS.%2BL.%26aulast%3DWongvipat%26aufirst%3DJ.%26aulast%3DPettersson%26aufirst%3DK.%26aulast%3DAbrahamsson%26aufirst%3DP.%2BA.%26aulast%3DScardino%26aufirst%3DP.%2BT.%26aulast%3DLarson%26aufirst%3DS.%2BM.%26aulast%3DLilja%26aufirst%3DH.%26aulast%3DLewis%26aufirst%3DJ.%2BS.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26atitle%3DImaging%2520androgen%2520receptor%2520signaling%2520with%2520a%2520radiotracer%2520targeting%2520free%2520prostate-specific%2520antigen%26jtitle%3DCancer%2520Discovery%26date%3D2012%26volume%3D2%26spage%3D320%26epage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">LeBeau, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denmeade, S. R.</span><span> </span><span class="NLM_article-title">Prostate-specific antigen is a ‘chymotrypsin-like’ serine protease with unique P1 substrate specificity</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3490</span><span class="NLM_x">–</span> <span class="NLM_lpage">3496</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi9001858" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=3490-3496&author=A.+M.+LeBeauauthor=P.+Singhauthor=J.+T.+Isaacsauthor=S.+R.+Denmeade&title=Prostate-specific+antigen+is+a+%E2%80%98chymotrypsin-like%E2%80%99+serine+protease+with+unique+P1+substrate+specificity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fbi9001858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi9001858%26sid%3Dliteratum%253Aachs%26aulast%3DLeBeau%26aufirst%3DA.%2BM.%26aulast%3DSingh%26aufirst%3DP.%26aulast%3DIsaacs%26aufirst%3DJ.%2BT.%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26atitle%3DProstate-specific%2520antigen%2520is%2520a%2520%25E2%2580%2598chymotrypsin-like%25E2%2580%2599%2520serine%2520protease%2520with%2520unique%2520P1%2520substrate%2520specificity%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D3490%26epage%3D3496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Denmeade, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malm, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovgren, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lilja, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, J. T.</span><span> </span><span class="NLM_article-title">Specific and efficient peptide substrates for assaying the proteolytic activity of prostate specific antigen</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">4924</span><span class="NLM_x">–</span> <span class="NLM_lpage">4930</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1997&pages=4924-4930&author=S.+R.+Denmeadeauthor=W.+Louauthor=J.+Malmauthor=J.+Lovgrenauthor=H.+Liljaauthor=J.+T.+Isaacs&title=Specific+and+efficient+peptide+substrates+for+assaying+the+proteolytic+activity+of+prostate+specific+antigen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26aulast%3DLou%26aufirst%3DW.%26aulast%3DMalm%26aufirst%3DJ.%26aulast%3DLovgren%26aufirst%3DJ.%26aulast%3DLilja%26aufirst%3DH.%26aulast%3DIsaacs%26aufirst%3DJ.%2BT.%26atitle%3DSpecific%2520and%2520efficient%2520peptide%2520substrates%2520for%2520assaying%2520the%2520proteolytic%2520activity%2520of%2520prostate%2520specific%2520antigen%26jtitle%3DCancer%2520Res.%26date%3D1997%26volume%3D57%26spage%3D4924%26epage%3D4930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Singh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeBeau, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lilja, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denmeade, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, J. I.</span><span> </span><span class="NLM_article-title">Molecular insights into substrate specificity of prostate specific antigen through structural modeling</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">984</span><span class="NLM_x">–</span> <span class="NLM_lpage">993</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2009&pages=984-993&author=P.+Singhauthor=A.+M.+LeBeauauthor=H.+Liljaauthor=S.+R.+Denmeadeauthor=J.+I.+Isaacs&title=Molecular+insights+into+substrate+specificity+of+prostate+specific+antigen+through+structural+modeling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DP.%26aulast%3DLeBeau%26aufirst%3DA.%2BM.%26aulast%3DLilja%26aufirst%3DH.%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26aulast%3DIsaacs%26aufirst%3DJ.%2BI.%26atitle%3DMolecular%2520insights%2520into%2520substrate%2520specificity%2520of%2520prostate%2520specific%2520antigen%2520through%2520structural%2520modeling%26jtitle%3DProteins%26date%3D2009%26volume%3D77%26spage%3D984%26epage%3D993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">LeBeau, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denmeade, S. R.</span><span> </span><span class="NLM_article-title">Potent and selective peptidyl boronic acid inhibitors of the serine protease prostate-specific antigen</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">665</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm301718c&amp;key=10.1016%2Fj.chembiol.2008.05.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm301718c&amp;key=18635003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm301718c&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslGmtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=665-674&author=A.+M.+LeBeauauthor=P.+Singhauthor=J.+T.+Isaacsauthor=S.+R.+Denmeade&title=Potent+and+selective+peptidyl+boronic+acid+inhibitors+of+the+serine+protease+prostate-specific+antigen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and selective peptidyl boronic acid inhibitors of the serine protease prostate-specific antigen</span></div><div class="casAuthors">LeBeau, Aaron M.; Singh, Pratap; Isaacs, John T.; Denmeade, Samuel R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">665-674</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Prostate cancer cells produce high (microgram to milligram/mL) levels of the serine protease Prostate-Specific Antigen (PSA).  PSA is enzymically active in the extracellular fluid surrounding prostate cancers but is found at 1,000- to 10,000-fold lower concns. in the circulation, where it is inactivated due to binding to abundant serum protease inhibitors.  The exclusive presence of high levels of active PSA within prostate cancer sites makes PSA an attractive candidate for targeted imaging and therapeutics.  A synthetic approach based on a peptide substrate identified first peptide aldehyde and then boronic acid inhibitors of PSA.  The best of these had the sequence Cbz-Ser-Ser-Lys-Leu-(boro)Leu, with a Ki for PSA of 65 nM.  The inhibitor had a 60-fold higher Ki for chymotrypsin.  A validated model of PSA's catalytic site confirmed the crit. interactions between the inhibitor and residues within the PSA enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1EWg1W1qwXbVg90H21EOLACvtfcHk0lgfoXlD0x4BqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslGmtL0%253D&md5=ff449d09c36c2f8c6402d571c4baeec7</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2008.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2008.05.020%26sid%3Dliteratum%253Aachs%26aulast%3DLeBeau%26aufirst%3DA.%2BM.%26aulast%3DSingh%26aufirst%3DP.%26aulast%3DIsaacs%26aufirst%3DJ.%2BT.%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26atitle%3DPotent%2520and%2520selective%2520peptidyl%2520boronic%2520acid%2520inhibitors%2520of%2520the%2520serine%2520protease%2520prostate-specific%2520antigen%26jtitle%3DChem.%2520Biol.%26date%3D2008%26volume%3D15%26spage%3D665%26epage%3D674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Matteson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michnick, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, C. D.</span><span> </span><span class="NLM_article-title">[(1<i>R</i>)-1-Acetamido-3-(methylthuio)propyl]boronic acid and the X-ray structure of its ethylene glycol ester</span> <span class="citation_source-journal">Organometallics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">726</span><span class="NLM_x">–</span> <span class="NLM_lpage">729</span></span><div class="citationLinks">[<a href="/doi/10.1021/om00105a022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1989&pages=726-729&author=D.+S.+Mattesonauthor=T.+J.+Michnickauthor=R.+D.+Willettauthor=C.+D.+Patterson&title=%5B%281R%29-1-Acetamido-3-%28methylthuio%29propyl%5Dboronic+acid+and+the+X-ray+structure+of+its+ethylene+glycol+ester"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fom00105a022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fom00105a022%26sid%3Dliteratum%253Aachs%26aulast%3DMatteson%26aufirst%3DD.%2BS.%26aulast%3DMichnick%26aufirst%3DT.%2BJ.%26aulast%3DWillett%26aufirst%3DR.%2BD.%26aulast%3DPatterson%26aufirst%3DC.%2BD.%26atitle%3D%255B%25281R%2529-1-Acetamido-3-%2528methylthuio%2529propyl%255Dboronic%2520acid%2520and%2520the%2520X-ray%2520structure%2520of%2520its%2520ethylene%2520glycol%2520ester%26jtitle%3DOrganometallics%26date%3D1989%26volume%3D8%26spage%3D726%26epage%3D729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Debaene, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Silva, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pianowski, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duran, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winssinger, N.</span><span> </span><span class="NLM_article-title">Expanding the scope of PNA-encoded libraries: divergent synthesis of libraries targeting cysteine, serine and metalloproteases as well as tyrosine phosphatases</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">6577</span><span class="NLM_x">–</span> <span class="NLM_lpage">6586</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm301718c&amp;key=10.1016%2Fj.tet.2007.03.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm301718c&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtVanu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2007&pages=6577-6586&author=F.+Debaeneauthor=J.+A.+Da+Silvaauthor=Z.+Pianowskiauthor=F.+J.+Duranauthor=N.+Winssinger&title=Expanding+the+scope+of+PNA-encoded+libraries%3A+divergent+synthesis+of+libraries+targeting+cysteine%2C+serine+and+metalloproteases+as+well+as+tyrosine+phosphatases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Expanding the scope of PNA-encoded libraries: divergent synthesis of libraries targeting cysteine, serine and metallo-proteases as well as tyrosine phosphatases</span></div><div class="casAuthors">Debaene, Francois; Da Silva, Julien A.; Pianowski, Zbigniew; Duran, Fernando J.; Winssinger, Nicolas</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">6577-6586</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Seven PNA-encoded combinatorial libraries targeting proteases and phosphatases with covalent reversible and irreversible mechanism-based inhibitors were prepd.  The libraries were synthesized using modified PNA monomers, which dramatically increase the water soly. of the libraries in biol. relevant buffers.  The libraries were shown to selectively inhibit targeted enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpALOuekrkDuLVg90H21EOLACvtfcHk0lgfoXlD0x4BqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtVanu7s%253D&md5=9ca7ac041164c9c3095a09d545fa1799</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2007.03.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2007.03.033%26sid%3Dliteratum%253Aachs%26aulast%3DDebaene%26aufirst%3DF.%26aulast%3DDa%2BSilva%26aufirst%3DJ.%2BA.%26aulast%3DPianowski%26aufirst%3DZ.%26aulast%3DDuran%26aufirst%3DF.%2BJ.%26aulast%3DWinssinger%26aufirst%3DN.%26atitle%3DExpanding%2520the%2520scope%2520of%2520PNA-encoded%2520libraries%253A%2520divergent%2520synthesis%2520of%2520libraries%2520targeting%2520cysteine%252C%2520serine%2520and%2520metalloproteases%2520as%2520well%2520as%2520tyrosine%2520phosphatases%26jtitle%3DTetrahedron%26date%3D2007%26volume%3D63%26spage%3D6577%26epage%3D6586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Elgendy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodwin, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scully, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skordalakes, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakkar, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deadman, J. J.</span><span> </span><span class="NLM_article-title">Design of a novel class of bifunctional thrombin inhibitors, synthesised by the first application of peptide boronates of solid phase chemistry</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">3305</span><span class="NLM_x">–</span> <span class="NLM_lpage">3308</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1997&pages=3305-3308&author=S.+Elgendyauthor=+Patel.author=D.+Greenauthor=C.+A.+Goodwinauthor=M.+F.+Scullyauthor=W.+Husmanauthor=E.+Skordalakesauthor=V.+V.+Kakkarauthor=J.+J.+Deadman&title=Design+of+a+novel+class+of+bifunctional+thrombin+inhibitors%2C+synthesised+by+the+first+application+of+peptide+boronates+of+solid+phase+chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DElgendy%26aufirst%3DS.%26aulast%3DPatel.%26aulast%3DGreen%26aufirst%3DD.%26aulast%3DGoodwin%26aufirst%3DC.%2BA.%26aulast%3DScully%26aufirst%3DM.%2BF.%26aulast%3DHusman%26aufirst%3DW.%26aulast%3DSkordalakes%26aufirst%3DE.%26aulast%3DKakkar%26aufirst%3DV.%2BV.%26aulast%3DDeadman%26aufirst%3DJ.%2BJ.%26atitle%3DDesign%2520of%2520a%2520novel%2520class%2520of%2520bifunctional%2520thrombin%2520inhibitors%252C%2520synthesised%2520by%2520the%2520first%2520application%2520of%2520peptide%2520boronates%2520of%2520solid%2520phase%2520chemistry%26jtitle%3DTetrahedron%2520Lett.%26date%3D1997%26volume%3D38%26spage%3D3305%26epage%3D3308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Q.</span><span> </span><span class="NLM_article-title">Design, synthesis, biological evaluation, and structure–activity relationship (SAR) discussion of dipeptidyl boronate proteasome inhibitors, part I: comprehensive understanding of the SAR of alpha-amino acid boronates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4192</span><span class="NLM_x">–</span> <span class="NLM_lpage">4199</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9005093" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4192-4199&author=Y.+Zhuauthor=X.+Zhaoauthor=X.+Zhuauthor=G.+Wuauthor=Y.+Liauthor=Y.+Maauthor=Y.+Yuanauthor=J.+Yangauthor=Y.+Huauthor=L.+Aiauthor=Q.+Gao&title=Design%2C+synthesis%2C+biological+evaluation%2C+and+structure%E2%80%93activity+relationship+%28SAR%29+discussion+of+dipeptidyl+boronate+proteasome+inhibitors%2C+part+I%3A+comprehensive+understanding+of+the+SAR+of+alpha-amino+acid+boronates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm9005093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9005093%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DYuan%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DAi%26aufirst%3DL.%26aulast%3DGao%26aufirst%3DQ.%26atitle%3DDesign%252C%2520synthesis%252C%2520biological%2520evaluation%252C%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520%2528SAR%2529%2520discussion%2520of%2520dipeptidyl%2520boronate%2520proteasome%2520inhibitors%252C%2520part%2520I%253A%2520comprehensive%2520understanding%2520of%2520the%2520SAR%2520of%2520alpha-amino%2520acid%2520boronates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4192%26epage%3D4199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, R.</span><span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of tripeptide boronic acid proteasome inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6851</span><span class="NLM_x">–</span> <span class="NLM_lpage">6861</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=6851-6861&author=Y.+Zhuauthor=S.+Yaoauthor=B.+Xuauthor=Z.+Geauthor=J.+Cuiauthor=T.+Chengauthor=R.+Li&title=Design%2C+synthesis+and+biological+evaluation+of+tripeptide+boronic+acid+proteasome+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DYao%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DGe%26aufirst%3DZ.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DR.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520tripeptide%2520boronic%2520acid%2520proteasome%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D6851%26epage%3D6861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Watanabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Momose, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akamatsu, Y.</span><span> </span><span class="NLM_article-title">Structure–activity relationship of boronic acid derivatives of tyropeptin: proteasome inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">5839</span><span class="NLM_x">–</span> <span class="NLM_lpage">5842</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=5839-5842&author=T.+Watanabeauthor=H.+Abeauthor=I.+Momoseauthor=Y.+Takahashiauthor=D.+Ikedaauthor=Y.+Akamatsu&title=Structure%E2%80%93activity+relationship+of+boronic+acid+derivatives+of+tyropeptin%3A+proteasome+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DAbe%26aufirst%3DH.%26aulast%3DMomose%26aufirst%3DI.%26aulast%3DTakahashi%26aufirst%3DY.%26aulast%3DIkeda%26aufirst%3DD.%26aulast%3DAkamatsu%26aufirst%3DY.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520of%2520boronic%2520acid%2520derivatives%2520of%2520tyropeptin%253A%2520proteasome%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D5839%26epage%3D5842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Watanabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Momose, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umezawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akamatsu, Y.</span><span> </span><span class="NLM_article-title">Synthesis of boronic acid derivatives of tyropeptin: proteasome inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2343</span><span class="NLM_x">–</span> <span class="NLM_lpage">2345</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2343-2345&author=T.+Watanabeauthor=I.+Momoseauthor=M.+Abeauthor=H.+Abeauthor=R.+Sawaauthor=Y.+Umezawaauthor=D.+Ikedaauthor=Y.+Takahashiauthor=Y.+Akamatsu&title=Synthesis+of+boronic+acid+derivatives+of+tyropeptin%3A+proteasome+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DMomose%26aufirst%3DI.%26aulast%3DAbe%26aufirst%3DM.%26aulast%3DAbe%26aufirst%3DH.%26aulast%3DSawa%26aufirst%3DR.%26aulast%3DUmezawa%26aufirst%3DY.%26aulast%3DIkeda%26aufirst%3DD.%26aulast%3DTakahashi%26aufirst%3DY.%26aulast%3DAkamatsu%26aufirst%3DY.%26atitle%3DSynthesis%2520of%2520boronic%2520acid%2520derivatives%2520of%2520tyropeptin%253A%2520proteasome%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2343%26epage%3D2345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Auffinger, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hays, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westhof, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, P. S.</span><span> </span><span class="NLM_article-title">Halogen bonds in biological molecules</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">16789</span><span class="NLM_x">–</span> <span class="NLM_lpage">16794</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm301718c&amp;key=10.1073%2Fpnas.0407607101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm301718c&amp;key=15557000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm301718c&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFansr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=16789-16794&author=P.+Auffingerauthor=F.+A.+Haysauthor=E.+Westhofauthor=P.+S.+Ho&title=Halogen+bonds+in+biological+molecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Halogen bonds in biological molecules</span></div><div class="casAuthors">Auffinger, Pascal; Hays, Franklin A.; Westhof, Eric; Ho, P. Shing</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">16789-16794</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Short oxygen-halogen interactions have been known in org. chem. since the 1950s and recently have been exploited in the design of supramol. assemblies.  The present survey of protein and nucleic acid structures reveals similar halogen bonds as potentially stabilizing inter- and intramol. interactions that can affect ligand binding and mol. folding.  A halogen bond in biomols. can be defined as a short C-X···O-Y interaction (C-X is a carbon-bonded chlorine, bromine, or iodine, and O-Y is a carbonyl, hydroxyl, charged carboxylate, or phosphate group), where the X···O distance is less than or equal to the sums of the resp. van der Waals radii (3.27 Å for Cl···O, 3.37 Å for Br···O, and 3.50 Å for I···O) and can conform to the geometry seen in small mols., with the C-X···O angle ≈165° (consistent with a strong directional polarization of the halogen) and the X···O-Y angle ≈120°.  Alternative geometries can be imposed by the more complex environment found in biomols., depending on which of the two types of donor systems are involved in the interaction: (i) the lone pair electrons of oxygen (and, to a lesser extent, nitrogen and sulfur) atoms or (ii) the delocalized π-electrons of peptide bonds or carboxylate or amide groups.  Thus, the specific geometry and diversity of the interacting partners of halogen bonds offer new and versatile tools for the design of ligands as drugs and materials in nanotechnol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPMdZU91iT77Vg90H21EOLACvtfcHk0lgFtWefIwUOYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFansr3P&md5=dfcce25d4e336c66294f6ab8ce412154</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0407607101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0407607101%26sid%3Dliteratum%253Aachs%26aulast%3DAuffinger%26aufirst%3DP.%26aulast%3DHays%26aufirst%3DF.%2BA.%26aulast%3DWesthof%26aufirst%3DE.%26aulast%3DHo%26aufirst%3DP.%2BS.%26atitle%3DHalogen%2520bonds%2520in%2520biological%2520molecules%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2004%26volume%3D101%26spage%3D16789%26epage%3D16794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Howard, E. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanishvili, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cachau, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitschler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chevrier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamour, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Zandt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moras, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joachimiak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podjarny, A. D.</span><span> </span><span class="NLM_article-title">Ultrahigh resolution drug design I: Details of interactions in human aldose reductase–inhibitor complex at 0.66 Å</span> <span class="citation_source-journal">Proteins: Struct., Funct., Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">792</span><span class="NLM_x">–</span> <span class="NLM_lpage">804</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=792-804&author=E.+I.+Howardauthor=R.+Sanishviliauthor=R.+E.+Cachauauthor=A.+Mitschlerauthor=B.+Chevrierauthor=P.+Barthauthor=V.+Lamourauthor=M.+Van+Zandtauthor=E.+Sibleyauthor=C.+Bonauthor=T.+R.+Morasauthor=A.+Joachimiakauthor=A.+D.+Podjarny&title=Ultrahigh+resolution+drug+design+I%3A+Details+of+interactions+in+human+aldose+reductase%E2%80%93inhibitor+complex+at+0.66+%C3%85"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoward%26aufirst%3DE.%2BI.%26aulast%3DSanishvili%26aufirst%3DR.%26aulast%3DCachau%26aufirst%3DR.%2BE.%26aulast%3DMitschler%26aufirst%3DA.%26aulast%3DChevrier%26aufirst%3DB.%26aulast%3DBarth%26aufirst%3DP.%26aulast%3DLamour%26aufirst%3DV.%26aulast%3DVan%2BZandt%26aufirst%3DM.%26aulast%3DSibley%26aufirst%3DE.%26aulast%3DBon%26aufirst%3DC.%26aulast%3DMoras%26aufirst%3DT.%2BR.%26aulast%3DJoachimiak%26aufirst%3DA.%26aulast%3DPodjarny%26aufirst%3DA.%2BD.%26atitle%3DUltrahigh%2520resolution%2520drug%2520design%2520I%253A%2520Details%2520of%2520interactions%2520in%2520human%2520aldose%2520reductase%25E2%2580%2593inhibitor%2520complex%2520at%25200.66%2520%25C3%2585%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2004%26volume%3D55%26spage%3D792%26epage%3D804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Dekker, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Disley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hastings, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reader, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julyan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweit, J.</span><span> </span><span class="NLM_article-title">Functional comparison of annexin V analogues labeled indirectly and directly with iodine-124</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">413</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm301718c&amp;key=10.1016%2Fj.nucmedbio.2005.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm301718c&amp;key=15878510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm301718c&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVKksro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2005&pages=403-413&author=B.+Dekkerauthor=H.+Keenauthor=D.+Shawauthor=L.+Disleyauthor=D.+Hastingsauthor=J.+Hadfieldauthor=A.+Readerauthor=D.+Allanauthor=P.+Julyanauthor=A.+Watsonauthor=J.+Zweit&title=Functional+comparison+of+annexin+V+analogues+labeled+indirectly+and+directly+with+iodine-124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Functional comparison of annexin V analogues labeled indirectly and directly with iodine-124</span></div><div class="casAuthors">Dekker, Bronwen; Keen, Heather; Shaw, David; Disley, Lynn; Hastings, David; Hadfield, John; Reader, Andrew; Allan, Donald; Julyan, Peter; Watson, Alastair; Zweit, Jamal</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">403-413</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">We are interested in imaging cell death in vivo using annexin V radiolabeled with 124I.  In this study, [124I]4IB-annexin V and [124I]4IB-ovalbumin were made using [124I]N-hydroxysuccinimidyl-4-iodobenzoate prepd. by iododestannylation of N-hydroxysuccinimidyl-4-(tributylstannyl)benzoate.  [124I]4IB-annexin V binds to phosphatidylserine-coated microtiter plates and apoptotic Jurkat cells and accumulates in hepatic apoptotic lesions in mice treated with anti-Fas antibody, while [124I]4IB-ovalbumin does not.  In comparison with 124I-annexin V, [124I]4IB-annexin V has a higher rate of binding to phosphatidylserine in vitro, a higher kidney and urine uptake, a lower thyroid and stomach content uptake, greater plasma stability and a lower rate of plasma clearance.  Binding of radioactivity to apoptotic cells relative to normal cells in vitro and in vivo appears to be lower for [124I]4IB-annexin V than for 124I-annexin V.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbmIDr1P0gOLVg90H21EOLACvtfcHk0ljg53yda9dliA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVKksro%253D&md5=d7dc3e89b659f69d321a0ce7bb678e3a</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2005.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2005.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DDekker%26aufirst%3DB.%26aulast%3DKeen%26aufirst%3DH.%26aulast%3DShaw%26aufirst%3DD.%26aulast%3DDisley%26aufirst%3DL.%26aulast%3DHastings%26aufirst%3DD.%26aulast%3DHadfield%26aufirst%3DJ.%26aulast%3DReader%26aufirst%3DA.%26aulast%3DAllan%26aufirst%3DD.%26aulast%3DJulyan%26aufirst%3DP.%26aulast%3DWatson%26aufirst%3DA.%26aulast%3DZweit%26aufirst%3DJ.%26atitle%3DFunctional%2520comparison%2520of%2520annexin%2520V%2520analogues%2520labeled%2520indirectly%2520and%2520directly%2520with%2520iodine-124%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2005%26volume%3D32%26spage%3D403%26epage%3D413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Nanus, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milowsky, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostakoglu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith-Jones, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallabahajosula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bander, N. H.</span><span> </span><span class="NLM_article-title">Clinical use of monoclonal antibody HuJ591 therapy: targeting prostate specific membrane antigen</span> <span class="citation_source-journal">J. Urol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x">, </span> <span class="NLM_fpage">S84</span><span class="NLM_x">–</span> <span class="NLM_lpage">S88</span><div class="note"><p class="first last">discussion S88–S89.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2003&pages=S84-S88&author=D.+M.+Nanusauthor=M.+I.+Milowskyauthor=L.+Kostakogluauthor=P.+M.+Smith-Jonesauthor=S.+Vallabahajosulaauthor=S.+J.+Goldsmithauthor=N.+H.+Bander&title=Clinical+use+of+monoclonal+antibody+HuJ591+therapy%3A+targeting+prostate+specific+membrane+antigen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNanus%26aufirst%3DD.%2BM.%26aulast%3DMilowsky%26aufirst%3DM.%2BI.%26aulast%3DKostakoglu%26aufirst%3DL.%26aulast%3DSmith-Jones%26aufirst%3DP.%2BM.%26aulast%3DVallabahajosula%26aufirst%3DS.%26aulast%3DGoldsmith%26aufirst%3DS.%2BJ.%26aulast%3DBander%26aufirst%3DN.%2BH.%26atitle%3DClinical%2520use%2520of%2520monoclonal%2520antibody%2520HuJ591%2520therapy%253A%2520targeting%2520prostate%2520specific%2520membrane%2520antigen%26jtitle%3DJ.%2520Urol.%26date%3D2003%26volume%3D170%26spage%3DS84%26epage%3DS88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Smith-Jones, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallabahajosula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastidas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bander, N. H.</span><span> </span><span class="NLM_article-title">Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">610</span><span class="NLM_x">–</span> <span class="NLM_lpage">617</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm301718c&amp;key=12679407" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm301718c&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtlKnsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=610-617&author=P.+M.+Smith-Jonesauthor=S.+Vallabahajosulaauthor=V.+Navarroauthor=D.+Bastidasauthor=S.+J.+Goldsmithauthor=N.+H.+Bander&title=Radiolabeled+monoclonal+antibodies+specific+to+the+extracellular+domain+of+prostate-specific+membrane+antigen%3A+preclinical+studies+in+nude+mice+bearing+LNCaP+human+prostate+tumor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor</span></div><div class="casAuthors">Smith-Jones, Peter M.; Vallabhajosula, Shankar; Navarro, Vincent; Bastidas, Diego; Goldsmith, Stanley J.; Bander, Neil H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">610-617</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine</span>)
        </div><div class="casAbstract">Prostate-specific membrane antigen (PSMA), a transmembrane glycoprotein, is highly expressed by virtually all prostate cancers.  PSMA is also expressed on the tumor vascular endothelium of virtually all solid carcinomas and sarcomas but not on normal vascular endothelium.  PSMA is currently the focus of several diagnostic and therapeutic strategies.  We have previously reported on the radiolabeling and in vitro binding properties of monoclonal antibodies (mAbs) (J415, J533, and J591) that recognize and bind with high affinity to the extracellular domain of PSMA (PSMAext).  This article reports on the in vivo behavior and tumor uptake of 131I- and 111In-labeled anti-PSMAext mAbs (J415, J533, and J591) and their potential utility for radioimmunotherapy.  Methods: In nude mice bearing PSMA-pos. human LNCaP tumors, the pharmacokinetics, biodistribution, and tumor uptake of these antibodies was compared with 111In-7E11 mAb, specific to the intracellular domain of PSMA (PSMAint).  Autoradiog. studies were done to identify intratumoral distribution of radiolabeled mAbs.  Results: With 131I-labeled antibodies, the net tumor retention of radioactivity by day 6 was significantly higher with J415 (15.4% ± 1.1 %) and 7E11 (14.5% ± 1.7%) than with J591 (9.58% ± 1.1 %).  By contrast, the tumor uptake of 111In-DOTA-labeled J415 and J591 gradually increased with time and was quite similar to that of 7E11.  In addn., the blood clearance of 111In-labeled J415 and J591 antibodies was relatively faster than that of radiolabeled 7E11.  As a consequence, the tumor-to-blood ratios with J415 and J591 were higher than that of 7E11.  The localization of radiolabeled anti-PSMAext antibodies in PSMA-pos. LNCaP tumors was highly specific because the tumor uptake of 131I-labeled J415 and J591 was more than twice that of a nonspecific antibody.  Furthermore, the tumor uptake of 131I-J591 was almost 20 times higher in PSMA-pos. LNCaP tumors than in PSMA-neg. PC3 and DU145 tumor xenografts.  Autoradiog. studies suggested that 7E11 (anti-PSMAint) distinctly favors localization to areas of necrosis whereas J415 and J591 (anti-PSMAext) demonstrated a distinct preferential accumulation in areas of viable tumor.  Conclusion: These results clearly demonstrate that PSMA-specific internalizing antibodies such as J415 and J591 may be the ideal mAbs for the development of novel therapeutic methods to target the delivery of β-emitting radionuclides (131I, 90Y, and 177Lu) for the treatment of PSMA-pos. tumors.  In addn., because J591 and J415 mAbs are specific to PSMAext, thus targeting viable tumor, these immunoconjugates are better candidates for targeted radioimmunotherapy than are antibodies targeting PSMAint.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqISIjgSybaqrVg90H21EOLACvtfcHk0ljg53yda9dliA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtlKnsbw%253D&md5=4aad4f06380d2d49c327cdf4f504ce89</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmith-Jones%26aufirst%3DP.%2BM.%26aulast%3DVallabahajosula%26aufirst%3DS.%26aulast%3DNavarro%26aufirst%3DV.%26aulast%3DBastidas%26aufirst%3DD.%26aulast%3DGoldsmith%26aufirst%3DS.%2BJ.%26aulast%3DBander%26aufirst%3DN.%2BH.%26atitle%3DRadiolabeled%2520monoclonal%2520antibodies%2520specific%2520to%2520the%2520extracellular%2520domain%2520of%2520prostate-specific%2520membrane%2520antigen%253A%2520preclinical%2520studies%2520in%2520nude%2520mice%2520bearing%2520LNCaP%2520human%2520prostate%2520tumor%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2003%26volume%3D44%26spage%3D610%26epage%3D617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Cohen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peehl, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamarei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giudice, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenfeld, R. G.</span><span> </span><span class="NLM_article-title">Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">1046</span><span class="NLM_x">–</span> <span class="NLM_lpage">1053</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm301718c&amp;key=10.1210%2Fjc.75.4.1046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm301718c&amp;key=1383255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm301718c&amp;key=1%3ACAS%3A528%3ADyaK3sXitVGrtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1992&pages=1046-1053&author=P.+Cohenauthor=H.+C.+Gravesauthor=D.+M.+Peehlauthor=M.+Kamareiauthor=L.+C.+Giudiceauthor=R.+G.+Rosenfeld&title=Prostate-specific+antigen+%28PSA%29+is+an+insulin-like+growth+factor+binding+protein-3+protease+found+in+seminal+plasma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma</span></div><div class="casAuthors">Cohen, Pinchas; Graves, Howard C. B.; Peehl, Donna M.; Kamarei, Mehdi; Giudice, Linda C.; Rosenfeld, Ron G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1046-53</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    </div><div class="casAbstract">IGF binding protein-3 (IGFBP-3), the major serum carrier protein for the IGFs, is absent from Western ligand blots of seminal plasma, but is detectable by RIA.  IGFBP-3 protease activity has recently been described in pregnancy serum.  The possibility was examd. that seminal plasma contains an IGFBP-3 protease, by incubating seminal plasma with 125I-labeled human IGFBP-3.  Seminal plasma had potent IGFBP-3 protease activity with a cleavage pattern different from that of pregnancy serum.  Prostate-specific antigen (PSA) is a serine protease found in semen.  Autoradiographs measuring IGFBP-3 protease activity demonstrated that purified PSA cleaved IGFBP-3, yielding a cleavage pattern identical to that of seminal plasma.  IGFBP-2 and -4 in seminal plasma were not degraded by PSA.  Cleavage of IGFBP-3 by PSA resulted in a marked redn. in the binding affinity of the fragments to IGF-I, but not IGF-II.  PSA may thus serve to modulate IGF function within the reproductive system or in prostate cancer by altering IGF-IGFBP-3 interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5Khiuaj51ybVg90H21EOLACvtfcHk0ljrgIzOYShj8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXitVGrtbo%253D&md5=8fa410669c8f4f2f7ee8b55e1b2fbcd4</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1210%2Fjc.75.4.1046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.75.4.1046%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DGraves%26aufirst%3DH.%2BC.%26aulast%3DPeehl%26aufirst%3DD.%2BM.%26aulast%3DKamarei%26aufirst%3DM.%26aulast%3DGiudice%26aufirst%3DL.%2BC.%26aulast%3DRosenfeld%26aufirst%3DR.%2BG.%26atitle%3DProstate-specific%2520antigen%2520%2528PSA%2529%2520is%2520an%2520insulin-like%2520growth%2520factor%2520binding%2520protein-3%2520protease%2520found%2520in%2520seminal%2520plasma%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D1992%26volume%3D75%26spage%3D1046%26epage%3D1053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Iwamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockett, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lilja, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gershagen, S.</span><span> </span><span class="NLM_article-title">Alteration of the hormonal bioactivity of parathyroid hormone-related protein (PTHrP) as a result of limited proteolysis by prostate-specific antigen</span> <span class="citation_source-journal">Urology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">325</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1996&pages=317-325&author=M.+Iwamuraauthor=J.+Hellmanauthor=A.+T.+Cockettauthor=H.+Liljaauthor=S.+Gershagen&title=Alteration+of+the+hormonal+bioactivity+of+parathyroid+hormone-related+protein+%28PTHrP%29+as+a+result+of+limited+proteolysis+by+prostate-specific+antigen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIwamura%26aufirst%3DM.%26aulast%3DHellman%26aufirst%3DJ.%26aulast%3DCockett%26aufirst%3DA.%2BT.%26aulast%3DLilja%26aufirst%3DH.%26aulast%3DGershagen%26aufirst%3DS.%26atitle%3DAlteration%2520of%2520the%2520hormonal%2520bioactivity%2520of%2520parathyroid%2520hormone-related%2520protein%2520%2528PTHrP%2529%2520as%2520a%2520result%2520of%2520limited%2520proteolysis%2520by%2520prostate-specific%2520antigen%26jtitle%3DUrology%26date%3D1996%26volume%3D48%26spage%3D317%26epage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Cramer, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peehl, D, M.</span><span> </span><span class="NLM_article-title">Prostate specific antigen cleaves parathyroid hormone-related protein in the PTH-like domain: inactivation of PTHrP-stimulated cAMP accumulation in mouse osteoblasts</span> <span class="citation_source-journal">J. Urol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">156</span><span class="NLM_x">, </span> <span class="NLM_fpage">526</span><span class="NLM_x">–</span> <span class="NLM_lpage">531</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm301718c&amp;key=10.1016%2FS0022-5347%2801%2965919-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm301718c&amp;key=8683730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm301718c&amp;key=1%3ACAS%3A528%3ADyaK28XkvFartLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=1996&pages=526-531&author=S.+D.+Cramerauthor=Z.+Chenauthor=D%2C+M.+Peehl&title=Prostate+specific+antigen+cleaves+parathyroid+hormone-related+protein+in+the+PTH-like+domain%3A+inactivation+of+PTHrP-stimulated+cAMP+accumulation+in+mouse+osteoblasts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Prostate specific antigen cleaves parathyroid hormone-related protein in the PTH-like domain: Inactivation of PTHrP-stimulated cAMP accumulation in mouse osteoblasts</span></div><div class="casAuthors">Cramer, Scott D.; Chen, Zuxiong; Peehl, Donna M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Urology (Baltimore)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">2, Pt. 1</span>),
    <span class="NLM_cas:pages">526-531</span>CODEN:
                <span class="NLM_cas:coden">JOURAA</span>;
        ISSN:<span class="NLM_cas:issn">0022-5347</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">The purpose of this study was to det. whether parathyroid hormone-related protein (PTHrP) is a substrate of prostate-specific antigen (PSA) and how the biol. activity of PTHrP may be altered by cleavage with PSA.  PSA cleavage of recombinant human PTHrP 1-141 was conducted in vitro at 37° and analyzed by SDS-PAGE.  Five rounds of automated amino-terminal amino acid sequence anal. were performed on blotted PSA-cleaved PTHrP peptide fragments to det. the PSA cleavage sites.  The mouse osteoblast cell line MC3T3-E1 was used to test whether PSA cleavage of PTHrP 1-141 altered its ability to stimulate cAMP prodn.  PSA specifically cleaved PTHrP 1-141 in a time- and dose-dependent manner.  Cleavage of PTHrP 1-141 by PSA generated fragments on Coomassie-stained acrylamide gels that migrated with mobilities that corresponded to 19.5, 17, 15 and <7 kDa.  The preferred PSA cleavage site of PTHrP 1-141 was detd. to be at the carboxyl-terminus of phenylalanine 23, consistent with chymotryptic-like enzymic activity of PSA.  Cleavage of PTHrP by PSA completely abolished the ability of PTHrP to stimulate cAMP prodn.  Thus, cleavage of PTHrP 1-141 by PSA carboxyl-terminal to phenylalanine 23 represents a unique pattern of PTHrP processing that may be specific to the prostate.  Prostate-specific antigen inactivation of the cAMP-inducing activity of PTHrP 1-141 demonstrates that PSA cleavage regulates the biol. activity of PTHrP.  These results have implications for the role of PTHrP in prostate cancer metastasis to bone and its subsequent regulation of bone remodeling.  Study of the biol. activities of the PSA-generated PTHrP peptides identified in this study merits further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp3vqjFhU9O7Vg90H21EOLACvtfcHk0ljrgIzOYShj8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XkvFartLs%253D&md5=f537278800b1f1530acd7036cedf2e46</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS0022-5347%2801%2965919-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-5347%252801%252965919-6%26sid%3Dliteratum%253Aachs%26aulast%3DCramer%26aufirst%3DS.%2BD.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DPeehl%26aufirst%3DD%252C%2BM.%26atitle%3DProstate%2520specific%2520antigen%2520cleaves%2520parathyroid%2520hormone-related%2520protein%2520in%2520the%2520PTH-like%2520domain%253A%2520inactivation%2520of%2520PTHrP-stimulated%2520cAMP%2520accumulation%2520in%2520mouse%2520osteoblasts%26jtitle%3DJ.%2520Urol.%26date%3D1996%26volume%3D156%26spage%3D526%26epage%3D531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Dallas, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cramer, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peehl, D. M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonewald, L. F.</span><span> </span><span class="NLM_article-title">Preferential production of latent transforming growth factor-2 by primary prostatic epithelial cells and its activation by prostate-specific antigen</span> <span class="citation_source-journal">J. Cell. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">202</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">370</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm301718c&amp;key=10.1002%2Fjcp.20147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm301718c&amp;key=15389580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm301718c&amp;key=1%3ACAS%3A528%3ADC%252BD2MXot1ajsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=2005&pages=361-370&author=S.+L.+Dallasauthor=S.+Zhaoauthor=S.+D.+Cramerauthor=Z.+Chenauthor=D.+M+Peehlauthor=L.+F.+Bonewald&title=Preferential+production+of+latent+transforming+growth+factor-2+by+primary+prostatic+epithelial+cells+and+its+activation+by+prostate-specific+antigen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Preferential production of latent transforming growth factor β-2 by primary prostatic epithelial cells and its activation by prostate-specific antigen</span></div><div class="casAuthors">Dallas, S. L.; Zhao, S.; Cramer, S. D.; Chen, Z.; Peehl, D. M.; Bonewald, L. F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">202</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">361-370</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Three mammalian isoforms of transforming growth factor-β (TGFβ) are known, TGFβ1, 2, and 3, that have non-overlapping functions during development.  However, their specific roles in cancers such as prostate cancer are less clear.  Here we show that primary cultures of prostatic epithelial cells preferentially produce and activate the latent TGFβ2 isoform.  Paired cultures of normal and malignant prostate cells from prostate cancer patients produced predominantly the TGFβ2 isoform, with 30- to 70-fold less TGFβ1.  By mono-Q ion exchange chromatog., three major peaks of latent TGFβ2 activity were obsd. corresponding to the known small latent TGFβ2 complex, the known large latent TGFβ2 complex and a novel eluting peak of latent TGFβ2.  Although prostate cells are known to activate latent TGFβ, the mechanism for activation is currently unclear.  We investigated whether prostate specific antigen (PSA), a serine protease used as a clin. marker for prostate cancer, could play a role in the activation of latent TGFβ.  Unlike plasmin, a known activator of both latent TGFβ1 and 2, PSA specifically activated the recombinant small latent form of TGFβ2, but not TGFβ1.  Prostate epithelial cells, therefore, preferentially produce the TGFβ2 isoform and PSA, a protease produced by the prostate, specifically targets the activation of this TGFβ isoform.  PSA-mediated activation of latent TGFβ2 may be an important mechanism for autocrine TGFβ regulation in the prostate and may potentially contribute to the formation of osteoblastic lesions in bone metastatic prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpd9LDnfcGdXrVg90H21EOLACvtfcHk0lhtISXZ9Hxm4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXot1ajsA%253D%253D&md5=0f9bfa5aa46fd213e7203a981129bc0a</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fjcp.20147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.20147%26sid%3Dliteratum%253Aachs%26aulast%3DDallas%26aufirst%3DS.%2BL.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DCramer%26aufirst%3DS.%2BD.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DPeehl%26aufirst%3DD.%2BM%26aulast%3DBonewald%26aufirst%3DL.%2BF.%26atitle%3DPreferential%2520production%2520of%2520latent%2520transforming%2520growth%2520factor-2%2520by%2520primary%2520prostatic%2520epithelial%2520cells%2520and%2520its%2520activation%2520by%2520prostate-specific%2520antigen%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2005%26volume%3D202%26spage%3D361%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Lilja, H.; Piironen, T. P.; Rittenhouse, H. G.; Mikolajczyk, S. D.; Slawin, K. M.</span> <span class="citation_source-book">Comprehensive Textbook of Genitourinary Oncology</span>; <span class="NLM_publisher-name">Lippincott Williams and Wilkins Publishers</span>: <span class="NLM_publisher-loc">Philadelphia</span>,<span class="NLM_x"> </span><span class="NLM_year">2000</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">638</span><span class="NLM_x">–</span> <span class="NLM_lpage">650</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=638-650&author=H.+Lilja&author=T.+P.+Piironen&author=H.+G.+Rittenhouse&author=S.+D.+Mikolajczyk&author=K.+M.+Slawin&title=Comprehensive+Textbook+of+Genitourinary+Oncology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLilja%26aufirst%3DH.%26btitle%3DComprehensive%2520Textbook%2520of%2520Genitourinary%2520Oncology%26pub%3DLippincott%2520Williams%2520and%2520Wilkins%2520Publishers%26date%3D2000%26spage%3D638%26epage%3D650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Williams, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jelinek, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litvinov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotter, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denmeade, S. R.</span><span> </span><span class="NLM_article-title">Enzymatically active prostate-specific antigen promotes growth of human prostate cancers</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">1595</span><span class="NLM_x">–</span> <span class="NLM_lpage">1607</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm301718c&amp;key=10.1002%2Fpros.21375" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm301718c&amp;key=21394741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm301718c&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Srs7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=1595-1607&author=S.+A.+Williamsauthor=C.+A.+Jelinekauthor=I.+Litvinovauthor=R.+J.+Cotterauthor=J.+T.+Isaacsauthor=S.+R.+Denmeade&title=Enzymatically+active+prostate-specific+antigen+promotes+growth+of+human+prostate+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Enzymatically active prostate-specific antigen promotes growth of human prostate cancers</span></div><div class="casAuthors">Williams, Simon A.; Jelinek, Christine A.; Litvinov, Ivan; Cotter, Robert J.; Isaacs, John T.; Denmeade, Samuel R.</div><div class="citationInfo"><span class="NLM_cas:title">Prostate (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1595-1607</span>CODEN:
                <span class="NLM_cas:coden">PRSTDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-4137</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">BACKGROUND: Prostate specific antigen (PSA) is the best-known member of the kallikrein-related peptidase family, with an established role as a prostatic disease biomarker.  Although it is produced at high levels by all stages of prostate cancer, it is uncertain if PSA plays a role in prostate cancer initiation and progression.  We decided to investigate the impact of PSA and its enzymic activity on tumor cell growth rates.  METHODS: A gene-specific shRNA lentiviral construct reduced endogenous PSA expression in the LNCaP human prostate cancer cell line.  Resulting changes in growth rates in vitro and in vivo were detd.  Using a mass spectroscopy-based approach, alterations to the LNCaP proteome due to reduced PSA were measured.  Finally, to evaluate the importance of PSA's proteolytic activity, the PSA-null Du145 human prostate cancer cell line was engineered to express either enzymically inactive pro-PSA (WT) or a furin-activated variant (FR) with high enzymic activity.  The resulting clones were evaluated for PSA-induced changes in growth rates in vivo and in vitro.  RESULTS: Lowered PSA levels dramatically reduced LNCaP growth rates.  Expressing active PSA (FR), but not the inactive WT variant, conferred a growth advantage on Du145 cells.  Proteomics anal. revealed global changes to the LNCaP proteome as a result of reduced PSA expression.  CONCLUSIONS: These studies demonstrate the importance of PSA to prostate cancer cell growth.  We also show that the enzymic activity of PSA confers an enhanced growth rate to human prostate cancer cells, suggesting a causal role in prostate cancer progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEF1sRKW1LubVg90H21EOLACvtfcHk0lhtISXZ9Hxm4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Srs7nO&md5=f220dd09a3b85112e943e1c452eb8bc4</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fpros.21375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpros.21375%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DS.%2BA.%26aulast%3DJelinek%26aufirst%3DC.%2BA.%26aulast%3DLitvinov%26aufirst%3DI.%26aulast%3DCotter%26aufirst%3DR.%2BJ.%26aulast%3DIsaacs%26aufirst%3DJ.%2BT.%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26atitle%3DEnzymatically%2520active%2520prostate-specific%2520antigen%2520promotes%2520growth%2520of%2520human%2520prostate%2520cancers%26jtitle%3DProstate%26date%3D2011%26volume%3D71%26spage%3D1595%26epage%3D1607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">O’Keefe, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guise, T. A.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of bone metastasis and therapeutic implications</span> <span class="citation_source-journal">Clin. Orthoped. Relat. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">415</span><span class="NLM_x">, </span> <span class="NLM_fpage">S100</span><span class="NLM_x">–</span> <span class="NLM_lpage">S104</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=415&publication_year=2003&pages=S100-S104&author=R.+J.+O%E2%80%99Keefeauthor=T.+A.+Guise&title=Molecular+mechanisms+of+bone+metastasis+and+therapeutic+implications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Keefe%26aufirst%3DR.%2BJ.%26aulast%3DGuise%26aufirst%3DT.%2BA.%26atitle%3DMolecular%2520mechanisms%2520of%2520bone%2520metastasis%2520and%2520therapeutic%2520implications%26jtitle%3DClin.%2520Orthoped.%2520Relat.%2520Res.%26date%3D2003%26volume%3D415%26spage%3DS100%26epage%3DS104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Roodman, G. D.</span><span> </span><span class="NLM_article-title">Mechanisms of bone metastasis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">1655</span><span class="NLM_x">–</span> <span class="NLM_lpage">1664</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm301718c&amp;key=10.1056%2FNEJMra030831" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm301718c&amp;key=15084698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm301718c&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjt1WksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2004&pages=1655-1664&author=G.+D.+Roodman&title=Mechanisms+of+bone+metastasis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of bone metastasis</span></div><div class="casAuthors">Roodman, G. David</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1655-1664</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review on the mol. mechanisms involved in osteolytic and osteoblastic metastases, which are a frequent complication of cancer.  The use of gene arrays and proteomics and the availability of appropriate animal models of bone metastasis have permitted the identification of factors produced by the tumor cells themselves or by the microenvironment in response to the tumor that mediate the process of bone destruction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprLLCQ6YLAl7Vg90H21EOLACvtfcHk0lhtISXZ9Hxm4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjt1WksLY%253D&md5=6bd3c31cbe5f0c8310661c87861f4724</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1056%2FNEJMra030831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra030831%26sid%3Dliteratum%253Aachs%26aulast%3DRoodman%26aufirst%3DG.%2BD.%26atitle%3DMechanisms%2520of%2520bone%2520metastasis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D350%26spage%3D1655%26epage%3D1664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Ulmert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wongvipat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahamsson, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scardino, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lilja, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyers, C. L.</span><span> </span><span class="NLM_article-title">Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen</span> <span class="citation_source-journal">Cancer Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">320</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=320-327&author=D.+Ulmertauthor=M.+J.+Evansauthor=J.+P.+Hollandauthor=S.+L.+Riceauthor=J.+Wongvipatauthor=K.+Petterssonauthor=P.+A.+Abrahamssonauthor=P.+T.+Scardinoauthor=S.+M.+Larsonauthor=H.+Liljaauthor=J.+S.+Lewisauthor=C.+L.+Sawyers&title=Imaging+androgen+receptor+signaling+with+a+radiotracer+targeting+free+prostate-specific+antigen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUlmert%26aufirst%3DD.%26aulast%3DEvans%26aufirst%3DM.%2BJ.%26aulast%3DHolland%26aufirst%3DJ.%2BP.%26aulast%3DRice%26aufirst%3DS.%2BL.%26aulast%3DWongvipat%26aufirst%3DJ.%26aulast%3DPettersson%26aufirst%3DK.%26aulast%3DAbrahamsson%26aufirst%3DP.%2BA.%26aulast%3DScardino%26aufirst%3DP.%2BT.%26aulast%3DLarson%26aufirst%3DS.%2BM.%26aulast%3DLilja%26aufirst%3DH.%26aulast%3DLewis%26aufirst%3DJ.%2BS.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26atitle%3DImaging%2520androgen%2520receptor%2520signaling%2520with%2520a%2520radiotracer%2520targeting%2520free%2520prostate-specific%2520antigen%26jtitle%3DCancer%2520Discovery%26date%3D2012%26volume%3D2%26spage%3D320%26epage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Adlington, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoull, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNulty, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubauer, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, G. J.</span><span> </span><span class="NLM_article-title">Design, synthesis, and proposed active site binding analysis of monocyclic 2-azetidinone inhibitors of prostate specific antigen</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1491</span><span class="NLM_x">–</span> <span class="NLM_lpage">1508</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000145g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=1491-1508&author=R.+M.+Adlingtonauthor=J.+E.+Baldwinauthor=G.+W.+Beckerauthor=B.+Chenauthor=L.+Chengauthor=S.+L.+Cooperauthor=R.+B.+Hermannauthor=T.+J.+Howeauthor=W.+McCoullauthor=A.+M.+McNultyauthor=B.+L.+Neubauerauthor=G.+J.+Pritchard&title=Design%2C+synthesis%2C+and+proposed+active+site+binding+analysis+of+monocyclic+2-azetidinone+inhibitors+of+prostate+specific+antigen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm000145g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000145g%26sid%3Dliteratum%253Aachs%26aulast%3DAdlington%26aufirst%3DR.%2BM.%26aulast%3DBaldwin%26aufirst%3DJ.%2BE.%26aulast%3DBecker%26aufirst%3DG.%2BW.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DCooper%26aufirst%3DS.%2BL.%26aulast%3DHermann%26aufirst%3DR.%2BB.%26aulast%3DHowe%26aufirst%3DT.%2BJ.%26aulast%3DMcCoull%26aufirst%3DW.%26aulast%3DMcNulty%26aufirst%3DA.%2BM.%26aulast%3DNeubauer%26aufirst%3DB.%2BL.%26aulast%3DPritchard%26aufirst%3DG.%2BJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520proposed%2520active%2520site%2520binding%2520analysis%2520of%2520monocyclic%25202-azetidinone%2520inhibitors%2520of%2520prostate%2520specific%2520antigen%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D1491%26epage%3D1508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Adlington, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoull, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNulty, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubauer, B L.</span><span> </span><span class="NLM_article-title">Design and synthesis of novel monocyclic β-lactam inhibitors of prostate-specific antigen</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1689</span><span class="NLM_x">–</span> <span class="NLM_lpage">1694</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1997&pages=1689-1694&author=R.+M.+Adlingtonauthor=J.+E.+Baldwinauthor=B.+Chenauthor=S.+L.+Cooperauthor=W.+McCoullauthor=G.+J.+Pritchardauthor=T.+J.+Howeauthor=G.+W.+Beckerauthor=R.+B.+Hermannauthor=A.+M.+McNultyauthor=B+L.+Neubauer&title=Design+and+synthesis+of+novel+monocyclic+%CE%B2-lactam+inhibitors+of+prostate-specific+antigen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdlington%26aufirst%3DR.%2BM.%26aulast%3DBaldwin%26aufirst%3DJ.%2BE.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DCooper%26aufirst%3DS.%2BL.%26aulast%3DMcCoull%26aufirst%3DW.%26aulast%3DPritchard%26aufirst%3DG.%2BJ.%26aulast%3DHowe%26aufirst%3DT.%2BJ.%26aulast%3DBecker%26aufirst%3DG.%2BW.%26aulast%3DHermann%26aufirst%3DR.%2BB.%26aulast%3DMcNulty%26aufirst%3DA.%2BM.%26aulast%3DNeubauer%26aufirst%3DB%2BL.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%2520monocyclic%2520%25CE%25B2-lactam%2520inhibitors%2520of%2520prostate-specific%2520antigen%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1997%26volume%3D7%26spage%3D1689%26epage%3D1694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Knight, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabin, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gale, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maycock, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weston, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westler, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorn, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finke, P. E.</span><span> </span><span class="NLM_article-title">Specificity, stability, and potency of monocyclic β-lactam inhibitors of human leukocyte elastase</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">8160</span><span class="NLM_x">–</span> <span class="NLM_lpage">8170</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=8160-8170&author=W.+B.+Knightauthor=B.+G.+Greenauthor=R.+M.+Chabinauthor=P.+Galeauthor=A.+L.+Maycockauthor=H.+Westonauthor=D.+W.+Kuoauthor=W.+M.+Westlerauthor=C.+P.+Dornauthor=P.+E.+Finke&title=Specificity%2C+stability%2C+and+potency+of+monocyclic+%CE%B2-lactam+inhibitors+of+human+leukocyte+elastase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DW.%2BB.%26aulast%3DGreen%26aufirst%3DB.%2BG.%26aulast%3DChabin%26aufirst%3DR.%2BM.%26aulast%3DGale%26aufirst%3DP.%26aulast%3DMaycock%26aufirst%3DA.%2BL.%26aulast%3DWeston%26aufirst%3DH.%26aulast%3DKuo%26aufirst%3DD.%2BW.%26aulast%3DWestler%26aufirst%3DW.%2BM.%26aulast%3DDorn%26aufirst%3DC.%2BP.%26aulast%3DFinke%26aufirst%3DP.%2BE.%26atitle%3DSpecificity%252C%2520stability%252C%2520and%2520potency%2520of%2520monocyclic%2520%25CE%25B2-lactam%2520inhibitors%2520of%2520human%2520leukocyte%2520elastase%26jtitle%3DBiochemistry%26date%3D1992%26volume%3D35%26spage%3D8160%26epage%3D8170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Green, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Underwood, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gale, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maycock, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liesch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgey, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorn, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finke, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagmann, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacCoss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westler, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, W. B.</span><span> </span><span class="NLM_article-title">Mechanism of inhibition of human leucocyte elastase by β-lactams. Stability, reactivation kinetics, and products of β-lactam-derived E–I complexes</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">14331</span><span class="NLM_x">–</span> <span class="NLM_lpage">14243</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1995&pages=14331-14243&author=B.+G.+Greenauthor=R.+Chabinauthor=S.+Millsauthor=D.+J.+Underwoodauthor=S.+K.+Shahauthor=D.+Kuoauthor=P.+Galeauthor=A.+L.+Maycockauthor=J.+Lieschauthor=C.+S.+Burgeyauthor=J.+B.+Dohertyauthor=C.+P.+Dornauthor=P.+E.+Finkeauthor=W.+K.+Hagmannauthor=J.+J.+Haleauthor=M.+MacCossauthor=W.+M.+Westlerauthor=W.+B.+Knight&title=Mechanism+of+inhibition+of+human+leucocyte+elastase+by+%CE%B2-lactams.+Stability%2C+reactivation+kinetics%2C+and+products+of+%CE%B2-lactam-derived+E%E2%80%93I+complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DB.%2BG.%26aulast%3DChabin%26aufirst%3DR.%26aulast%3DMills%26aufirst%3DS.%26aulast%3DUnderwood%26aufirst%3DD.%2BJ.%26aulast%3DShah%26aufirst%3DS.%2BK.%26aulast%3DKuo%26aufirst%3DD.%26aulast%3DGale%26aufirst%3DP.%26aulast%3DMaycock%26aufirst%3DA.%2BL.%26aulast%3DLiesch%26aufirst%3DJ.%26aulast%3DBurgey%26aufirst%3DC.%2BS.%26aulast%3DDoherty%26aufirst%3DJ.%2BB.%26aulast%3DDorn%26aufirst%3DC.%2BP.%26aulast%3DFinke%26aufirst%3DP.%2BE.%26aulast%3DHagmann%26aufirst%3DW.%2BK.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DMacCoss%26aufirst%3DM.%26aulast%3DWestler%26aufirst%3DW.%2BM.%26aulast%3DKnight%26aufirst%3DW.%2BB.%26atitle%3DMechanism%2520of%2520inhibition%2520of%2520human%2520leucocyte%2520elastase%2520by%2520%25CE%25B2-lactams.%2520Stability%252C%2520reactivation%2520kinetics%252C%2520and%2520products%2520of%2520%25CE%25B2-lactam-derived%2520E%25E2%2580%2593I%2520complexes%26jtitle%3DBiochemistry%26date%3D1995%26volume%3D44%26spage%3D14331%26epage%3D14243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Huang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knoell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazegh-Azam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tashjian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedstrom, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abeles, R. H.</span><span> </span><span class="NLM_article-title">Modulation of recombinant human prostate-specific antigen: activation by hofmeister salts and inhibition by azapeptides</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">11734</span><span class="NLM_x">–</span> <span class="NLM_lpage">11741</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi010364j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=11734-11741&author=A.+Huangauthor=C.+Knoellauthor=G.+Feyauthor=M.+Hazegh-Azamauthor=A.+Tashjianauthor=L.+Hedstromauthor=R.+H.+Abeles&title=Modulation+of+recombinant+human+prostate-specific+antigen%3A+activation+by+hofmeister+salts+and+inhibition+by+azapeptides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fbi010364j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi010364j%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DA.%26aulast%3DKnoell%26aufirst%3DC.%26aulast%3DFey%26aufirst%3DG.%26aulast%3DHazegh-Azam%26aufirst%3DM.%26aulast%3DTashjian%26aufirst%3DA.%26aulast%3DHedstrom%26aufirst%3DL.%26aulast%3DAbeles%26aufirst%3DR.%2BH.%26atitle%3DModulation%2520of%2520recombinant%2520human%2520prostate-specific%2520antigen%253A%2520activation%2520by%2520hofmeister%2520salts%2520and%2520inhibition%2520by%2520azapeptides%26jtitle%3DBiochemistry%26date%3D2001%26volume%3D40%26spage%3D11734%26epage%3D11741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Koistinen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wohlfart, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattsson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahdenpera, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenman, U. H.</span><span> </span><span class="NLM_article-title">Novel small molecule inhibitors for prostate-specific antigen</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">1143</span><span class="NLM_x">–</span> <span class="NLM_lpage">1151</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=1143-1151&author=H.+Koistinenauthor=G.+Wohlfartauthor=J.+M.+Mattssonauthor=P.+Wuauthor=J.+Lahdenperaauthor=U.+H.+Stenman&title=Novel+small+molecule+inhibitors+for+prostate-specific+antigen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoistinen%26aufirst%3DH.%26aulast%3DWohlfart%26aufirst%3DG.%26aulast%3DMattsson%26aufirst%3DJ.%2BM.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DLahdenpera%26aufirst%3DJ.%26aulast%3DStenman%26aufirst%3DU.%2BH.%26atitle%3DNovel%2520small%2520molecule%2520inhibitors%2520for%2520prostate-specific%2520antigen%26jtitle%3DProstate%26date%3D2008%26volume%3D68%26spage%3D1143%26epage%3D1151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Mikolajczyk, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partin, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rittenhouse, H. G.</span><span> </span><span class="NLM_article-title">Free prostate-specific antigen is becoming more complex</span> <span class="citation_source-journal">Urology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">797</span><span class="NLM_x">–</span> <span class="NLM_lpage">802</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2002&pages=797-802&author=A.+D.+Mikolajczykauthor=L.+S.+Marksauthor=A.+W.+Partinauthor=H.+G.+Rittenhouse&title=Free+prostate-specific+antigen+is+becoming+more+complex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMikolajczyk%26aufirst%3DA.%2BD.%26aulast%3DMarks%26aufirst%3DL.%2BS.%26aulast%3DPartin%26aufirst%3DA.%2BW.%26aulast%3DRittenhouse%26aufirst%3DH.%2BG.%26atitle%3DFree%2520prostate-specific%2520antigen%2520is%2520becoming%2520more%2520complex%26jtitle%3DUrology%26date%3D2002%26volume%3D59%26spage%3D797%26epage%3D802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Matteson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadhu, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lienhard, G. E.</span><span> </span><span class="NLM_article-title"><i>R</i>-1-Acetamido-2-phenylethaneboronic acid. A specific transition-state analog for chymotrypsin</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">5241</span><span class="NLM_x">–</span> <span class="NLM_lpage">5242</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00407a051" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=1981&pages=5241-5242&author=D.+S.+Mattesonauthor=K.+M.+Sadhuauthor=G.+E.+Lienhard&title=R-1-Acetamido-2-phenylethaneboronic+acid.+A+specific+transition-state+analog+for+chymotrypsin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fja00407a051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00407a051%26sid%3Dliteratum%253Aachs%26aulast%3DMatteson%26aufirst%3DD.%2BS.%26aulast%3DSadhu%26aufirst%3DK.%2BM.%26aulast%3DLienhard%26aufirst%3DG.%2BE.%26atitle%3DR-1-Acetamido-2-phenylethaneboronic%2520acid.%2520A%2520specific%2520transition-state%2520analog%2520for%2520chymotrypsin%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1981%26volume%3D103%26spage%3D5241%26epage%3D5242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Matteson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadhu, K. M.</span><span> </span><span class="NLM_article-title">Synthesis of 1-amino-2-phenylethane-1-boronic acid derivatives</span> <span class="citation_source-journal">Organometallics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">614</span><span class="NLM_x">–</span> <span class="NLM_lpage">618</span></span><div class="citationLinks">[<a href="/doi/10.1021/om00082a019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm301718c&amp;key=1%3ACAS%3A528%3ADyaL2cXhsFKltbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1984&pages=614-618&author=D.+S.+Mattesonauthor=K.+M.+Sadhu&title=Synthesis+of+1-amino-2-phenylethane-1-boronic+acid+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 1-amino-2-phenylethane-1-boronic acid derivatives</span></div><div class="casAuthors">Matteson, Donald S.; Sadhu, Kizhakethil Mathew</div><div class="citationInfo"><span class="NLM_cas:title">Organometallics</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">614-18</span>CODEN:
                <span class="NLM_cas:coden">ORGND7</span>;
        ISSN:<span class="NLM_cas:issn">0276-7333</span>.
    </div><div class="casAbstract">The B analog of N-acetylphenylalanine, (R)-1-acetamido-2-phenylethane-1-boronic acid (I), was synthesized from (+)-pinanediol phenylmethane-1-boronate, which was converted by LiCHCl2 to the (S)-1-chloro-2-phenylethane-1-boronate, then with N-lithiohexamethyldisilazane to the silylated 1-amino-2-phenylethane-1-boronic ester, which was desilylated and acetylated in situ to (+)-pinanediol (R)-1-acetamido-2-phenylethane-1-boronate and then cleaved to the free I with BCl3.  1-Amino-2-phenylethane-1-boronate esters were isolable but unstable, deboronating to PhCH2CH2NH2 under the influence of heat or hydroxylic solvents.  1-Amino-2-phenylethane-1-boronic acid, though not isolable, partially survives for 1 h in cold aq. soln.  Attempts to synthesize stable α-acetamidoboronate esters directly by reaction of LiNHAc with 1-halo-2-phenylethane-1-boronates resulted in a major proportion of O-alkylation to form imino esters.  Pinacol 1-acetamidino-2-phenylethane-1-boronate was obtained from the α-iodoboronate and acetamidine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2H94XPY3MlbVg90H21EOLACvtfcHk0liiKZVfbKb4AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXhsFKltbo%253D&md5=5785b03fed72bc3f6773483aed1f0e9f</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fom00082a019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fom00082a019%26sid%3Dliteratum%253Aachs%26aulast%3DMatteson%26aufirst%3DD.%2BS.%26aulast%3DSadhu%26aufirst%3DK.%2BM.%26atitle%3DSynthesis%2520of%25201-amino-2-phenylethane-1-boronic%2520acid%2520derivatives%26jtitle%3DOrganometallics%26date%3D1984%26volume%3D3%26spage%3D614%26epage%3D618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Matteson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jesthi, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadhu, K. M.</span><span> </span><span class="NLM_article-title">Synthesis and properties of pinanediol α-amido boronic esters</span> <span class="citation_source-journal">Organometallics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1284</span><span class="NLM_x">–</span> <span class="NLM_lpage">1288</span></span><div class="citationLinks">[<a href="/doi/10.1021/om00086a024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1984&pages=1284-1288&author=D.+S.+Mattesonauthor=P.+K.+Jesthiauthor=K.+M.+Sadhu&title=Synthesis+and+properties+of+pinanediol+%CE%B1-amido+boronic+esters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fom00086a024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fom00086a024%26sid%3Dliteratum%253Aachs%26aulast%3DMatteson%26aufirst%3DD.%2BS.%26aulast%3DJesthi%26aufirst%3DP.%2BK.%26aulast%3DSadhu%26aufirst%3DK.%2BM.%26atitle%3DSynthesis%2520and%2520properties%2520of%2520pinanediol%2520%25CE%25B1-amido%2520boronic%2520esters%26jtitle%3DOrganometallics%26date%3D1984%26volume%3D3%26spage%3D1284%26epage%3D1288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Hansen, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosch, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greiveldinger-Poenaru, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartlett, P. A.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of macrocyclic transition state analog inhibitors for α-chymotrypsin</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">8465</span><span class="NLM_x">–</span> <span class="NLM_lpage">8470</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo034837z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=8465-8470&author=K.+K.+Hansenauthor=B.+Groschauthor=S.+Greiveldinger-Poenaruauthor=P.+A.+Bartlett&title=Synthesis+and+evaluation+of+macrocyclic+transition+state+analog+inhibitors+for+%CE%B1-chymotrypsin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjo034837z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo034837z%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DK.%2BK.%26aulast%3DGrosch%26aufirst%3DB.%26aulast%3DGreiveldinger-Poenaru%26aufirst%3DS.%26aulast%3DBartlett%26aufirst%3DP.%2BA.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520macrocyclic%2520transition%2520state%2520analog%2520inhibitors%2520for%2520%25CE%25B1-chymotrypsin%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2003%26volume%3D68%26spage%3D8465%26epage%3D8470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Wityak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Earl, R., A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abelman, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bethel, Y. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kettner, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMillan, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mersinger, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesti, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankin, F. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chorvat, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Confalone, P. N.</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">3717</span><span class="NLM_x">–</span> <span class="NLM_lpage">3722</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00117a024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Wityak%2C+J.%3B+Earl%2C+R.%2C+A.%3B+Abelman%2C+M.+M.%3B+Bethel%2C+Y.+B.%3B+Fisher%2C+B.+N.%3B+Kauffman%2C+G.+S.%3B+Kettner%2C+C.+A.%3B+Ma%2C+P.%3B+McMillan%2C+J.+L.%3B+Mersinger%2C+L.+J.%3B+Pesti%2C+J.%3B+Pierce%2C+M.+E.%3B+Rankin%2C+F.+W.%3B+Chorvat%2C+R.+J.%3B+Confalone%2C+P.+N.J.+Org.+Chem.+1995%2C+60%2C+3717%E2%80%933722"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjo00117a024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00117a024%26sid%3Dliteratum%253Aachs%26aulast%3DWityak%26aufirst%3DJ.%26aulast%3DEarl%26aufirst%3DR.%252C%2BA.%26aulast%3DAbelman%26aufirst%3DM.%2BM.%26aulast%3DBethel%26aufirst%3DY.%2BB.%26aulast%3DFisher%26aufirst%3DB.%2BN.%26aulast%3DKauffman%26aufirst%3DG.%2BS.%26aulast%3DKettner%26aufirst%3DC.%2BA.%26aulast%3DMa%26aufirst%3DP.%26aulast%3DMcMillan%26aufirst%3DJ.%2BL.%26aulast%3DMersinger%26aufirst%3DL.%2BJ.%26aulast%3DPesti%26aufirst%3DJ.%26aulast%3DPierce%26aufirst%3DM.%2BE.%26aulast%3DRankin%26aufirst%3DF.%2BW.%26aulast%3DChorvat%26aufirst%3DR.%2BJ.%26aulast%3DConfalone%26aufirst%3DP.%2BN.%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1995%26volume%3D60%26spage%3D3717%26epage%3D3722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foss, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimmagadda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullambhatla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castanares, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupold, S. E .</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babich, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mease, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomper, M. G.</span><span> </span><span class="NLM_article-title">Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7933</span><span class="NLM_x">–</span> <span class="NLM_lpage">7943</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801055h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm301718c&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVKlu7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7933-7943&author=Y.+Chenauthor=C.+A.+Fossauthor=Y.+Byunauthor=S.+Nimmagaddaauthor=M.+Pullambhatlaauthor=J.+J.+Foxauthor=M.+Castanaresauthor=S.+E+.+Lupoldauthor=J.+W.+Babichauthor=R.+C.+Measeauthor=M.+G.+Pomper&title=Radiohalogenated+prostate-specific+membrane+antigen+%28PSMA%29-based+ureas+as+imaging+agents+for+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Radiohalogenated Prostate-Specific Membrane Antigen (PSMA)-Based Ureas as Imaging Agents for Prostate Cancer</span></div><div class="casAuthors">Chen, Ying; Foss, Catherine A.; Byun, Youngjoo; Nimmagadda, Sridhar; Pullambhatla, Mrudula; Fox, James J.; Castanares, Mark; Lupold, Shawn E.; Babich, John W.; Mease, Ronnie C.; Pomper, Martin G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7933-7943</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To extend our development of new imaging agents targeting the prostate-specific membrane antigen (PSMA), we have used the versatile intermediate 2-[3-(5-amino-1-carboxy-pentyl)-ureido]-pentanedioic acid (Lys-C(O)-Glu), which allows ready incorporation of radiohalogens for single photon emission computed tomog. (SPECT) and positron emission tomog. (PET).  We prepd. 2-[3-[1-carboxy-5-(4-[125I]iodo-benzoylamino)-pentyl]-ureido]-pentanedioic acid ([125I]3), 2-[3-[1-carboxy-5-(4-[18F]fluoro-benzoylamino)-pentyl]-ureido]-pentanedioic acid ([18F]6), and 2-(3-[1-carboxy-5-[(5-[125I]iodo-pyridine-3-carbonyl)-amino]-pentyl]-ureido)-pentanedioic acid ([125I]8) in 65-80% (nondecay-cor.), 30-35% (decay cor.), and 59-75% (nondecay-cor.) radiochem. yields.  Compd. [125I]3 demonstrated 8.8 ± 4.7% injected dose per g (%ID/g) within PSMA+ PC-3 PIP tumor at 30 min postinjection, which persisted, with clear delineation of the tumor by SPECT.  Similar tumor uptake values at early time points were demonstrated for [18F]6 (using PET) and [125I]8.  Because of the many radiohalogenated moieties that can be attached via the ε amino group, the intermediate Lys-C(O)-Glu is an attractive template upon which to develop new imaging agents for prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_c7_c3TRKQ7Vg90H21EOLACvtfcHk0lgBXV5Ube-ijg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVKlu7bE&md5=cf1e18c253f469491ec6065535be6be1</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm801055h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801055h%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DFoss%26aufirst%3DC.%2BA.%26aulast%3DByun%26aufirst%3DY.%26aulast%3DNimmagadda%26aufirst%3DS.%26aulast%3DPullambhatla%26aufirst%3DM.%26aulast%3DFox%26aufirst%3DJ.%2BJ.%26aulast%3DCastanares%26aufirst%3DM.%26aulast%3DLupold%26aufirst%3DS.%2BE%2B.%26aulast%3DBabich%26aufirst%3DJ.%2BW.%26aulast%3DMease%26aufirst%3DR.%2BC.%26aulast%3DPomper%26aufirst%3DM.%2BG.%26atitle%3DRadiohalogenated%2520prostate-specific%2520membrane%2520antigen%2520%2528PSMA%2529-based%2520ureas%2520as%2520imaging%2520agents%2520for%2520prostate%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7933%26epage%3D7943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 15 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yao-Ling Wang, Sha Liu, Zhu-Jun Yu, Yuan Lei, Meng-Yi Huang, Yu-Hang Yan, Qiang Ma, Yang Zheng, Hui Deng, Ying Sun, Chengyong Wu, Yamei Yu, Qiang Chen, Zhenling Wang, Yong Wu, <span class="NLM_string-name hlFld-ContribAuthor">Guo-Bo Li</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Development of (1-(3′-Mercaptopropanamido)methyl)boronic Acid Derived Broad-Spectrum, Dual-Action Inhibitors of Metallo- and Serine-β-lactamases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (15)
                                     , 7160-7184. <a href="https://doi.org/10.1021/acs.jmedchem.9b00735" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00735</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00735%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDevelopment%252Bof%252B%2525281-%2525283%2525E2%252580%2525B2-Mercaptopropanamido%252529methyl%252529boronic%252BAcid%252BDerived%252BBroad-Spectrum%25252C%252BDual-Action%252BInhibitors%252Bof%252BMetallo-%252Band%252BSerine-%2525CE%2525B2-lactamases%26aulast%3DWang%26aufirst%3DYao-Ling%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D05052019%26date%3D17072019%26date%3D03072019%26volume%3D62%26issue%3D15%26spage%3D7160%26epage%3D7184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Stanley
C. Xie, David L. Gillett, Natalie J. Spillman, Christopher Tsu, Madeline R. Luth, Sabine Ottilie, Sandra Duffy, Alexandra E. Gould, Paul Hales, Benjamin A. Seager, Carlie L. Charron, Frank Bruzzese, Xiaofeng Yang, Xiansi Zhao, Shih-Chung Huang, Craig A. Hutton, Jeremy N. Burrows, Elizabeth A. Winzeler, Vicky M. Avery, Lawrence R. Dick, <span class="NLM_string-name hlFld-ContribAuthor">Leann Tilley</span>. </span><span class="cited-content_cbyCitation_article-title">Target Validation and Identification of Novel Boronate Inhibitors of the Plasmodium falciparum Proteasome. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (22)
                                     , 10053-10066. <a href="https://doi.org/10.1021/acs.jmedchem.8b01161" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01161</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01161%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTarget%252BValidation%252Band%252BIdentification%252Bof%252BNovel%252BBoronate%252BInhibitors%252Bof%252Bthe%252BPlasmodium%252Bfalciparum%252BProteasome%26aulast%3DXie%26aufirst%3DStanley%2BC.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D24072018%26date%3D07112018%26date%3D29102018%26volume%3D61%26issue%3D22%26spage%3D10053%26epage%3D10066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sara  Pellegrino</span>, <span class="hlFld-ContribAuthor ">Alessandro  Contini</span>, <span class="hlFld-ContribAuthor ">Maria Luisa  Gelmi</span>, <span class="hlFld-ContribAuthor ">Leonardo  Lo Presti</span>, <span class="hlFld-ContribAuthor ">Raffaella  Soave</span>, and <span class="hlFld-ContribAuthor ">Emanuela  Erba</span>  . </span><span class="cited-content_cbyCitation_article-title">Asymmetric Modular Synthesis of a Semirigid Dipeptide Mimetic by Cascade Cycloaddition/Ring Rearrangement and Borohydride Reduction. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2014,</strong> <em>79 </em>
                                    (7)
                                     , 3094-3102. <a href="https://doi.org/10.1021/jo500237j" title="DOI URL">https://doi.org/10.1021/jo500237j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo500237j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo500237j%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DAsymmetric%252BModular%252BSynthesis%252Bof%252Ba%252BSemirigid%252BDipeptide%252BMimetic%252Bby%252BCascade%252BCycloaddition%25252FRing%252BRearrangement%252Band%252BBorohydride%252BReduction%26aulast%3DPellegrino%26aufirst%3DSara%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D30012014%26date%3D25032014%26date%3D04042014%26date%3D17032014%26volume%3D79%26issue%3D7%26spage%3D3094%26epage%3D3102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Prashanth  Anamthathmakula</span>, <span class="hlFld-ContribAuthor ">Wipawee  Winuthayanon</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanism of semen liquefaction and its potential for a novel non-hormonal contraception†. </span><span class="cited-content_cbyCitation_journal-name">Biology of Reproduction</span><span> <strong>2020,</strong> <em>103 </em>
                                    (2)
                                     , 411-426. <a href="https://doi.org/10.1093/biolre/ioaa075" title="DOI URL">https://doi.org/10.1093/biolre/ioaa075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/biolre/ioaa075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fbiolre%2Fioaa075%26sid%3Dliteratum%253Aachs%26jtitle%3DBiology%2520of%2520Reproduction%26atitle%3DMechanism%252Bof%252Bsemen%252Bliquefaction%252Band%252Bits%252Bpotential%252Bfor%252Ba%252Bnovel%252Bnon-hormonal%252Bcontraception%2525E2%252580%2525A0%26aulast%3DAnamthathmakula%26aufirst%3DPrashanth%26date%3D2020%26date%3D2020%26volume%3D103%26issue%3D2%26spage%3D411%26epage%3D426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bo  Huang</span>, <span class="hlFld-ContribAuthor ">Xing-Pei  Liu</span>, <span class="hlFld-ContribAuthor ">Jing-Shuai  Chen</span>, <span class="hlFld-ContribAuthor ">Chang-jie  Mao</span>, <span class="hlFld-ContribAuthor ">He-Lin  Niu</span>, <span class="hlFld-ContribAuthor ">Bao-Kang  Jin</span>. </span><span class="cited-content_cbyCitation_article-title">Electrochemiluminescence immunoassay for the prostate-specific antigen by using a CdS/chitosan/g-C3N4 nanocomposite. </span><span class="cited-content_cbyCitation_journal-name">Microchimica Acta</span><span> <strong>2020,</strong> <em>187 </em>
                                    (3)
                                     <a href="https://doi.org/10.1007/s00604-020-4125-y" title="DOI URL">https://doi.org/10.1007/s00604-020-4125-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00604-020-4125-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00604-020-4125-y%26sid%3Dliteratum%253Aachs%26jtitle%3DMicrochimica%2520Acta%26atitle%3DElectrochemiluminescence%252Bimmunoassay%252Bfor%252Bthe%252Bprostate-specific%252Bantigen%252Bby%252Busing%252Ba%252BCdS%25252Fchitosan%25252Fg-C3N4%252Bnanocomposite%26aulast%3DHuang%26aufirst%3DBo%26date%3D2020%26date%3D2020%26volume%3D187%26issue%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Afshin  Moradi</span>, <span class="hlFld-ContribAuthor ">Srilakshmi  Srinivasan</span>, <span class="hlFld-ContribAuthor ">Judith  Clements</span>, <span class="hlFld-ContribAuthor ">Jyotsna  Batra</span>. </span><span class="cited-content_cbyCitation_article-title">Beyond the biomarker role: prostate-specific antigen (PSA) in the prostate cancer microenvironment. </span><span class="cited-content_cbyCitation_journal-name">Cancer and Metastasis Reviews</span><span> <strong>2019,</strong> <em>38 </em>
                                    (3)
                                     , 333-346. <a href="https://doi.org/10.1007/s10555-019-09815-3" title="DOI URL">https://doi.org/10.1007/s10555-019-09815-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10555-019-09815-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10555-019-09815-3%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520and%2520Metastasis%2520Reviews%26atitle%3DBeyond%252Bthe%252Bbiomarker%252Brole%25253A%252Bprostate-specific%252Bantigen%252B%252528PSA%252529%252Bin%252Bthe%252Bprostate%252Bcancer%252Bmicroenvironment%26aulast%3DMoradi%26aufirst%3DAfshin%26date%3D2019%26date%3D2019%26volume%3D38%26issue%3D3%26spage%3D333%26epage%3D346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniela  Loessner</span>, <span class="hlFld-ContribAuthor ">Peter  Goettig</span>, <span class="hlFld-ContribAuthor ">Sarah  Preis</span>, <span class="hlFld-ContribAuthor ">Johanna  Felber</span>, <span class="hlFld-ContribAuthor ">Holger  Bronger</span>, <span class="hlFld-ContribAuthor ">Judith A.  Clements</span>, <span class="hlFld-ContribAuthor ">Julia  Dorn</span>, <span class="hlFld-ContribAuthor ">Viktor  Magdolen</span>. </span><span class="cited-content_cbyCitation_article-title">Kallikrein-related peptidases represent attractive therapeutic targets for ovarian cancer. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2018,</strong> <em>22 </em>
                                    (9)
                                     , 745-763. <a href="https://doi.org/10.1080/14728222.2018.1512587" title="DOI URL">https://doi.org/10.1080/14728222.2018.1512587</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14728222.2018.1512587&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14728222.2018.1512587%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3DKallikrein-related%252Bpeptidases%252Brepresent%252Battractive%252Btherapeutic%252Btargets%252Bfor%252Bovarian%252Bcancer%26aulast%3DLoessner%26aufirst%3DDaniela%26date%3D2018%26date%3D2018%26volume%3D22%26issue%3D9%26spage%3D745%26epage%3D763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maya B.  Kostova</span>, <span class="hlFld-ContribAuthor ">William Nathaniel  Brennen</span>, <span class="hlFld-ContribAuthor ">David  Lopez</span>, <span class="hlFld-ContribAuthor ">Lizamma  Anthony</span>, <span class="hlFld-ContribAuthor ">Hao  Wang</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Platz</span>, <span class="hlFld-ContribAuthor ">Samuel R.  Denmeade</span>. </span><span class="cited-content_cbyCitation_article-title">PSA-alpha-2-macroglobulin complex is enzymatically active in the serum of patients with advanced prostate cancer and can degrade circulating peptide hormones. </span><span class="cited-content_cbyCitation_journal-name">The Prostate</span><span> <strong>2018,</strong> <em>78 </em>
                                    (11)
                                     , 819-829. <a href="https://doi.org/10.1002/pros.23539" title="DOI URL">https://doi.org/10.1002/pros.23539</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/pros.23539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fpros.23539%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Prostate%26atitle%3DPSA-alpha-2-macroglobulin%252Bcomplex%252Bis%252Benzymatically%252Bactive%252Bin%252Bthe%252Bserum%252Bof%252Bpatients%252Bwith%252Badvanced%252Bprostate%252Bcancer%252Band%252Bcan%252Bdegrade%252Bcirculating%252Bpeptide%252Bhormones%26aulast%3DKostova%26aufirst%3DMaya%2BB.%26date%3D2018%26date%3D2018%26volume%3D78%26issue%3D11%26spage%3D819%26epage%3D829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fei  Yang</span>, <span class="hlFld-ContribAuthor ">Mingyan  Zhu</span>, <span class="hlFld-ContribAuthor ">Jinyi  Zhang</span>, <span class="hlFld-ContribAuthor ">Huchen  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of biologically active boron-containing compounds. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2018,</strong> <em>9 </em>
                                    (2)
                                     , 201-211. <a href="https://doi.org/10.1039/C7MD00552K" title="DOI URL">https://doi.org/10.1039/C7MD00552K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7MD00552K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7MD00552K%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DSynthesis%252Bof%252Bbiologically%252Bactive%252Bboron-containing%252Bcompounds%26aulast%3DYang%26aufirst%3DFei%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D2%26spage%3D201%26epage%3D211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomoya  Shiro</span>, <span class="hlFld-ContribAuthor ">Anne  Schuhmacher</span>, <span class="hlFld-ContribAuthor ">Moritz K.  Jackl</span>, <span class="hlFld-ContribAuthor ">Jeffrey W.  Bode</span>. </span><span class="cited-content_cbyCitation_article-title">Facile synthesis of α-aminoboronic acids from amines and potassium acyltrifluoroborates (KATs)
              via
              trifluoroborate-iminiums (TIMs). </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2018,</strong> <em>9 </em>
                                    (23)
                                     , 5191-5196. <a href="https://doi.org/10.1039/C8SC01486H" title="DOI URL">https://doi.org/10.1039/C8SC01486H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8SC01486H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8SC01486H%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DFacile%252Bsynthesis%252Bof%252B%2525CE%2525B1-aminoboronic%252Bacids%252Bfrom%252Bamines%252Band%252Bpotassium%252Bacyltrifluoroborates%252B%252528KATs%252529%252Bvia%252Btrifluoroborate-iminiums%252B%252528TIMs%252529%26aulast%3DShiro%26aufirst%3DTomoya%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D23%26spage%3D5191%26epage%3D5196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Margaritis  Avgeris</span>, <span class="hlFld-ContribAuthor ">Andreas  Scorilas</span>. </span><span class="cited-content_cbyCitation_article-title">Kallikrein-related peptidases (KLKs) as emerging therapeutic targets: focus on prostate cancer and skin pathologies. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2016,</strong> <em>20 </em>
                                    (7)
                                     , 801-818. <a href="https://doi.org/10.1517/14728222.2016.1147560" title="DOI URL">https://doi.org/10.1517/14728222.2016.1147560</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/14728222.2016.1147560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F14728222.2016.1147560%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3DKallikrein-related%252Bpeptidases%252B%252528KLKs%252529%252Bas%252Bemerging%252Btherapeutic%252Btargets%25253A%252Bfocus%252Bon%252Bprostate%252Bcancer%252Band%252Bskin%252Bpathologies%26aulast%3DAvgeris%26aufirst%3DMargaritis%26date%3D2016%26date%3D2016%26volume%3D20%26issue%3D7%26spage%3D801%26epage%3D818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">T.  Kryza</span>, <span class="hlFld-ContribAuthor ">M.L.  Silva</span>, <span class="hlFld-ContribAuthor ">D.  Loessner</span>, <span class="hlFld-ContribAuthor ">N.  Heuzé-Vourc'h</span>, <span class="hlFld-ContribAuthor ">J.A.  Clements</span>. </span><span class="cited-content_cbyCitation_article-title">The kallikrein-related peptidase family: Dysregulation and functions during cancer progression. </span><span class="cited-content_cbyCitation_journal-name">Biochimie</span><span> <strong>2016,</strong> <em>122 </em>, 283-299. <a href="https://doi.org/10.1016/j.biochi.2015.09.002" title="DOI URL">https://doi.org/10.1016/j.biochi.2015.09.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biochi.2015.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biochi.2015.09.002%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimie%26atitle%3DThe%252Bkallikrein-related%252Bpeptidase%252Bfamily%25253A%252BDysregulation%252Band%252Bfunctions%252Bduring%252Bcancer%252Bprogression%26aulast%3DKryza%26aufirst%3DT.%26date%3D2016%26volume%3D122%26spage%3D283%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Patricia  Andrés</span>, <span class="hlFld-ContribAuthor ">Gema  Ballano</span>, <span class="hlFld-ContribAuthor ">M. Isabel  Calaza</span>, <span class="hlFld-ContribAuthor ">Carlos  Cativiela</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of α-aminoboronic acids. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2016,</strong> <em>45 </em>
                                    (8)
                                     , 2291-2307. <a href="https://doi.org/10.1039/C5CS00886G" title="DOI URL">https://doi.org/10.1039/C5CS00886G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5CS00886G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5CS00886G%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DSynthesis%252Bof%252B%2525CE%2525B1-aminoboronic%252Bacids%26aulast%3DAndr%25C3%25A9s%26aufirst%3DPatricia%26date%3D2016%26date%3D2016%26volume%3D45%26issue%3D8%26spage%3D2291%26epage%3D2307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tao  Wang</span>, <span class="hlFld-ContribAuthor ">Yuzhou  Wu</span>, <span class="hlFld-ContribAuthor ">Seah Ling  Kuan</span>, <span class="hlFld-ContribAuthor ">Oliver  Dumele</span>, <span class="hlFld-ContribAuthor ">Markus  Lamla</span>, <span class="hlFld-ContribAuthor ">David Y. W.  Ng</span>, <span class="hlFld-ContribAuthor ">Matthias  Arzt</span>, <span class="hlFld-ContribAuthor ">Jessica  Thomas</span>, <span class="hlFld-ContribAuthor ">Jan O.  Mueller </span>, <span class="hlFld-ContribAuthor ">Christopher  Barner-Kowollik </span>, <span class="hlFld-ContribAuthor ">Tanja  Weil</span>. </span><span class="cited-content_cbyCitation_article-title">A Disulfide Intercalator Toolbox for the Site-Directed Modification of Polypeptides. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2015,</strong> <em>21 </em>
                                    (1)
                                     , 228-238. <a href="https://doi.org/10.1002/chem.201403965" title="DOI URL">https://doi.org/10.1002/chem.201403965</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201403965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201403965%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DA%252BDisulfide%252BIntercalator%252BToolbox%252Bfor%252Bthe%252BSite-Directed%252BModification%252Bof%252BPolypeptides%26aulast%3DWang%26aufirst%3DTao%26date%3D2015%26date%3D2014%26volume%3D21%26issue%3D1%26spage%3D228%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Konstantinos  Mavridis</span>, <span class="hlFld-ContribAuthor ">Margaritis  Avgeris</span>, <span class="hlFld-ContribAuthor ">Andreas  Scorilas</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting kallikrein-related peptidases in prostate cancer. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2014,</strong> <em>18 </em>
                                    (4)
                                     , 365-383. <a href="https://doi.org/10.1517/14728222.2014.880693" title="DOI URL">https://doi.org/10.1517/14728222.2014.880693</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/14728222.2014.880693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F14728222.2014.880693%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3DTargeting%252Bkallikrein-related%252Bpeptidases%252Bin%252Bprostate%252Bcancer%26aulast%3DMavridis%26aufirst%3DKonstantinos%26date%3D2014%26date%3D2014%26volume%3D18%26issue%3D4%26spage%3D365%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/medium/jm-2012-01718c_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/large/jm-2012-01718c_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301718c&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/medium/jm-2012-01718c_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/large/jm-2012-01718c_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Pinanediol Protected Phenylalanine Boronic Acid,<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> (boro-Pin)Phe<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/large/jm-2012-01718c_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301718c&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) (+)-pinanediol, Et<sub>2</sub>O, MgSO<sub>4</sub>, rt, 85%; (b) LiCHCl<sub>2</sub>, ZnCl<sub>2</sub>, THF, −100 °C, 80%; (c) LiN(SiMe<sub>3</sub>)<sub>2</sub>, THF, −78 °C; (d) TFA, Et<sub>2</sub>O, 0 °C, 73%.</p></p></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/medium/jm-2012-01718c_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/large/jm-2012-01718c_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Schematic Illustration of Solid Phase Peptide Synthesis and Subsequent Conjugation to Boronic Acids ((boro)Phe and (boro)Bpg Are Used As Examples)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/large/jm-2012-01718c_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301718c&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/medium/jm-2012-01718c_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/large/jm-2012-01718c_0009.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. PSA Active Site Interactions with Amino Acids in P1–P5 Positions of Peptide Boronic Acid <b>20</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/large/jm-2012-01718c_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301718c&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Substrate binding pockets on the protease are labeled as S.</p></p></figure><figure data-id="fig1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/medium/jm-2012-01718c_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/large/jm-2012-01718c_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of peptide boronic acids with hydrophobic amino acid substituents in the P5 position.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/large/jm-2012-01718c_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301718c&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/medium/jm-2012-01718c_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/large/jm-2012-01718c_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. PSA inhibitor blocks PSA binding to serum protease inhibitors and alters PSA blood levels. (A) Western blot analysis of inhibition of PSA complex formation with A<sub>2</sub>M and ACT. FP = control non-PSA containing female plasma; all mixtures were incubated for overnight at room temperature. (B) PSA measurements using Hybritech assay of 100 ng/mL PSA in RPMI + 1% bovine serum albumin + 1 μM <b>6</b> or 1 μM Z-SSKn-OH peptide + <b>6</b> or 1 μM <b>20</b>. (C) Free and total PSA levels in serum of mice bearing PSA-producing LNCaP prostate cancer xenografts either untreated or receiving three courses of <b>20</b> at dose of 10 mg/kg for five consecutive days/week. (D) Free and total PSA levels per g of tumor and ratio of free/total PSA in mice treated as in (C).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/large/jm-2012-01718c_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301718c&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/medium/jm-2012-01718c_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/large/jm-2012-01718c_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Evaluation of the activity of inhibitor <b>20</b> in the presence of bovine serum in the media.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/large/jm-2012-01718c_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301718c&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/medium/jm-2012-01718c_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/large/jm-2012-01718c_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In vivo evaluation of <b>20</b>, Ahx-FSQn(boro)Bpg. Mice bearing subcutaneous PSA-producing LNCaP prostate cancer xenografts were either untreated (tumor control) or received three courses of <b>20</b> at dose of 10 mg/kg for five consecutive days/week (treatment interval indicated by gray bars).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/large/jm-2012-01718c_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301718c&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/medium/jm-2012-01718c_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/large/jm-2012-01718c_0010.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Peptide Radiolabeling with [<sup>125</sup>I]SIB and Preparation of Cold Reference<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/large/jm-2012-01718c_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301718c&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) <i>N</i>-Hydroxysuccinimidyl-4-iodobenzoate, triethylamine, MeOH, rt, 30 min; (b) [125I]<i>N</i>-hydroxysuccinimidyl-4-iodobenzoate, triethylamine, DMF, rt, 40 min.</p></p></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/medium/jm-2012-01718c_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/large/jm-2012-01718c_0006.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Evaluation of <sup>125</sup>I labeled PSA inhibitor in vivo. (A) Blood clearance of [<sup>125</sup>I]SIB-Ahx-NaphSQn(boro)F from mice blood measured over time. Data shows counts per second normalized to starting counts obtained in plasma as 2 h. Four animals were sacrificed at each time point. (B) Biodistribution of [<sup>125</sup>I]SIB-Ahx-NaphSQn(boro)F, shown as percent of injected dose per gram (%ID/gram). Two mice were sacrificed per time point. Tissues were harvested at 2, 4, and 6 h, weighed, and counted in a gamma counter. Mice had PSA expressing LNCaP xenografts in bilateral flanks. (C) Biodistribution of [<sup>125</sup>I]SIB-Ahx-FSQn(boro)Bpg <b>26</b> and [<sup>125</sup>I]SIB-Ahx-FSQn(boro-Pin)Bpg <b>27</b>, shown as percent of injected dose per gram (%ID/gram). Each drug was injected into two mice, and one animal was sacrificed per time point. Tissues were harvested at 2 and 4 h, weighed, and counted in gamma counter. Mice had single PSA expressing LNCaP xenografts.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm301718c/production/images/large/jm-2012-01718c_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301718c&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i38">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77874" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77874" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 48 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Watt, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">M’Timkulu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loor, R.</span><span> </span><span class="NLM_article-title">Human prostate-specific antigen: structural and functional similarity with serine proteases</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">3166</span><span class="NLM_x">–</span> <span class="NLM_lpage">3170</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1986&pages=3166-3170&author=K.+W.+Wattauthor=P.+J.+Leeauthor=T.+M%E2%80%99Timkuluauthor=W.+P.+Chanauthor=R.+Loor&title=Human+prostate-specific+antigen%3A+structural+and+functional+similarity+with+serine+proteases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWatt%26aufirst%3DK.%2BW.%26aulast%3DLee%26aufirst%3DP.%2BJ.%26aulast%3DM%25E2%2580%2599Timkulu%26aufirst%3DT.%26aulast%3DChan%26aufirst%3DW.%2BP.%26aulast%3DLoor%26aufirst%3DR.%26atitle%3DHuman%2520prostate-specific%2520antigen%253A%2520structural%2520and%2520functional%2520similarity%2520with%2520serine%2520proteases%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1986%26volume%3D83%26spage%3D3166%26epage%3D3170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Lilja, H.</span><span> </span><span class="NLM_article-title">A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">1899</span><span class="NLM_x">–</span> <span class="NLM_lpage">1903</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=1985&pages=1899-1903&author=H.+Lilja&title=A+kallikrein-like+serine+protease+in+prostatic+fluid+cleaves+the+predominant+seminal+vesicle+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLilja%26aufirst%3DH.%26atitle%3DA%2520kallikrein-like%2520serine%2520protease%2520in%2520prostatic%2520fluid%2520cleaves%2520the%2520predominant%2520seminal%2520vesicle%2520protein%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1985%26volume%3D76%26spage%3D1899%26epage%3D1903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Yousef, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamandis, E. P.</span><span> </span><span class="NLM_article-title">An overview of the kallikrein gene families in humans and other species: emerging candidate tumor markers</span> <span class="citation_source-journal">Clin. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">443</span><span class="NLM_x">–</span> <span class="NLM_lpage">452</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm301718c&amp;key=10.1016%2FS0009-9120%2803%2900055-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm301718c&amp;key=12951170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm301718c&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvVygtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2003&pages=443-452&author=G.+M.+Yousefauthor=E.+P.+Diamandis&title=An+overview+of+the+kallikrein+gene+families+in+humans+and+other+species%3A+emerging+candidate+tumor+markers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">An overview of the kallikrein gene families in humans and other species: emerging candidate tumour markers</span></div><div class="casAuthors">Yousef, George M.; Diamandis, Eleftherios P.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Biochemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">443-452</span>CODEN:
                <span class="NLM_cas:coden">CLBIAS</span>;
        ISSN:<span class="NLM_cas:issn">0009-9120</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review.  Kallikreins are serine proteases with diverse physiol. functions.  They are represented by multigene families in many animal species, esp. in rat and mouse.  Recently, the human kallikrein gene family has been fully characterized and includes 15 members, tandemly localized on chromosome 19q13.4.  A new definition has now been proposed for kallikreins, which is not based on function but, rather, on close proximity and structural similarities.  In this review, we summarize available information about kallikreins in many animal species with special emphasis on human kallikreins.  We discuss the common structural features of kallikreins at the DNA, mRNA and protein levels and overview their evolutionary history.  Kallikreins are expressed in a wide range of tissues including the salivary gland, endocrine or endocrine-related tissues such as testis, prostate, breast and endometrium and in the central nervous system.  Most, if not all, genes are under steroid hormone regulation.  Accumulating evidence indicates that kallikreins are involved in many pathol. conditions.  Of special interest is the potential role of kallikreins in the central nervous system.  In addn., many kallikreins seem to be candidate tumor markers for many malignancies, esp. those of endocrine-related organs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp18_jEx9bSzrVg90H21EOLACvtfcHk0lio1cMUBSBglQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvVygtrw%253D&md5=090376727b5132f7882f5de06a1ab127</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0009-9120%2803%2900055-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0009-9120%252803%252900055-9%26sid%3Dliteratum%253Aachs%26aulast%3DYousef%26aufirst%3DG.%2BM.%26aulast%3DDiamandis%26aufirst%3DE.%2BP.%26atitle%3DAn%2520overview%2520of%2520the%2520kallikrein%2520gene%2520families%2520in%2520humans%2520and%2520other%2520species%253A%2520emerging%2520candidate%2520tumor%2520markers%26jtitle%3DClin.%2520Biochem.%26date%3D2003%26volume%3D36%26spage%3D443%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Williams, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denmeade, S. R.</span><span> </span><span class="NLM_article-title">Does PSA play a role as a promoting agent during the initiation and/or progression of prostate cancer?</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">312</span><span class="NLM_x">–</span> <span class="NLM_lpage">329</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=312-329&author=S.+A.+Williamsauthor=P.+Singhauthor=J.+T.+Isaacsauthor=S.+R.+Denmeade&title=Does+PSA+play+a+role+as+a+promoting+agent+during+the+initiation+and%2For+progression+of+prostate+cancer%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DS.%2BA.%26aulast%3DSingh%26aufirst%3DP.%26aulast%3DIsaacs%26aufirst%3DJ.%2BT.%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26atitle%3DDoes%2520PSA%2520play%2520a%2520role%2520as%2520a%2520promoting%2520agent%2520during%2520the%2520initiation%2520and%252For%2520progression%2520of%2520prostate%2520cancer%253F%26jtitle%3DProstate%26date%3D2007%26volume%3D67%26spage%3D312%26epage%3D329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Denmeade, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sokoll, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, J. T.</span><span> </span><span class="NLM_article-title">Concentration of enzymatically active prostate-specific antigen (PSA) in the extracellular fluid of primary human prostate cancers and human prostatic cancer xenograft models</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2001&pages=1-6&author=S.+R.+Denmeadeauthor=L.+J.+Sokollauthor=D.+W.+Chanauthor=S.+R.+Khanauthor=J.+T.+Isaacs&title=Concentration+of+enzymatically+active+prostate-specific+antigen+%28PSA%29+in+the+extracellular+fluid+of+primary+human+prostate+cancers+and+human+prostatic+cancer+xenograft+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26aulast%3DSokoll%26aufirst%3DL.%2BJ.%26aulast%3DChan%26aufirst%3DD.%2BW.%26aulast%3DKhan%26aufirst%3DS.%2BR.%26aulast%3DIsaacs%26aufirst%3DJ.%2BT.%26atitle%3DConcentration%2520of%2520enzymatically%2520active%2520prostate-specific%2520antigen%2520%2528PSA%2529%2520in%2520the%2520extracellular%2520fluid%2520of%2520primary%2520human%2520prostate%2520cancers%2520and%2520human%2520prostatic%2520cancer%2520xenograft%2520models%26jtitle%3DProstate%26date%3D2001%26volume%3D48%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Lilja, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlen, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matikainen, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovgren, T.</span><span> </span><span class="NLM_article-title">Prostate-specific antigen in serum occurs predominantly in complex with a1-antichymotrypsin</span> <span class="citation_source-journal">Clin. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">1618</span><span class="NLM_x">–</span> <span class="NLM_lpage">1625</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm301718c&amp;key=1716536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm301718c&amp;key=1%3ACAS%3A528%3ADyaK3MXmtVGntL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1991&pages=1618-1625&author=H.+Liljaauthor=A.+Christenssonauthor=U.+Dahlenauthor=M.+T.+Matikainenauthor=O.+Nilssonauthor=K.+Petterssonauthor=T.+Lovgren&title=Prostate-specific+antigen+in+serum+occurs+predominantly+in+complex+with+a1-antichymotrypsin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Prostate-specific antigen in serum occurs predominantly in complex with α1-antichymotrypsin</span></div><div class="casAuthors">Lilja, Hans; Christensson, Anders; Dahlen, Ulrika; Matikainen, Marja Terttu; Nilsson, Olle; Pettersson, Kim; Lovgren, Timo</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Chemistry (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1618-25</span>CODEN:
                <span class="NLM_cas:coden">CLCHAU</span>;
        ISSN:<span class="NLM_cas:issn">0009-9147</span>.
    </div><div class="casAbstract">Immunol. measurements of the serum concn. of prostate-specific antigen (PSA), an abundant prostatic-secreted serine proteinase, are frequently used to monitor patients with prostate cancer, though it has not been ascertained whether this immunoreactivity represents a PSA zymogen, the active proteinase, or PSA complexed to extracellular proteinase inhibitors.  To characterize the PSA immunoreactivity in serum, the present study used monoclonal antibodies produced against PSA and a polyclonal rabbit IgG against α1-antichymotrypsin in the design of three noncompetitive PSA assays: assay T, which detected PSA both when present as the active proteinase and when complexed to α1-antichymotrypsin; assay F, which recognized the active proteinase but most poorly detected PSA complexed to α1-antichymotrypsin; and assay C, which was specific for PSA complexed to α1-antichymotrypsin.  The three assays were used to measure PSA immunoreactivity in 64 patients' sera and in the effluent after gel chromatog. of sera from four patients.  This identified an 80- to 90-kDa complex between PSA and α1-antichymotrypsin as the predominant fraction of the PSA immunoreactivity in blood plasma; an immunoreactive 25- to 40-kDa compd. was the minor fraction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq58I-zBax5c7Vg90H21EOLACvtfcHk0lio1cMUBSBglQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXmtVGntL4%253D&md5=998ce91567f588d2c044308ad8ffaa47</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLilja%26aufirst%3DH.%26aulast%3DChristensson%26aufirst%3DA.%26aulast%3DDahlen%26aufirst%3DU.%26aulast%3DMatikainen%26aufirst%3DM.%2BT.%26aulast%3DNilsson%26aufirst%3DO.%26aulast%3DPettersson%26aufirst%3DK.%26aulast%3DLovgren%26aufirst%3DT.%26atitle%3DProstate-specific%2520antigen%2520in%2520serum%2520occurs%2520predominantly%2520in%2520complex%2520with%2520a1-antichymotrypsin%26jtitle%3DClin.%2520Chem.%26date%3D1991%26volume%3D37%26spage%3D1618%26epage%3D1625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Stenman, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leinonen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfthan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rannikko, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuhkanen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfthan, O.</span><span> </span><span class="NLM_article-title">A complex between prostate specific antigen and a1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1991&pages=222-226&author=U.+H.+Stenmanauthor=J.+Leinonenauthor=H.+Alfthanauthor=S.+Rannikkoauthor=K.+Tuhkanenauthor=O.+Alfthan&title=A+complex+between+prostate+specific+antigen+and+a1-antichymotrypsin+is+the+major+form+of+prostate-specific+antigen+in+serum+of+patients+with+prostatic+cancer%3A+assay+of+the+complex+improves+clinical+sensitivity+for+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStenman%26aufirst%3DU.%2BH.%26aulast%3DLeinonen%26aufirst%3DJ.%26aulast%3DAlfthan%26aufirst%3DH.%26aulast%3DRannikko%26aufirst%3DS.%26aulast%3DTuhkanen%26aufirst%3DK.%26aulast%3DAlfthan%26aufirst%3DO.%26atitle%3DA%2520complex%2520between%2520prostate%2520specific%2520antigen%2520and%2520a1-antichymotrypsin%2520is%2520the%2520major%2520form%2520of%2520prostate-specific%2520antigen%2520in%2520serum%2520of%2520patients%2520with%2520prostatic%2520cancer%253A%2520assay%2520of%2520the%2520complex%2520improves%2520clinical%2520sensitivity%2520for%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D1991%26volume%3D51%26spage%3D222%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Denmeade, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakobsen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lilja, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, J. T.</span><span> </span><span class="NLM_article-title">Prostate-specific antigen (PSA) activated thapsigargin prodrug as targeted therapy for prostate cancer</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">990</span><span class="NLM_x">–</span> <span class="NLM_lpage">1000</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm301718c&amp;key=10.1093%2Fjnci%2F95.13.990" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm301718c&amp;key=12837835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm301718c&amp;key=1%3ACAS%3A528%3ADC%252BD3sXltFygtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2003&pages=990-1000&author=S.+R.+Denmeadeauthor=C.+Jakobsenauthor=S.+Janssenauthor=S.+R.+Khanauthor=H.+Liljaauthor=S.+B.+Christensenauthor=J.+T.+Isaacs&title=Prostate-specific+antigen+%28PSA%29+activated+thapsigargin+prodrug+as+targeted+therapy+for+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer</span></div><div class="casAuthors">Denmeade, Samuel R.; Jakobsen, Carsten M.; Janssen, Samuel; Khan, Saeed R.; Garrett, Elizabeth S.; Lilja, Hans; Christensen, S. Brogger; Isaacs, John T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">990-1000</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Std. anti-proliferative chemotherapy is relatively ineffective against slowly proliferating androgen-independent prostate cancer cells within metastatic sites.  In contrast, the lipophilic cytotoxin thapsigargin, which causes apoptosis by disrupting intracellular free Ca2+ levels, is effective against both proliferative and quiescent (i.e., G0-arrested) cells.  However, thapsigargin's mechanism of action indicates that it is unlikely to be selective for cancer cells or prostate cells.  We coupled a chem. modified form of thapsigargin, L12ADT, to a peptide carrier that is a substrate for the prostate-specific antigen (PSA) protease to produce a sol., cell-impermeant latent prodrug that is specifically activated extracellularly within metastatic prostate cancer sites by PSA.  We analyzed the kinetics of PSA hydrolysis of the prodrug, the in vitro cytotoxicity of the prodrug against PSA-producing LNCaP human prostate cancer and PSA non-producing HCT-116 human colon cancer cells, and the in vivo pharmacokinetics of the prodrug in mice.  We also analyzed antitumor efficacy of the prodrug in nude mice xenograft models of prostate cancer (using LNCaP cells) and renal carcinoma (using human SN12C cells).  The L12ADT peptide prodrug was hydrolyzed efficiently by PSA, was selectively toxic to PSA-producing prostate cancer cells in vitro, and was stable in human plasma.  A single dose of 7 mg/kg resulted in a peak serum prodrug concn. of 15.4±1.1 μM and a half-life of approx. 2.8 h.  Over 24 h, less than 0.5% of free L12ADT was obsd. in plasma.  Levels of prodrug and liberated L12ADT in prostate cancer xenograft tumors were approx. eightfold and sixfold, resp., higher than the in vitro LD50s.  Prostate cancer xenograft tumors in mice treated with prodrug by i.v. administration were growth-inhibited without substantial host toxicity.  Continuous s.c. prodrug administration in mice produced complete growth inhibition of established PSA-producing prostate cancer xenograft tumors but had no effect on PSA non-producing renal carcinoma xenograft tumors.  Further development of PSA-activated thapsigargin prodrugs as therapy for metastatic prostate cancer is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF5KzcmdurTrVg90H21EOLACvtfcHk0ljqjykE8xt7RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXltFygtb4%253D&md5=1d4d04fa16cf7ce8989727164379d5cc</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F95.13.990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F95.13.990%26sid%3Dliteratum%253Aachs%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26aulast%3DJakobsen%26aufirst%3DC.%26aulast%3DJanssen%26aufirst%3DS.%26aulast%3DKhan%26aufirst%3DS.%2BR.%26aulast%3DLilja%26aufirst%3DH.%26aulast%3DChristensen%26aufirst%3DS.%2BB.%26aulast%3DIsaacs%26aufirst%3DJ.%2BT.%26atitle%3DProstate-specific%2520antigen%2520%2528PSA%2529%2520activated%2520thapsigargin%2520prodrug%2520as%2520targeted%2520therapy%2520for%2520prostate%2520cancer%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2003%26volume%3D95%26spage%3D990%26epage%3D1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Williams, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merchant, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett-Mayer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckley, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denmeade, S. R.</span><span> </span><span class="NLM_article-title">A prostate-specific antigen-activated channel-forming toxin as therapy for prostatic disease</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">376</span><span class="NLM_x">–</span> <span class="NLM_lpage">385</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm301718c&amp;key=10.1093%2Fjnci%2Fdjk065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm301718c&amp;key=17341729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm301718c&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvVOksLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2007&pages=376-385&author=S.+A.+Williamsauthor=R.+F.+Merchantauthor=E.+Garrett-Mayerauthor=J.+T.+Isaacsauthor=J.+T.+Buckleyauthor=S.+R.+Denmeade&title=A+prostate-specific+antigen-activated+channel-forming+toxin+as+therapy+for+prostatic+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A prostate-specific antigen-activated channel-forming toxin as therapy for prostatic disease</span></div><div class="casAuthors">Williams, Simon A.; Merchant, Rosemina F.; Garrett-Mayer, Elizabeth; Isaacs, John T.; Buckley, J. Thomas; Denmeade, Samuel R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">376-385</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Most men will develop prostatic abnormalities, such as benign prostatic hyperplasia (BPH) or prostate cancer, as they age.  Prostate-specific antigen (PSA) is a serine protease that is secreted at high levels by the normal and diseased prostate.  Therapies that are activated by PSA may prove effective in treating prostatic malignancies.  We modified proaerolysin (PA), the inactive precursor of a bacterial cytolytic pore-forming protein, to produce a PSA-activated protoxin (PRX302).  The viability of the prostate adenocarcinoma cell lines LNCaP, PC-3, CWR22H, and DU145 and the bladder cancer cell line TSU after treatment with PA or PRX302 in the presence or absence of purified PSA was assayed.  Mice carrying xenograft tumors derived from LNCaP, CWR22H, or TSU cells were treated with intratumoral injection of PA or PRX302, and tumor size was monitored.  To test the safety of PRX302, we administered it into the PSA-secreting prostate glands of cynomolgus monkeys.  All statistical tests were two-sided.  Native PA was highly toxic in vitro but had no tumor-specific effects in vitro or in vivo.  Picomolar concns. of PRX302 led to PSA-dependent decreases in cell viability in vitro (PRX302 vs. PRX302 + PSA: DU145 cells, mean viability = 78.7% vs. mean = 1.6%, difference = 77.1%, 95% confidence interval [CI] = 70.6% to 86.1%; P<.001; TSU cells, mean = 100.2% vs. mean = 1.4%, difference = 98.8%, 95% CI = 96.4% to 104.0%; P < .001).  Single intratumoral injections of PRX302 produced substantial and often complete regression of PSA-secreting human prostate cancer xenografts (5 μg dose, complete regression in 6 of 26 mice bearing LNCaP or CWR22H xenografts [23%]; 10 μg dose, complete regression in 10 of 26 mice [38.5%]) but not PSA-null bladder cancer xenografts.  The prostates of cynomolgus monkeys injected with a single dose of PRX302 displayed extensive but organ-confined damage, with no toxicity to neighboring organs or general morbidity.  Our observations demonstrate the potential safe and effective intraprostatic application of this engineered protoxin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGXBHWqz3hS7Vg90H21EOLACvtfcHk0ljqjykE8xt7RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvVOksLc%253D&md5=71e66b054765e4db7ebd96bcb08d4a24</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjk065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjk065%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DS.%2BA.%26aulast%3DMerchant%26aufirst%3DR.%2BF.%26aulast%3DGarrett-Mayer%26aufirst%3DE.%26aulast%3DIsaacs%26aufirst%3DJ.%2BT.%26aulast%3DBuckley%26aufirst%3DJ.%2BT.%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26atitle%3DA%2520prostate-specific%2520antigen-activated%2520channel-forming%2520toxin%2520as%2520therapy%2520for%2520prostatic%2520disease%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2007%26volume%3D99%26spage%3D376%26epage%3D385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Ulmert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wongvipat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahamsson, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scardino, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lilja, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyers, C. L.</span><span> </span><span class="NLM_article-title">Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen</span> <span class="citation_source-journal">Cancer Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">320</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=320-327&author=D.+Ulmertauthor=M.+J.+Evansauthor=J.+P.+Hollandauthor=S.+L.+Riceauthor=J.+Wongvipatauthor=K.+Petterssonauthor=P.+A.+Abrahamssonauthor=P.+T.+Scardinoauthor=S.+M.+Larsonauthor=H.+Liljaauthor=J.+S.+Lewisauthor=C.+L.+Sawyers&title=Imaging+androgen+receptor+signaling+with+a+radiotracer+targeting+free+prostate-specific+antigen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUlmert%26aufirst%3DD.%26aulast%3DEvans%26aufirst%3DM.%2BJ.%26aulast%3DHolland%26aufirst%3DJ.%2BP.%26aulast%3DRice%26aufirst%3DS.%2BL.%26aulast%3DWongvipat%26aufirst%3DJ.%26aulast%3DPettersson%26aufirst%3DK.%26aulast%3DAbrahamsson%26aufirst%3DP.%2BA.%26aulast%3DScardino%26aufirst%3DP.%2BT.%26aulast%3DLarson%26aufirst%3DS.%2BM.%26aulast%3DLilja%26aufirst%3DH.%26aulast%3DLewis%26aufirst%3DJ.%2BS.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26atitle%3DImaging%2520androgen%2520receptor%2520signaling%2520with%2520a%2520radiotracer%2520targeting%2520free%2520prostate-specific%2520antigen%26jtitle%3DCancer%2520Discovery%26date%3D2012%26volume%3D2%26spage%3D320%26epage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">LeBeau, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denmeade, S. R.</span><span> </span><span class="NLM_article-title">Prostate-specific antigen is a ‘chymotrypsin-like’ serine protease with unique P1 substrate specificity</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3490</span><span class="NLM_x">–</span> <span class="NLM_lpage">3496</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi9001858" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=3490-3496&author=A.+M.+LeBeauauthor=P.+Singhauthor=J.+T.+Isaacsauthor=S.+R.+Denmeade&title=Prostate-specific+antigen+is+a+%E2%80%98chymotrypsin-like%E2%80%99+serine+protease+with+unique+P1+substrate+specificity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fbi9001858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi9001858%26sid%3Dliteratum%253Aachs%26aulast%3DLeBeau%26aufirst%3DA.%2BM.%26aulast%3DSingh%26aufirst%3DP.%26aulast%3DIsaacs%26aufirst%3DJ.%2BT.%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26atitle%3DProstate-specific%2520antigen%2520is%2520a%2520%25E2%2580%2598chymotrypsin-like%25E2%2580%2599%2520serine%2520protease%2520with%2520unique%2520P1%2520substrate%2520specificity%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D3490%26epage%3D3496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Denmeade, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malm, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovgren, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lilja, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, J. T.</span><span> </span><span class="NLM_article-title">Specific and efficient peptide substrates for assaying the proteolytic activity of prostate specific antigen</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">4924</span><span class="NLM_x">–</span> <span class="NLM_lpage">4930</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1997&pages=4924-4930&author=S.+R.+Denmeadeauthor=W.+Louauthor=J.+Malmauthor=J.+Lovgrenauthor=H.+Liljaauthor=J.+T.+Isaacs&title=Specific+and+efficient+peptide+substrates+for+assaying+the+proteolytic+activity+of+prostate+specific+antigen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26aulast%3DLou%26aufirst%3DW.%26aulast%3DMalm%26aufirst%3DJ.%26aulast%3DLovgren%26aufirst%3DJ.%26aulast%3DLilja%26aufirst%3DH.%26aulast%3DIsaacs%26aufirst%3DJ.%2BT.%26atitle%3DSpecific%2520and%2520efficient%2520peptide%2520substrates%2520for%2520assaying%2520the%2520proteolytic%2520activity%2520of%2520prostate%2520specific%2520antigen%26jtitle%3DCancer%2520Res.%26date%3D1997%26volume%3D57%26spage%3D4924%26epage%3D4930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Singh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeBeau, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lilja, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denmeade, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, J. I.</span><span> </span><span class="NLM_article-title">Molecular insights into substrate specificity of prostate specific antigen through structural modeling</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">984</span><span class="NLM_x">–</span> <span class="NLM_lpage">993</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2009&pages=984-993&author=P.+Singhauthor=A.+M.+LeBeauauthor=H.+Liljaauthor=S.+R.+Denmeadeauthor=J.+I.+Isaacs&title=Molecular+insights+into+substrate+specificity+of+prostate+specific+antigen+through+structural+modeling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DP.%26aulast%3DLeBeau%26aufirst%3DA.%2BM.%26aulast%3DLilja%26aufirst%3DH.%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26aulast%3DIsaacs%26aufirst%3DJ.%2BI.%26atitle%3DMolecular%2520insights%2520into%2520substrate%2520specificity%2520of%2520prostate%2520specific%2520antigen%2520through%2520structural%2520modeling%26jtitle%3DProteins%26date%3D2009%26volume%3D77%26spage%3D984%26epage%3D993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">LeBeau, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denmeade, S. R.</span><span> </span><span class="NLM_article-title">Potent and selective peptidyl boronic acid inhibitors of the serine protease prostate-specific antigen</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">665</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm301718c&amp;key=10.1016%2Fj.chembiol.2008.05.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm301718c&amp;key=18635003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm301718c&amp;key=1%3ACAS%3A528%3ADC%252BD1cXoslGmtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=665-674&author=A.+M.+LeBeauauthor=P.+Singhauthor=J.+T.+Isaacsauthor=S.+R.+Denmeade&title=Potent+and+selective+peptidyl+boronic+acid+inhibitors+of+the+serine+protease+prostate-specific+antigen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and selective peptidyl boronic acid inhibitors of the serine protease prostate-specific antigen</span></div><div class="casAuthors">LeBeau, Aaron M.; Singh, Pratap; Isaacs, John T.; Denmeade, Samuel R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">665-674</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Prostate cancer cells produce high (microgram to milligram/mL) levels of the serine protease Prostate-Specific Antigen (PSA).  PSA is enzymically active in the extracellular fluid surrounding prostate cancers but is found at 1,000- to 10,000-fold lower concns. in the circulation, where it is inactivated due to binding to abundant serum protease inhibitors.  The exclusive presence of high levels of active PSA within prostate cancer sites makes PSA an attractive candidate for targeted imaging and therapeutics.  A synthetic approach based on a peptide substrate identified first peptide aldehyde and then boronic acid inhibitors of PSA.  The best of these had the sequence Cbz-Ser-Ser-Lys-Leu-(boro)Leu, with a Ki for PSA of 65 nM.  The inhibitor had a 60-fold higher Ki for chymotrypsin.  A validated model of PSA's catalytic site confirmed the crit. interactions between the inhibitor and residues within the PSA enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1EWg1W1qwXbVg90H21EOLACvtfcHk0li8-3lUjyYH_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXoslGmtL0%253D&md5=ff449d09c36c2f8c6402d571c4baeec7</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2008.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2008.05.020%26sid%3Dliteratum%253Aachs%26aulast%3DLeBeau%26aufirst%3DA.%2BM.%26aulast%3DSingh%26aufirst%3DP.%26aulast%3DIsaacs%26aufirst%3DJ.%2BT.%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26atitle%3DPotent%2520and%2520selective%2520peptidyl%2520boronic%2520acid%2520inhibitors%2520of%2520the%2520serine%2520protease%2520prostate-specific%2520antigen%26jtitle%3DChem.%2520Biol.%26date%3D2008%26volume%3D15%26spage%3D665%26epage%3D674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Matteson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michnick, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, C. D.</span><span> </span><span class="NLM_article-title">[(1<i>R</i>)-1-Acetamido-3-(methylthuio)propyl]boronic acid and the X-ray structure of its ethylene glycol ester</span> <span class="citation_source-journal">Organometallics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">726</span><span class="NLM_x">–</span> <span class="NLM_lpage">729</span></span><div class="citationLinks">[<a href="/doi/10.1021/om00105a022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1989&pages=726-729&author=D.+S.+Mattesonauthor=T.+J.+Michnickauthor=R.+D.+Willettauthor=C.+D.+Patterson&title=%5B%281R%29-1-Acetamido-3-%28methylthuio%29propyl%5Dboronic+acid+and+the+X-ray+structure+of+its+ethylene+glycol+ester"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fom00105a022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fom00105a022%26sid%3Dliteratum%253Aachs%26aulast%3DMatteson%26aufirst%3DD.%2BS.%26aulast%3DMichnick%26aufirst%3DT.%2BJ.%26aulast%3DWillett%26aufirst%3DR.%2BD.%26aulast%3DPatterson%26aufirst%3DC.%2BD.%26atitle%3D%255B%25281R%2529-1-Acetamido-3-%2528methylthuio%2529propyl%255Dboronic%2520acid%2520and%2520the%2520X-ray%2520structure%2520of%2520its%2520ethylene%2520glycol%2520ester%26jtitle%3DOrganometallics%26date%3D1989%26volume%3D8%26spage%3D726%26epage%3D729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Debaene, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Da Silva, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pianowski, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duran, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winssinger, N.</span><span> </span><span class="NLM_article-title">Expanding the scope of PNA-encoded libraries: divergent synthesis of libraries targeting cysteine, serine and metalloproteases as well as tyrosine phosphatases</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">6577</span><span class="NLM_x">–</span> <span class="NLM_lpage">6586</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm301718c&amp;key=10.1016%2Fj.tet.2007.03.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm301718c&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtVanu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2007&pages=6577-6586&author=F.+Debaeneauthor=J.+A.+Da+Silvaauthor=Z.+Pianowskiauthor=F.+J.+Duranauthor=N.+Winssinger&title=Expanding+the+scope+of+PNA-encoded+libraries%3A+divergent+synthesis+of+libraries+targeting+cysteine%2C+serine+and+metalloproteases+as+well+as+tyrosine+phosphatases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Expanding the scope of PNA-encoded libraries: divergent synthesis of libraries targeting cysteine, serine and metallo-proteases as well as tyrosine phosphatases</span></div><div class="casAuthors">Debaene, Francois; Da Silva, Julien A.; Pianowski, Zbigniew; Duran, Fernando J.; Winssinger, Nicolas</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">6577-6586</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Seven PNA-encoded combinatorial libraries targeting proteases and phosphatases with covalent reversible and irreversible mechanism-based inhibitors were prepd.  The libraries were synthesized using modified PNA monomers, which dramatically increase the water soly. of the libraries in biol. relevant buffers.  The libraries were shown to selectively inhibit targeted enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpALOuekrkDuLVg90H21EOLACvtfcHk0li8-3lUjyYH_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtVanu7s%253D&md5=9ca7ac041164c9c3095a09d545fa1799</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2007.03.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2007.03.033%26sid%3Dliteratum%253Aachs%26aulast%3DDebaene%26aufirst%3DF.%26aulast%3DDa%2BSilva%26aufirst%3DJ.%2BA.%26aulast%3DPianowski%26aufirst%3DZ.%26aulast%3DDuran%26aufirst%3DF.%2BJ.%26aulast%3DWinssinger%26aufirst%3DN.%26atitle%3DExpanding%2520the%2520scope%2520of%2520PNA-encoded%2520libraries%253A%2520divergent%2520synthesis%2520of%2520libraries%2520targeting%2520cysteine%252C%2520serine%2520and%2520metalloproteases%2520as%2520well%2520as%2520tyrosine%2520phosphatases%26jtitle%3DTetrahedron%26date%3D2007%26volume%3D63%26spage%3D6577%26epage%3D6586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Elgendy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodwin, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scully, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skordalakes, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakkar, V. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deadman, J. J.</span><span> </span><span class="NLM_article-title">Design of a novel class of bifunctional thrombin inhibitors, synthesised by the first application of peptide boronates of solid phase chemistry</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">3305</span><span class="NLM_x">–</span> <span class="NLM_lpage">3308</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1997&pages=3305-3308&author=S.+Elgendyauthor=+Patel.author=D.+Greenauthor=C.+A.+Goodwinauthor=M.+F.+Scullyauthor=W.+Husmanauthor=E.+Skordalakesauthor=V.+V.+Kakkarauthor=J.+J.+Deadman&title=Design+of+a+novel+class+of+bifunctional+thrombin+inhibitors%2C+synthesised+by+the+first+application+of+peptide+boronates+of+solid+phase+chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DElgendy%26aufirst%3DS.%26aulast%3DPatel.%26aulast%3DGreen%26aufirst%3DD.%26aulast%3DGoodwin%26aufirst%3DC.%2BA.%26aulast%3DScully%26aufirst%3DM.%2BF.%26aulast%3DHusman%26aufirst%3DW.%26aulast%3DSkordalakes%26aufirst%3DE.%26aulast%3DKakkar%26aufirst%3DV.%2BV.%26aulast%3DDeadman%26aufirst%3DJ.%2BJ.%26atitle%3DDesign%2520of%2520a%2520novel%2520class%2520of%2520bifunctional%2520thrombin%2520inhibitors%252C%2520synthesised%2520by%2520the%2520first%2520application%2520of%2520peptide%2520boronates%2520of%2520solid%2520phase%2520chemistry%26jtitle%3DTetrahedron%2520Lett.%26date%3D1997%26volume%3D38%26spage%3D3305%26epage%3D3308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Q.</span><span> </span><span class="NLM_article-title">Design, synthesis, biological evaluation, and structure–activity relationship (SAR) discussion of dipeptidyl boronate proteasome inhibitors, part I: comprehensive understanding of the SAR of alpha-amino acid boronates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4192</span><span class="NLM_x">–</span> <span class="NLM_lpage">4199</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9005093" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4192-4199&author=Y.+Zhuauthor=X.+Zhaoauthor=X.+Zhuauthor=G.+Wuauthor=Y.+Liauthor=Y.+Maauthor=Y.+Yuanauthor=J.+Yangauthor=Y.+Huauthor=L.+Aiauthor=Q.+Gao&title=Design%2C+synthesis%2C+biological+evaluation%2C+and+structure%E2%80%93activity+relationship+%28SAR%29+discussion+of+dipeptidyl+boronate+proteasome+inhibitors%2C+part+I%3A+comprehensive+understanding+of+the+SAR+of+alpha-amino+acid+boronates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm9005093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9005093%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DYuan%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DAi%26aufirst%3DL.%26aulast%3DGao%26aufirst%3DQ.%26atitle%3DDesign%252C%2520synthesis%252C%2520biological%2520evaluation%252C%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520%2528SAR%2529%2520discussion%2520of%2520dipeptidyl%2520boronate%2520proteasome%2520inhibitors%252C%2520part%2520I%253A%2520comprehensive%2520understanding%2520of%2520the%2520SAR%2520of%2520alpha-amino%2520acid%2520boronates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4192%26epage%3D4199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, R.</span><span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of tripeptide boronic acid proteasome inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6851</span><span class="NLM_x">–</span> <span class="NLM_lpage">6861</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=6851-6861&author=Y.+Zhuauthor=S.+Yaoauthor=B.+Xuauthor=Z.+Geauthor=J.+Cuiauthor=T.+Chengauthor=R.+Li&title=Design%2C+synthesis+and+biological+evaluation+of+tripeptide+boronic+acid+proteasome+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DYao%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DB.%26aulast%3DGe%26aufirst%3DZ.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DR.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520tripeptide%2520boronic%2520acid%2520proteasome%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D6851%26epage%3D6861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Watanabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Momose, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akamatsu, Y.</span><span> </span><span class="NLM_article-title">Structure–activity relationship of boronic acid derivatives of tyropeptin: proteasome inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">5839</span><span class="NLM_x">–</span> <span class="NLM_lpage">5842</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=5839-5842&author=T.+Watanabeauthor=H.+Abeauthor=I.+Momoseauthor=Y.+Takahashiauthor=D.+Ikedaauthor=Y.+Akamatsu&title=Structure%E2%80%93activity+relationship+of+boronic+acid+derivatives+of+tyropeptin%3A+proteasome+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DAbe%26aufirst%3DH.%26aulast%3DMomose%26aufirst%3DI.%26aulast%3DTakahashi%26aufirst%3DY.%26aulast%3DIkeda%26aufirst%3DD.%26aulast%3DAkamatsu%26aufirst%3DY.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520of%2520boronic%2520acid%2520derivatives%2520of%2520tyropeptin%253A%2520proteasome%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D5839%26epage%3D5842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Watanabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Momose, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umezawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akamatsu, Y.</span><span> </span><span class="NLM_article-title">Synthesis of boronic acid derivatives of tyropeptin: proteasome inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2343</span><span class="NLM_x">–</span> <span class="NLM_lpage">2345</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2343-2345&author=T.+Watanabeauthor=I.+Momoseauthor=M.+Abeauthor=H.+Abeauthor=R.+Sawaauthor=Y.+Umezawaauthor=D.+Ikedaauthor=Y.+Takahashiauthor=Y.+Akamatsu&title=Synthesis+of+boronic+acid+derivatives+of+tyropeptin%3A+proteasome+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DMomose%26aufirst%3DI.%26aulast%3DAbe%26aufirst%3DM.%26aulast%3DAbe%26aufirst%3DH.%26aulast%3DSawa%26aufirst%3DR.%26aulast%3DUmezawa%26aufirst%3DY.%26aulast%3DIkeda%26aufirst%3DD.%26aulast%3DTakahashi%26aufirst%3DY.%26aulast%3DAkamatsu%26aufirst%3DY.%26atitle%3DSynthesis%2520of%2520boronic%2520acid%2520derivatives%2520of%2520tyropeptin%253A%2520proteasome%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2343%26epage%3D2345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Auffinger, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hays, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westhof, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, P. S.</span><span> </span><span class="NLM_article-title">Halogen bonds in biological molecules</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">16789</span><span class="NLM_x">–</span> <span class="NLM_lpage">16794</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm301718c&amp;key=10.1073%2Fpnas.0407607101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm301718c&amp;key=15557000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm301718c&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFansr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=16789-16794&author=P.+Auffingerauthor=F.+A.+Haysauthor=E.+Westhofauthor=P.+S.+Ho&title=Halogen+bonds+in+biological+molecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Halogen bonds in biological molecules</span></div><div class="casAuthors">Auffinger, Pascal; Hays, Franklin A.; Westhof, Eric; Ho, P. Shing</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">16789-16794</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Short oxygen-halogen interactions have been known in org. chem. since the 1950s and recently have been exploited in the design of supramol. assemblies.  The present survey of protein and nucleic acid structures reveals similar halogen bonds as potentially stabilizing inter- and intramol. interactions that can affect ligand binding and mol. folding.  A halogen bond in biomols. can be defined as a short C-X···O-Y interaction (C-X is a carbon-bonded chlorine, bromine, or iodine, and O-Y is a carbonyl, hydroxyl, charged carboxylate, or phosphate group), where the X···O distance is less than or equal to the sums of the resp. van der Waals radii (3.27 Å for Cl···O, 3.37 Å for Br···O, and 3.50 Å for I···O) and can conform to the geometry seen in small mols., with the C-X···O angle ≈165° (consistent with a strong directional polarization of the halogen) and the X···O-Y angle ≈120°.  Alternative geometries can be imposed by the more complex environment found in biomols., depending on which of the two types of donor systems are involved in the interaction: (i) the lone pair electrons of oxygen (and, to a lesser extent, nitrogen and sulfur) atoms or (ii) the delocalized π-electrons of peptide bonds or carboxylate or amide groups.  Thus, the specific geometry and diversity of the interacting partners of halogen bonds offer new and versatile tools for the design of ligands as drugs and materials in nanotechnol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPMdZU91iT77Vg90H21EOLACvtfcHk0li7WCalpcOzCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFansr3P&md5=dfcce25d4e336c66294f6ab8ce412154</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0407607101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0407607101%26sid%3Dliteratum%253Aachs%26aulast%3DAuffinger%26aufirst%3DP.%26aulast%3DHays%26aufirst%3DF.%2BA.%26aulast%3DWesthof%26aufirst%3DE.%26aulast%3DHo%26aufirst%3DP.%2BS.%26atitle%3DHalogen%2520bonds%2520in%2520biological%2520molecules%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2004%26volume%3D101%26spage%3D16789%26epage%3D16794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Howard, E. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanishvili, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cachau, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitschler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chevrier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamour, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Zandt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moras, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joachimiak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Podjarny, A. D.</span><span> </span><span class="NLM_article-title">Ultrahigh resolution drug design I: Details of interactions in human aldose reductase–inhibitor complex at 0.66 Å</span> <span class="citation_source-journal">Proteins: Struct., Funct., Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">792</span><span class="NLM_x">–</span> <span class="NLM_lpage">804</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=792-804&author=E.+I.+Howardauthor=R.+Sanishviliauthor=R.+E.+Cachauauthor=A.+Mitschlerauthor=B.+Chevrierauthor=P.+Barthauthor=V.+Lamourauthor=M.+Van+Zandtauthor=E.+Sibleyauthor=C.+Bonauthor=T.+R.+Morasauthor=A.+Joachimiakauthor=A.+D.+Podjarny&title=Ultrahigh+resolution+drug+design+I%3A+Details+of+interactions+in+human+aldose+reductase%E2%80%93inhibitor+complex+at+0.66+%C3%85"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoward%26aufirst%3DE.%2BI.%26aulast%3DSanishvili%26aufirst%3DR.%26aulast%3DCachau%26aufirst%3DR.%2BE.%26aulast%3DMitschler%26aufirst%3DA.%26aulast%3DChevrier%26aufirst%3DB.%26aulast%3DBarth%26aufirst%3DP.%26aulast%3DLamour%26aufirst%3DV.%26aulast%3DVan%2BZandt%26aufirst%3DM.%26aulast%3DSibley%26aufirst%3DE.%26aulast%3DBon%26aufirst%3DC.%26aulast%3DMoras%26aufirst%3DT.%2BR.%26aulast%3DJoachimiak%26aufirst%3DA.%26aulast%3DPodjarny%26aufirst%3DA.%2BD.%26atitle%3DUltrahigh%2520resolution%2520drug%2520design%2520I%253A%2520Details%2520of%2520interactions%2520in%2520human%2520aldose%2520reductase%25E2%2580%2593inhibitor%2520complex%2520at%25200.66%2520%25C3%2585%26jtitle%3DProteins%253A%2520Struct.%252C%2520Funct.%252C%2520Genet.%26date%3D2004%26volume%3D55%26spage%3D792%26epage%3D804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Dekker, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Disley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hastings, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadfield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reader, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julyan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweit, J.</span><span> </span><span class="NLM_article-title">Functional comparison of annexin V analogues labeled indirectly and directly with iodine-124</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">413</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm301718c&amp;key=10.1016%2Fj.nucmedbio.2005.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm301718c&amp;key=15878510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm301718c&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVKksro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2005&pages=403-413&author=B.+Dekkerauthor=H.+Keenauthor=D.+Shawauthor=L.+Disleyauthor=D.+Hastingsauthor=J.+Hadfieldauthor=A.+Readerauthor=D.+Allanauthor=P.+Julyanauthor=A.+Watsonauthor=J.+Zweit&title=Functional+comparison+of+annexin+V+analogues+labeled+indirectly+and+directly+with+iodine-124"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Functional comparison of annexin V analogues labeled indirectly and directly with iodine-124</span></div><div class="casAuthors">Dekker, Bronwen; Keen, Heather; Shaw, David; Disley, Lynn; Hastings, David; Hadfield, John; Reader, Andrew; Allan, Donald; Julyan, Peter; Watson, Alastair; Zweit, Jamal</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">403-413</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">We are interested in imaging cell death in vivo using annexin V radiolabeled with 124I.  In this study, [124I]4IB-annexin V and [124I]4IB-ovalbumin were made using [124I]N-hydroxysuccinimidyl-4-iodobenzoate prepd. by iododestannylation of N-hydroxysuccinimidyl-4-(tributylstannyl)benzoate.  [124I]4IB-annexin V binds to phosphatidylserine-coated microtiter plates and apoptotic Jurkat cells and accumulates in hepatic apoptotic lesions in mice treated with anti-Fas antibody, while [124I]4IB-ovalbumin does not.  In comparison with 124I-annexin V, [124I]4IB-annexin V has a higher rate of binding to phosphatidylserine in vitro, a higher kidney and urine uptake, a lower thyroid and stomach content uptake, greater plasma stability and a lower rate of plasma clearance.  Binding of radioactivity to apoptotic cells relative to normal cells in vitro and in vivo appears to be lower for [124I]4IB-annexin V than for 124I-annexin V.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbmIDr1P0gOLVg90H21EOLACvtfcHk0ljPX9ucE6NV1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVKksro%253D&md5=d7dc3e89b659f69d321a0ce7bb678e3a</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2005.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2005.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DDekker%26aufirst%3DB.%26aulast%3DKeen%26aufirst%3DH.%26aulast%3DShaw%26aufirst%3DD.%26aulast%3DDisley%26aufirst%3DL.%26aulast%3DHastings%26aufirst%3DD.%26aulast%3DHadfield%26aufirst%3DJ.%26aulast%3DReader%26aufirst%3DA.%26aulast%3DAllan%26aufirst%3DD.%26aulast%3DJulyan%26aufirst%3DP.%26aulast%3DWatson%26aufirst%3DA.%26aulast%3DZweit%26aufirst%3DJ.%26atitle%3DFunctional%2520comparison%2520of%2520annexin%2520V%2520analogues%2520labeled%2520indirectly%2520and%2520directly%2520with%2520iodine-124%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2005%26volume%3D32%26spage%3D403%26epage%3D413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Nanus, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milowsky, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostakoglu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith-Jones, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallabahajosula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bander, N. H.</span><span> </span><span class="NLM_article-title">Clinical use of monoclonal antibody HuJ591 therapy: targeting prostate specific membrane antigen</span> <span class="citation_source-journal">J. Urol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x">, </span> <span class="NLM_fpage">S84</span><span class="NLM_x">–</span> <span class="NLM_lpage">S88</span><div class="note"><p class="first last">discussion S88–S89.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2003&pages=S84-S88&author=D.+M.+Nanusauthor=M.+I.+Milowskyauthor=L.+Kostakogluauthor=P.+M.+Smith-Jonesauthor=S.+Vallabahajosulaauthor=S.+J.+Goldsmithauthor=N.+H.+Bander&title=Clinical+use+of+monoclonal+antibody+HuJ591+therapy%3A+targeting+prostate+specific+membrane+antigen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNanus%26aufirst%3DD.%2BM.%26aulast%3DMilowsky%26aufirst%3DM.%2BI.%26aulast%3DKostakoglu%26aufirst%3DL.%26aulast%3DSmith-Jones%26aufirst%3DP.%2BM.%26aulast%3DVallabahajosula%26aufirst%3DS.%26aulast%3DGoldsmith%26aufirst%3DS.%2BJ.%26aulast%3DBander%26aufirst%3DN.%2BH.%26atitle%3DClinical%2520use%2520of%2520monoclonal%2520antibody%2520HuJ591%2520therapy%253A%2520targeting%2520prostate%2520specific%2520membrane%2520antigen%26jtitle%3DJ.%2520Urol.%26date%3D2003%26volume%3D170%26spage%3DS84%26epage%3DS88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Smith-Jones, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallabahajosula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastidas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bander, N. H.</span><span> </span><span class="NLM_article-title">Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">610</span><span class="NLM_x">–</span> <span class="NLM_lpage">617</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm301718c&amp;key=12679407" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm301718c&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtlKnsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=610-617&author=P.+M.+Smith-Jonesauthor=S.+Vallabahajosulaauthor=V.+Navarroauthor=D.+Bastidasauthor=S.+J.+Goldsmithauthor=N.+H.+Bander&title=Radiolabeled+monoclonal+antibodies+specific+to+the+extracellular+domain+of+prostate-specific+membrane+antigen%3A+preclinical+studies+in+nude+mice+bearing+LNCaP+human+prostate+tumor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor</span></div><div class="casAuthors">Smith-Jones, Peter M.; Vallabhajosula, Shankar; Navarro, Vincent; Bastidas, Diego; Goldsmith, Stanley J.; Bander, Neil H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">610-617</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine</span>)
        </div><div class="casAbstract">Prostate-specific membrane antigen (PSMA), a transmembrane glycoprotein, is highly expressed by virtually all prostate cancers.  PSMA is also expressed on the tumor vascular endothelium of virtually all solid carcinomas and sarcomas but not on normal vascular endothelium.  PSMA is currently the focus of several diagnostic and therapeutic strategies.  We have previously reported on the radiolabeling and in vitro binding properties of monoclonal antibodies (mAbs) (J415, J533, and J591) that recognize and bind with high affinity to the extracellular domain of PSMA (PSMAext).  This article reports on the in vivo behavior and tumor uptake of 131I- and 111In-labeled anti-PSMAext mAbs (J415, J533, and J591) and their potential utility for radioimmunotherapy.  Methods: In nude mice bearing PSMA-pos. human LNCaP tumors, the pharmacokinetics, biodistribution, and tumor uptake of these antibodies was compared with 111In-7E11 mAb, specific to the intracellular domain of PSMA (PSMAint).  Autoradiog. studies were done to identify intratumoral distribution of radiolabeled mAbs.  Results: With 131I-labeled antibodies, the net tumor retention of radioactivity by day 6 was significantly higher with J415 (15.4% ± 1.1 %) and 7E11 (14.5% ± 1.7%) than with J591 (9.58% ± 1.1 %).  By contrast, the tumor uptake of 111In-DOTA-labeled J415 and J591 gradually increased with time and was quite similar to that of 7E11.  In addn., the blood clearance of 111In-labeled J415 and J591 antibodies was relatively faster than that of radiolabeled 7E11.  As a consequence, the tumor-to-blood ratios with J415 and J591 were higher than that of 7E11.  The localization of radiolabeled anti-PSMAext antibodies in PSMA-pos. LNCaP tumors was highly specific because the tumor uptake of 131I-labeled J415 and J591 was more than twice that of a nonspecific antibody.  Furthermore, the tumor uptake of 131I-J591 was almost 20 times higher in PSMA-pos. LNCaP tumors than in PSMA-neg. PC3 and DU145 tumor xenografts.  Autoradiog. studies suggested that 7E11 (anti-PSMAint) distinctly favors localization to areas of necrosis whereas J415 and J591 (anti-PSMAext) demonstrated a distinct preferential accumulation in areas of viable tumor.  Conclusion: These results clearly demonstrate that PSMA-specific internalizing antibodies such as J415 and J591 may be the ideal mAbs for the development of novel therapeutic methods to target the delivery of β-emitting radionuclides (131I, 90Y, and 177Lu) for the treatment of PSMA-pos. tumors.  In addn., because J591 and J415 mAbs are specific to PSMAext, thus targeting viable tumor, these immunoconjugates are better candidates for targeted radioimmunotherapy than are antibodies targeting PSMAint.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqISIjgSybaqrVg90H21EOLACvtfcHk0ljPX9ucE6NV1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtlKnsbw%253D&md5=4aad4f06380d2d49c327cdf4f504ce89</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmith-Jones%26aufirst%3DP.%2BM.%26aulast%3DVallabahajosula%26aufirst%3DS.%26aulast%3DNavarro%26aufirst%3DV.%26aulast%3DBastidas%26aufirst%3DD.%26aulast%3DGoldsmith%26aufirst%3DS.%2BJ.%26aulast%3DBander%26aufirst%3DN.%2BH.%26atitle%3DRadiolabeled%2520monoclonal%2520antibodies%2520specific%2520to%2520the%2520extracellular%2520domain%2520of%2520prostate-specific%2520membrane%2520antigen%253A%2520preclinical%2520studies%2520in%2520nude%2520mice%2520bearing%2520LNCaP%2520human%2520prostate%2520tumor%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2003%26volume%3D44%26spage%3D610%26epage%3D617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Cohen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peehl, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamarei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giudice, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenfeld, R. G.</span><span> </span><span class="NLM_article-title">Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">1046</span><span class="NLM_x">–</span> <span class="NLM_lpage">1053</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm301718c&amp;key=10.1210%2Fjc.75.4.1046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm301718c&amp;key=1383255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm301718c&amp;key=1%3ACAS%3A528%3ADyaK3sXitVGrtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1992&pages=1046-1053&author=P.+Cohenauthor=H.+C.+Gravesauthor=D.+M.+Peehlauthor=M.+Kamareiauthor=L.+C.+Giudiceauthor=R.+G.+Rosenfeld&title=Prostate-specific+antigen+%28PSA%29+is+an+insulin-like+growth+factor+binding+protein-3+protease+found+in+seminal+plasma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma</span></div><div class="casAuthors">Cohen, Pinchas; Graves, Howard C. B.; Peehl, Donna M.; Kamarei, Mehdi; Giudice, Linda C.; Rosenfeld, Ron G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1046-53</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    </div><div class="casAbstract">IGF binding protein-3 (IGFBP-3), the major serum carrier protein for the IGFs, is absent from Western ligand blots of seminal plasma, but is detectable by RIA.  IGFBP-3 protease activity has recently been described in pregnancy serum.  The possibility was examd. that seminal plasma contains an IGFBP-3 protease, by incubating seminal plasma with 125I-labeled human IGFBP-3.  Seminal plasma had potent IGFBP-3 protease activity with a cleavage pattern different from that of pregnancy serum.  Prostate-specific antigen (PSA) is a serine protease found in semen.  Autoradiographs measuring IGFBP-3 protease activity demonstrated that purified PSA cleaved IGFBP-3, yielding a cleavage pattern identical to that of seminal plasma.  IGFBP-2 and -4 in seminal plasma were not degraded by PSA.  Cleavage of IGFBP-3 by PSA resulted in a marked redn. in the binding affinity of the fragments to IGF-I, but not IGF-II.  PSA may thus serve to modulate IGF function within the reproductive system or in prostate cancer by altering IGF-IGFBP-3 interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5Khiuaj51ybVg90H21EOLACvtfcHk0liGUneJa9iEtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXitVGrtbo%253D&md5=8fa410669c8f4f2f7ee8b55e1b2fbcd4</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1210%2Fjc.75.4.1046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.75.4.1046%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DGraves%26aufirst%3DH.%2BC.%26aulast%3DPeehl%26aufirst%3DD.%2BM.%26aulast%3DKamarei%26aufirst%3DM.%26aulast%3DGiudice%26aufirst%3DL.%2BC.%26aulast%3DRosenfeld%26aufirst%3DR.%2BG.%26atitle%3DProstate-specific%2520antigen%2520%2528PSA%2529%2520is%2520an%2520insulin-like%2520growth%2520factor%2520binding%2520protein-3%2520protease%2520found%2520in%2520seminal%2520plasma%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D1992%26volume%3D75%26spage%3D1046%26epage%3D1053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Iwamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockett, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lilja, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gershagen, S.</span><span> </span><span class="NLM_article-title">Alteration of the hormonal bioactivity of parathyroid hormone-related protein (PTHrP) as a result of limited proteolysis by prostate-specific antigen</span> <span class="citation_source-journal">Urology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">325</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1996&pages=317-325&author=M.+Iwamuraauthor=J.+Hellmanauthor=A.+T.+Cockettauthor=H.+Liljaauthor=S.+Gershagen&title=Alteration+of+the+hormonal+bioactivity+of+parathyroid+hormone-related+protein+%28PTHrP%29+as+a+result+of+limited+proteolysis+by+prostate-specific+antigen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIwamura%26aufirst%3DM.%26aulast%3DHellman%26aufirst%3DJ.%26aulast%3DCockett%26aufirst%3DA.%2BT.%26aulast%3DLilja%26aufirst%3DH.%26aulast%3DGershagen%26aufirst%3DS.%26atitle%3DAlteration%2520of%2520the%2520hormonal%2520bioactivity%2520of%2520parathyroid%2520hormone-related%2520protein%2520%2528PTHrP%2529%2520as%2520a%2520result%2520of%2520limited%2520proteolysis%2520by%2520prostate-specific%2520antigen%26jtitle%3DUrology%26date%3D1996%26volume%3D48%26spage%3D317%26epage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Cramer, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peehl, D, M.</span><span> </span><span class="NLM_article-title">Prostate specific antigen cleaves parathyroid hormone-related protein in the PTH-like domain: inactivation of PTHrP-stimulated cAMP accumulation in mouse osteoblasts</span> <span class="citation_source-journal">J. Urol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">156</span><span class="NLM_x">, </span> <span class="NLM_fpage">526</span><span class="NLM_x">–</span> <span class="NLM_lpage">531</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm301718c&amp;key=10.1016%2FS0022-5347%2801%2965919-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm301718c&amp;key=8683730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm301718c&amp;key=1%3ACAS%3A528%3ADyaK28XkvFartLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=1996&pages=526-531&author=S.+D.+Cramerauthor=Z.+Chenauthor=D%2C+M.+Peehl&title=Prostate+specific+antigen+cleaves+parathyroid+hormone-related+protein+in+the+PTH-like+domain%3A+inactivation+of+PTHrP-stimulated+cAMP+accumulation+in+mouse+osteoblasts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Prostate specific antigen cleaves parathyroid hormone-related protein in the PTH-like domain: Inactivation of PTHrP-stimulated cAMP accumulation in mouse osteoblasts</span></div><div class="casAuthors">Cramer, Scott D.; Chen, Zuxiong; Peehl, Donna M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Urology (Baltimore)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">2, Pt. 1</span>),
    <span class="NLM_cas:pages">526-531</span>CODEN:
                <span class="NLM_cas:coden">JOURAA</span>;
        ISSN:<span class="NLM_cas:issn">0022-5347</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">The purpose of this study was to det. whether parathyroid hormone-related protein (PTHrP) is a substrate of prostate-specific antigen (PSA) and how the biol. activity of PTHrP may be altered by cleavage with PSA.  PSA cleavage of recombinant human PTHrP 1-141 was conducted in vitro at 37° and analyzed by SDS-PAGE.  Five rounds of automated amino-terminal amino acid sequence anal. were performed on blotted PSA-cleaved PTHrP peptide fragments to det. the PSA cleavage sites.  The mouse osteoblast cell line MC3T3-E1 was used to test whether PSA cleavage of PTHrP 1-141 altered its ability to stimulate cAMP prodn.  PSA specifically cleaved PTHrP 1-141 in a time- and dose-dependent manner.  Cleavage of PTHrP 1-141 by PSA generated fragments on Coomassie-stained acrylamide gels that migrated with mobilities that corresponded to 19.5, 17, 15 and <7 kDa.  The preferred PSA cleavage site of PTHrP 1-141 was detd. to be at the carboxyl-terminus of phenylalanine 23, consistent with chymotryptic-like enzymic activity of PSA.  Cleavage of PTHrP by PSA completely abolished the ability of PTHrP to stimulate cAMP prodn.  Thus, cleavage of PTHrP 1-141 by PSA carboxyl-terminal to phenylalanine 23 represents a unique pattern of PTHrP processing that may be specific to the prostate.  Prostate-specific antigen inactivation of the cAMP-inducing activity of PTHrP 1-141 demonstrates that PSA cleavage regulates the biol. activity of PTHrP.  These results have implications for the role of PTHrP in prostate cancer metastasis to bone and its subsequent regulation of bone remodeling.  Study of the biol. activities of the PSA-generated PTHrP peptides identified in this study merits further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp3vqjFhU9O7Vg90H21EOLACvtfcHk0liGUneJa9iEtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XkvFartLs%253D&md5=f537278800b1f1530acd7036cedf2e46</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS0022-5347%2801%2965919-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-5347%252801%252965919-6%26sid%3Dliteratum%253Aachs%26aulast%3DCramer%26aufirst%3DS.%2BD.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DPeehl%26aufirst%3DD%252C%2BM.%26atitle%3DProstate%2520specific%2520antigen%2520cleaves%2520parathyroid%2520hormone-related%2520protein%2520in%2520the%2520PTH-like%2520domain%253A%2520inactivation%2520of%2520PTHrP-stimulated%2520cAMP%2520accumulation%2520in%2520mouse%2520osteoblasts%26jtitle%3DJ.%2520Urol.%26date%3D1996%26volume%3D156%26spage%3D526%26epage%3D531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Dallas, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cramer, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peehl, D. M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonewald, L. F.</span><span> </span><span class="NLM_article-title">Preferential production of latent transforming growth factor-2 by primary prostatic epithelial cells and its activation by prostate-specific antigen</span> <span class="citation_source-journal">J. Cell. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">202</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">370</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm301718c&amp;key=10.1002%2Fjcp.20147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm301718c&amp;key=15389580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm301718c&amp;key=1%3ACAS%3A528%3ADC%252BD2MXot1ajsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=2005&pages=361-370&author=S.+L.+Dallasauthor=S.+Zhaoauthor=S.+D.+Cramerauthor=Z.+Chenauthor=D.+M+Peehlauthor=L.+F.+Bonewald&title=Preferential+production+of+latent+transforming+growth+factor-2+by+primary+prostatic+epithelial+cells+and+its+activation+by+prostate-specific+antigen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Preferential production of latent transforming growth factor β-2 by primary prostatic epithelial cells and its activation by prostate-specific antigen</span></div><div class="casAuthors">Dallas, S. L.; Zhao, S.; Cramer, S. D.; Chen, Z.; Peehl, D. M.; Bonewald, L. F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">202</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">361-370</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Three mammalian isoforms of transforming growth factor-β (TGFβ) are known, TGFβ1, 2, and 3, that have non-overlapping functions during development.  However, their specific roles in cancers such as prostate cancer are less clear.  Here we show that primary cultures of prostatic epithelial cells preferentially produce and activate the latent TGFβ2 isoform.  Paired cultures of normal and malignant prostate cells from prostate cancer patients produced predominantly the TGFβ2 isoform, with 30- to 70-fold less TGFβ1.  By mono-Q ion exchange chromatog., three major peaks of latent TGFβ2 activity were obsd. corresponding to the known small latent TGFβ2 complex, the known large latent TGFβ2 complex and a novel eluting peak of latent TGFβ2.  Although prostate cells are known to activate latent TGFβ, the mechanism for activation is currently unclear.  We investigated whether prostate specific antigen (PSA), a serine protease used as a clin. marker for prostate cancer, could play a role in the activation of latent TGFβ.  Unlike plasmin, a known activator of both latent TGFβ1 and 2, PSA specifically activated the recombinant small latent form of TGFβ2, but not TGFβ1.  Prostate epithelial cells, therefore, preferentially produce the TGFβ2 isoform and PSA, a protease produced by the prostate, specifically targets the activation of this TGFβ isoform.  PSA-mediated activation of latent TGFβ2 may be an important mechanism for autocrine TGFβ regulation in the prostate and may potentially contribute to the formation of osteoblastic lesions in bone metastatic prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpd9LDnfcGdXrVg90H21EOLACvtfcHk0lgosh6JLEw1qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXot1ajsA%253D%253D&md5=0f9bfa5aa46fd213e7203a981129bc0a</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fjcp.20147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.20147%26sid%3Dliteratum%253Aachs%26aulast%3DDallas%26aufirst%3DS.%2BL.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DCramer%26aufirst%3DS.%2BD.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DPeehl%26aufirst%3DD.%2BM%26aulast%3DBonewald%26aufirst%3DL.%2BF.%26atitle%3DPreferential%2520production%2520of%2520latent%2520transforming%2520growth%2520factor-2%2520by%2520primary%2520prostatic%2520epithelial%2520cells%2520and%2520its%2520activation%2520by%2520prostate-specific%2520antigen%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2005%26volume%3D202%26spage%3D361%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Lilja, H.; Piironen, T. P.; Rittenhouse, H. G.; Mikolajczyk, S. D.; Slawin, K. M.</span> <span class="citation_source-book">Comprehensive Textbook of Genitourinary Oncology</span>; <span class="NLM_publisher-name">Lippincott Williams and Wilkins Publishers</span>: <span class="NLM_publisher-loc">Philadelphia</span>,<span class="NLM_x"> </span><span class="NLM_year">2000</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">638</span><span class="NLM_x">–</span> <span class="NLM_lpage">650</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=638-650&author=H.+Lilja&author=T.+P.+Piironen&author=H.+G.+Rittenhouse&author=S.+D.+Mikolajczyk&author=K.+M.+Slawin&title=Comprehensive+Textbook+of+Genitourinary+Oncology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLilja%26aufirst%3DH.%26btitle%3DComprehensive%2520Textbook%2520of%2520Genitourinary%2520Oncology%26pub%3DLippincott%2520Williams%2520and%2520Wilkins%2520Publishers%26date%3D2000%26spage%3D638%26epage%3D650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Williams, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jelinek, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litvinov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cotter, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacs, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denmeade, S. R.</span><span> </span><span class="NLM_article-title">Enzymatically active prostate-specific antigen promotes growth of human prostate cancers</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">1595</span><span class="NLM_x">–</span> <span class="NLM_lpage">1607</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm301718c&amp;key=10.1002%2Fpros.21375" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm301718c&amp;key=21394741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm301718c&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1Srs7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=1595-1607&author=S.+A.+Williamsauthor=C.+A.+Jelinekauthor=I.+Litvinovauthor=R.+J.+Cotterauthor=J.+T.+Isaacsauthor=S.+R.+Denmeade&title=Enzymatically+active+prostate-specific+antigen+promotes+growth+of+human+prostate+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Enzymatically active prostate-specific antigen promotes growth of human prostate cancers</span></div><div class="casAuthors">Williams, Simon A.; Jelinek, Christine A.; Litvinov, Ivan; Cotter, Robert J.; Isaacs, John T.; Denmeade, Samuel R.</div><div class="citationInfo"><span class="NLM_cas:title">Prostate (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1595-1607</span>CODEN:
                <span class="NLM_cas:coden">PRSTDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-4137</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">BACKGROUND: Prostate specific antigen (PSA) is the best-known member of the kallikrein-related peptidase family, with an established role as a prostatic disease biomarker.  Although it is produced at high levels by all stages of prostate cancer, it is uncertain if PSA plays a role in prostate cancer initiation and progression.  We decided to investigate the impact of PSA and its enzymic activity on tumor cell growth rates.  METHODS: A gene-specific shRNA lentiviral construct reduced endogenous PSA expression in the LNCaP human prostate cancer cell line.  Resulting changes in growth rates in vitro and in vivo were detd.  Using a mass spectroscopy-based approach, alterations to the LNCaP proteome due to reduced PSA were measured.  Finally, to evaluate the importance of PSA's proteolytic activity, the PSA-null Du145 human prostate cancer cell line was engineered to express either enzymically inactive pro-PSA (WT) or a furin-activated variant (FR) with high enzymic activity.  The resulting clones were evaluated for PSA-induced changes in growth rates in vivo and in vitro.  RESULTS: Lowered PSA levels dramatically reduced LNCaP growth rates.  Expressing active PSA (FR), but not the inactive WT variant, conferred a growth advantage on Du145 cells.  Proteomics anal. revealed global changes to the LNCaP proteome as a result of reduced PSA expression.  CONCLUSIONS: These studies demonstrate the importance of PSA to prostate cancer cell growth.  We also show that the enzymic activity of PSA confers an enhanced growth rate to human prostate cancer cells, suggesting a causal role in prostate cancer progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEF1sRKW1LubVg90H21EOLACvtfcHk0lgosh6JLEw1qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1Srs7nO&md5=f220dd09a3b85112e943e1c452eb8bc4</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fpros.21375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpros.21375%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DS.%2BA.%26aulast%3DJelinek%26aufirst%3DC.%2BA.%26aulast%3DLitvinov%26aufirst%3DI.%26aulast%3DCotter%26aufirst%3DR.%2BJ.%26aulast%3DIsaacs%26aufirst%3DJ.%2BT.%26aulast%3DDenmeade%26aufirst%3DS.%2BR.%26atitle%3DEnzymatically%2520active%2520prostate-specific%2520antigen%2520promotes%2520growth%2520of%2520human%2520prostate%2520cancers%26jtitle%3DProstate%26date%3D2011%26volume%3D71%26spage%3D1595%26epage%3D1607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">O’Keefe, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guise, T. A.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of bone metastasis and therapeutic implications</span> <span class="citation_source-journal">Clin. Orthoped. Relat. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">415</span><span class="NLM_x">, </span> <span class="NLM_fpage">S100</span><span class="NLM_x">–</span> <span class="NLM_lpage">S104</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=415&publication_year=2003&pages=S100-S104&author=R.+J.+O%E2%80%99Keefeauthor=T.+A.+Guise&title=Molecular+mechanisms+of+bone+metastasis+and+therapeutic+implications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Keefe%26aufirst%3DR.%2BJ.%26aulast%3DGuise%26aufirst%3DT.%2BA.%26atitle%3DMolecular%2520mechanisms%2520of%2520bone%2520metastasis%2520and%2520therapeutic%2520implications%26jtitle%3DClin.%2520Orthoped.%2520Relat.%2520Res.%26date%3D2003%26volume%3D415%26spage%3DS100%26epage%3DS104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Roodman, G. D.</span><span> </span><span class="NLM_article-title">Mechanisms of bone metastasis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">1655</span><span class="NLM_x">–</span> <span class="NLM_lpage">1664</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm301718c&amp;key=10.1056%2FNEJMra030831" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm301718c&amp;key=15084698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm301718c&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjt1WksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2004&pages=1655-1664&author=G.+D.+Roodman&title=Mechanisms+of+bone+metastasis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of bone metastasis</span></div><div class="casAuthors">Roodman, G. David</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1655-1664</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review on the mol. mechanisms involved in osteolytic and osteoblastic metastases, which are a frequent complication of cancer.  The use of gene arrays and proteomics and the availability of appropriate animal models of bone metastasis have permitted the identification of factors produced by the tumor cells themselves or by the microenvironment in response to the tumor that mediate the process of bone destruction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprLLCQ6YLAl7Vg90H21EOLACvtfcHk0lgosh6JLEw1qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjt1WksLY%253D&md5=6bd3c31cbe5f0c8310661c87861f4724</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1056%2FNEJMra030831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra030831%26sid%3Dliteratum%253Aachs%26aulast%3DRoodman%26aufirst%3DG.%2BD.%26atitle%3DMechanisms%2520of%2520bone%2520metastasis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D350%26spage%3D1655%26epage%3D1664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Ulmert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wongvipat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahamsson, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scardino, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lilja, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyers, C. L.</span><span> </span><span class="NLM_article-title">Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen</span> <span class="citation_source-journal">Cancer Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">320</span><span class="NLM_x">–</span> <span class="NLM_lpage">327</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=320-327&author=D.+Ulmertauthor=M.+J.+Evansauthor=J.+P.+Hollandauthor=S.+L.+Riceauthor=J.+Wongvipatauthor=K.+Petterssonauthor=P.+A.+Abrahamssonauthor=P.+T.+Scardinoauthor=S.+M.+Larsonauthor=H.+Liljaauthor=J.+S.+Lewisauthor=C.+L.+Sawyers&title=Imaging+androgen+receptor+signaling+with+a+radiotracer+targeting+free+prostate-specific+antigen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUlmert%26aufirst%3DD.%26aulast%3DEvans%26aufirst%3DM.%2BJ.%26aulast%3DHolland%26aufirst%3DJ.%2BP.%26aulast%3DRice%26aufirst%3DS.%2BL.%26aulast%3DWongvipat%26aufirst%3DJ.%26aulast%3DPettersson%26aufirst%3DK.%26aulast%3DAbrahamsson%26aufirst%3DP.%2BA.%26aulast%3DScardino%26aufirst%3DP.%2BT.%26aulast%3DLarson%26aufirst%3DS.%2BM.%26aulast%3DLilja%26aufirst%3DH.%26aulast%3DLewis%26aufirst%3DJ.%2BS.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26atitle%3DImaging%2520androgen%2520receptor%2520signaling%2520with%2520a%2520radiotracer%2520targeting%2520free%2520prostate-specific%2520antigen%26jtitle%3DCancer%2520Discovery%26date%3D2012%26volume%3D2%26spage%3D320%26epage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Adlington, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoull, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNulty, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubauer, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, G. J.</span><span> </span><span class="NLM_article-title">Design, synthesis, and proposed active site binding analysis of monocyclic 2-azetidinone inhibitors of prostate specific antigen</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1491</span><span class="NLM_x">–</span> <span class="NLM_lpage">1508</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000145g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=1491-1508&author=R.+M.+Adlingtonauthor=J.+E.+Baldwinauthor=G.+W.+Beckerauthor=B.+Chenauthor=L.+Chengauthor=S.+L.+Cooperauthor=R.+B.+Hermannauthor=T.+J.+Howeauthor=W.+McCoullauthor=A.+M.+McNultyauthor=B.+L.+Neubauerauthor=G.+J.+Pritchard&title=Design%2C+synthesis%2C+and+proposed+active+site+binding+analysis+of+monocyclic+2-azetidinone+inhibitors+of+prostate+specific+antigen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm000145g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000145g%26sid%3Dliteratum%253Aachs%26aulast%3DAdlington%26aufirst%3DR.%2BM.%26aulast%3DBaldwin%26aufirst%3DJ.%2BE.%26aulast%3DBecker%26aufirst%3DG.%2BW.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DCooper%26aufirst%3DS.%2BL.%26aulast%3DHermann%26aufirst%3DR.%2BB.%26aulast%3DHowe%26aufirst%3DT.%2BJ.%26aulast%3DMcCoull%26aufirst%3DW.%26aulast%3DMcNulty%26aufirst%3DA.%2BM.%26aulast%3DNeubauer%26aufirst%3DB.%2BL.%26aulast%3DPritchard%26aufirst%3DG.%2BJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520proposed%2520active%2520site%2520binding%2520analysis%2520of%2520monocyclic%25202-azetidinone%2520inhibitors%2520of%2520prostate%2520specific%2520antigen%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D1491%26epage%3D1508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Adlington, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoull, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNulty, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubauer, B L.</span><span> </span><span class="NLM_article-title">Design and synthesis of novel monocyclic β-lactam inhibitors of prostate-specific antigen</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1689</span><span class="NLM_x">–</span> <span class="NLM_lpage">1694</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1997&pages=1689-1694&author=R.+M.+Adlingtonauthor=J.+E.+Baldwinauthor=B.+Chenauthor=S.+L.+Cooperauthor=W.+McCoullauthor=G.+J.+Pritchardauthor=T.+J.+Howeauthor=G.+W.+Beckerauthor=R.+B.+Hermannauthor=A.+M.+McNultyauthor=B+L.+Neubauer&title=Design+and+synthesis+of+novel+monocyclic+%CE%B2-lactam+inhibitors+of+prostate-specific+antigen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdlington%26aufirst%3DR.%2BM.%26aulast%3DBaldwin%26aufirst%3DJ.%2BE.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DCooper%26aufirst%3DS.%2BL.%26aulast%3DMcCoull%26aufirst%3DW.%26aulast%3DPritchard%26aufirst%3DG.%2BJ.%26aulast%3DHowe%26aufirst%3DT.%2BJ.%26aulast%3DBecker%26aufirst%3DG.%2BW.%26aulast%3DHermann%26aufirst%3DR.%2BB.%26aulast%3DMcNulty%26aufirst%3DA.%2BM.%26aulast%3DNeubauer%26aufirst%3DB%2BL.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%2520monocyclic%2520%25CE%25B2-lactam%2520inhibitors%2520of%2520prostate-specific%2520antigen%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1997%26volume%3D7%26spage%3D1689%26epage%3D1694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Knight, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabin, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gale, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maycock, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weston, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westler, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorn, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finke, P. E.</span><span> </span><span class="NLM_article-title">Specificity, stability, and potency of monocyclic β-lactam inhibitors of human leukocyte elastase</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">8160</span><span class="NLM_x">–</span> <span class="NLM_lpage">8170</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=8160-8170&author=W.+B.+Knightauthor=B.+G.+Greenauthor=R.+M.+Chabinauthor=P.+Galeauthor=A.+L.+Maycockauthor=H.+Westonauthor=D.+W.+Kuoauthor=W.+M.+Westlerauthor=C.+P.+Dornauthor=P.+E.+Finke&title=Specificity%2C+stability%2C+and+potency+of+monocyclic+%CE%B2-lactam+inhibitors+of+human+leukocyte+elastase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DW.%2BB.%26aulast%3DGreen%26aufirst%3DB.%2BG.%26aulast%3DChabin%26aufirst%3DR.%2BM.%26aulast%3DGale%26aufirst%3DP.%26aulast%3DMaycock%26aufirst%3DA.%2BL.%26aulast%3DWeston%26aufirst%3DH.%26aulast%3DKuo%26aufirst%3DD.%2BW.%26aulast%3DWestler%26aufirst%3DW.%2BM.%26aulast%3DDorn%26aufirst%3DC.%2BP.%26aulast%3DFinke%26aufirst%3DP.%2BE.%26atitle%3DSpecificity%252C%2520stability%252C%2520and%2520potency%2520of%2520monocyclic%2520%25CE%25B2-lactam%2520inhibitors%2520of%2520human%2520leukocyte%2520elastase%26jtitle%3DBiochemistry%26date%3D1992%26volume%3D35%26spage%3D8160%26epage%3D8170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Green, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Underwood, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gale, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maycock, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liesch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgey, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorn, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finke, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagmann, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacCoss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westler, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, W. B.</span><span> </span><span class="NLM_article-title">Mechanism of inhibition of human leucocyte elastase by β-lactams. Stability, reactivation kinetics, and products of β-lactam-derived E–I complexes</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">14331</span><span class="NLM_x">–</span> <span class="NLM_lpage">14243</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1995&pages=14331-14243&author=B.+G.+Greenauthor=R.+Chabinauthor=S.+Millsauthor=D.+J.+Underwoodauthor=S.+K.+Shahauthor=D.+Kuoauthor=P.+Galeauthor=A.+L.+Maycockauthor=J.+Lieschauthor=C.+S.+Burgeyauthor=J.+B.+Dohertyauthor=C.+P.+Dornauthor=P.+E.+Finkeauthor=W.+K.+Hagmannauthor=J.+J.+Haleauthor=M.+MacCossauthor=W.+M.+Westlerauthor=W.+B.+Knight&title=Mechanism+of+inhibition+of+human+leucocyte+elastase+by+%CE%B2-lactams.+Stability%2C+reactivation+kinetics%2C+and+products+of+%CE%B2-lactam-derived+E%E2%80%93I+complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DB.%2BG.%26aulast%3DChabin%26aufirst%3DR.%26aulast%3DMills%26aufirst%3DS.%26aulast%3DUnderwood%26aufirst%3DD.%2BJ.%26aulast%3DShah%26aufirst%3DS.%2BK.%26aulast%3DKuo%26aufirst%3DD.%26aulast%3DGale%26aufirst%3DP.%26aulast%3DMaycock%26aufirst%3DA.%2BL.%26aulast%3DLiesch%26aufirst%3DJ.%26aulast%3DBurgey%26aufirst%3DC.%2BS.%26aulast%3DDoherty%26aufirst%3DJ.%2BB.%26aulast%3DDorn%26aufirst%3DC.%2BP.%26aulast%3DFinke%26aufirst%3DP.%2BE.%26aulast%3DHagmann%26aufirst%3DW.%2BK.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DMacCoss%26aufirst%3DM.%26aulast%3DWestler%26aufirst%3DW.%2BM.%26aulast%3DKnight%26aufirst%3DW.%2BB.%26atitle%3DMechanism%2520of%2520inhibition%2520of%2520human%2520leucocyte%2520elastase%2520by%2520%25CE%25B2-lactams.%2520Stability%252C%2520reactivation%2520kinetics%252C%2520and%2520products%2520of%2520%25CE%25B2-lactam-derived%2520E%25E2%2580%2593I%2520complexes%26jtitle%3DBiochemistry%26date%3D1995%26volume%3D44%26spage%3D14331%26epage%3D14243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Huang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knoell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazegh-Azam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tashjian, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedstrom, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abeles, R. H.</span><span> </span><span class="NLM_article-title">Modulation of recombinant human prostate-specific antigen: activation by hofmeister salts and inhibition by azapeptides</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">11734</span><span class="NLM_x">–</span> <span class="NLM_lpage">11741</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi010364j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=11734-11741&author=A.+Huangauthor=C.+Knoellauthor=G.+Feyauthor=M.+Hazegh-Azamauthor=A.+Tashjianauthor=L.+Hedstromauthor=R.+H.+Abeles&title=Modulation+of+recombinant+human+prostate-specific+antigen%3A+activation+by+hofmeister+salts+and+inhibition+by+azapeptides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fbi010364j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi010364j%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DA.%26aulast%3DKnoell%26aufirst%3DC.%26aulast%3DFey%26aufirst%3DG.%26aulast%3DHazegh-Azam%26aufirst%3DM.%26aulast%3DTashjian%26aufirst%3DA.%26aulast%3DHedstrom%26aufirst%3DL.%26aulast%3DAbeles%26aufirst%3DR.%2BH.%26atitle%3DModulation%2520of%2520recombinant%2520human%2520prostate-specific%2520antigen%253A%2520activation%2520by%2520hofmeister%2520salts%2520and%2520inhibition%2520by%2520azapeptides%26jtitle%3DBiochemistry%26date%3D2001%26volume%3D40%26spage%3D11734%26epage%3D11741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Koistinen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wohlfart, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattsson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahdenpera, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenman, U. H.</span><span> </span><span class="NLM_article-title">Novel small molecule inhibitors for prostate-specific antigen</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">1143</span><span class="NLM_x">–</span> <span class="NLM_lpage">1151</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=1143-1151&author=H.+Koistinenauthor=G.+Wohlfartauthor=J.+M.+Mattssonauthor=P.+Wuauthor=J.+Lahdenperaauthor=U.+H.+Stenman&title=Novel+small+molecule+inhibitors+for+prostate-specific+antigen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoistinen%26aufirst%3DH.%26aulast%3DWohlfart%26aufirst%3DG.%26aulast%3DMattsson%26aufirst%3DJ.%2BM.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DLahdenpera%26aufirst%3DJ.%26aulast%3DStenman%26aufirst%3DU.%2BH.%26atitle%3DNovel%2520small%2520molecule%2520inhibitors%2520for%2520prostate-specific%2520antigen%26jtitle%3DProstate%26date%3D2008%26volume%3D68%26spage%3D1143%26epage%3D1151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Mikolajczyk, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partin, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rittenhouse, H. G.</span><span> </span><span class="NLM_article-title">Free prostate-specific antigen is becoming more complex</span> <span class="citation_source-journal">Urology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">797</span><span class="NLM_x">–</span> <span class="NLM_lpage">802</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2002&pages=797-802&author=A.+D.+Mikolajczykauthor=L.+S.+Marksauthor=A.+W.+Partinauthor=H.+G.+Rittenhouse&title=Free+prostate-specific+antigen+is+becoming+more+complex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMikolajczyk%26aufirst%3DA.%2BD.%26aulast%3DMarks%26aufirst%3DL.%2BS.%26aulast%3DPartin%26aufirst%3DA.%2BW.%26aulast%3DRittenhouse%26aufirst%3DH.%2BG.%26atitle%3DFree%2520prostate-specific%2520antigen%2520is%2520becoming%2520more%2520complex%26jtitle%3DUrology%26date%3D2002%26volume%3D59%26spage%3D797%26epage%3D802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Matteson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadhu, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lienhard, G. E.</span><span> </span><span class="NLM_article-title"><i>R</i>-1-Acetamido-2-phenylethaneboronic acid. A specific transition-state analog for chymotrypsin</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">5241</span><span class="NLM_x">–</span> <span class="NLM_lpage">5242</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00407a051" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=1981&pages=5241-5242&author=D.+S.+Mattesonauthor=K.+M.+Sadhuauthor=G.+E.+Lienhard&title=R-1-Acetamido-2-phenylethaneboronic+acid.+A+specific+transition-state+analog+for+chymotrypsin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fja00407a051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00407a051%26sid%3Dliteratum%253Aachs%26aulast%3DMatteson%26aufirst%3DD.%2BS.%26aulast%3DSadhu%26aufirst%3DK.%2BM.%26aulast%3DLienhard%26aufirst%3DG.%2BE.%26atitle%3DR-1-Acetamido-2-phenylethaneboronic%2520acid.%2520A%2520specific%2520transition-state%2520analog%2520for%2520chymotrypsin%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1981%26volume%3D103%26spage%3D5241%26epage%3D5242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Matteson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadhu, K. M.</span><span> </span><span class="NLM_article-title">Synthesis of 1-amino-2-phenylethane-1-boronic acid derivatives</span> <span class="citation_source-journal">Organometallics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">614</span><span class="NLM_x">–</span> <span class="NLM_lpage">618</span></span><div class="citationLinks">[<a href="/doi/10.1021/om00082a019" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm301718c&amp;key=1%3ACAS%3A528%3ADyaL2cXhsFKltbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1984&pages=614-618&author=D.+S.+Mattesonauthor=K.+M.+Sadhu&title=Synthesis+of+1-amino-2-phenylethane-1-boronic+acid+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 1-amino-2-phenylethane-1-boronic acid derivatives</span></div><div class="casAuthors">Matteson, Donald S.; Sadhu, Kizhakethil Mathew</div><div class="citationInfo"><span class="NLM_cas:title">Organometallics</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">614-18</span>CODEN:
                <span class="NLM_cas:coden">ORGND7</span>;
        ISSN:<span class="NLM_cas:issn">0276-7333</span>.
    </div><div class="casAbstract">The B analog of N-acetylphenylalanine, (R)-1-acetamido-2-phenylethane-1-boronic acid (I), was synthesized from (+)-pinanediol phenylmethane-1-boronate, which was converted by LiCHCl2 to the (S)-1-chloro-2-phenylethane-1-boronate, then with N-lithiohexamethyldisilazane to the silylated 1-amino-2-phenylethane-1-boronic ester, which was desilylated and acetylated in situ to (+)-pinanediol (R)-1-acetamido-2-phenylethane-1-boronate and then cleaved to the free I with BCl3.  1-Amino-2-phenylethane-1-boronate esters were isolable but unstable, deboronating to PhCH2CH2NH2 under the influence of heat or hydroxylic solvents.  1-Amino-2-phenylethane-1-boronic acid, though not isolable, partially survives for 1 h in cold aq. soln.  Attempts to synthesize stable α-acetamidoboronate esters directly by reaction of LiNHAc with 1-halo-2-phenylethane-1-boronates resulted in a major proportion of O-alkylation to form imino esters.  Pinacol 1-acetamidino-2-phenylethane-1-boronate was obtained from the α-iodoboronate and acetamidine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2H94XPY3MlbVg90H21EOLACvtfcHk0lhDtFGnRRPOIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXhsFKltbo%253D&md5=5785b03fed72bc3f6773483aed1f0e9f</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fom00082a019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fom00082a019%26sid%3Dliteratum%253Aachs%26aulast%3DMatteson%26aufirst%3DD.%2BS.%26aulast%3DSadhu%26aufirst%3DK.%2BM.%26atitle%3DSynthesis%2520of%25201-amino-2-phenylethane-1-boronic%2520acid%2520derivatives%26jtitle%3DOrganometallics%26date%3D1984%26volume%3D3%26spage%3D614%26epage%3D618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Matteson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jesthi, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadhu, K. M.</span><span> </span><span class="NLM_article-title">Synthesis and properties of pinanediol α-amido boronic esters</span> <span class="citation_source-journal">Organometallics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1284</span><span class="NLM_x">–</span> <span class="NLM_lpage">1288</span></span><div class="citationLinks">[<a href="/doi/10.1021/om00086a024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1984&pages=1284-1288&author=D.+S.+Mattesonauthor=P.+K.+Jesthiauthor=K.+M.+Sadhu&title=Synthesis+and+properties+of+pinanediol+%CE%B1-amido+boronic+esters"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fom00086a024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fom00086a024%26sid%3Dliteratum%253Aachs%26aulast%3DMatteson%26aufirst%3DD.%2BS.%26aulast%3DJesthi%26aufirst%3DP.%2BK.%26aulast%3DSadhu%26aufirst%3DK.%2BM.%26atitle%3DSynthesis%2520and%2520properties%2520of%2520pinanediol%2520%25CE%25B1-amido%2520boronic%2520esters%26jtitle%3DOrganometallics%26date%3D1984%26volume%3D3%26spage%3D1284%26epage%3D1288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Hansen, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosch, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greiveldinger-Poenaru, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartlett, P. A.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of macrocyclic transition state analog inhibitors for α-chymotrypsin</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">8465</span><span class="NLM_x">–</span> <span class="NLM_lpage">8470</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo034837z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=8465-8470&author=K.+K.+Hansenauthor=B.+Groschauthor=S.+Greiveldinger-Poenaruauthor=P.+A.+Bartlett&title=Synthesis+and+evaluation+of+macrocyclic+transition+state+analog+inhibitors+for+%CE%B1-chymotrypsin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjo034837z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo034837z%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DK.%2BK.%26aulast%3DGrosch%26aufirst%3DB.%26aulast%3DGreiveldinger-Poenaru%26aufirst%3DS.%26aulast%3DBartlett%26aufirst%3DP.%2BA.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520macrocyclic%2520transition%2520state%2520analog%2520inhibitors%2520for%2520%25CE%25B1-chymotrypsin%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2003%26volume%3D68%26spage%3D8465%26epage%3D8470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Wityak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Earl, R., A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abelman, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bethel, Y. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kauffman, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kettner, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMillan, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mersinger, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesti, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankin, F. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chorvat, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Confalone, P. N.</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">3717</span><span class="NLM_x">–</span> <span class="NLM_lpage">3722</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00117a024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Wityak%2C+J.%3B+Earl%2C+R.%2C+A.%3B+Abelman%2C+M.+M.%3B+Bethel%2C+Y.+B.%3B+Fisher%2C+B.+N.%3B+Kauffman%2C+G.+S.%3B+Kettner%2C+C.+A.%3B+Ma%2C+P.%3B+McMillan%2C+J.+L.%3B+Mersinger%2C+L.+J.%3B+Pesti%2C+J.%3B+Pierce%2C+M.+E.%3B+Rankin%2C+F.+W.%3B+Chorvat%2C+R.+J.%3B+Confalone%2C+P.+N.J.+Org.+Chem.+1995%2C+60%2C+3717%E2%80%933722"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjo00117a024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00117a024%26sid%3Dliteratum%253Aachs%26aulast%3DWityak%26aufirst%3DJ.%26aulast%3DEarl%26aufirst%3DR.%252C%2BA.%26aulast%3DAbelman%26aufirst%3DM.%2BM.%26aulast%3DBethel%26aufirst%3DY.%2BB.%26aulast%3DFisher%26aufirst%3DB.%2BN.%26aulast%3DKauffman%26aufirst%3DG.%2BS.%26aulast%3DKettner%26aufirst%3DC.%2BA.%26aulast%3DMa%26aufirst%3DP.%26aulast%3DMcMillan%26aufirst%3DJ.%2BL.%26aulast%3DMersinger%26aufirst%3DL.%2BJ.%26aulast%3DPesti%26aufirst%3DJ.%26aulast%3DPierce%26aufirst%3DM.%2BE.%26aulast%3DRankin%26aufirst%3DF.%2BW.%26aulast%3DChorvat%26aufirst%3DR.%2BJ.%26aulast%3DConfalone%26aufirst%3DP.%2BN.%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1995%26volume%3D60%26spage%3D3717%26epage%3D3722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foss, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimmagadda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullambhatla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castanares, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupold, S. E .</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babich, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mease, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomper, M. G.</span><span> </span><span class="NLM_article-title">Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7933</span><span class="NLM_x">–</span> <span class="NLM_lpage">7943</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801055h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm301718c&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVKlu7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7933-7943&author=Y.+Chenauthor=C.+A.+Fossauthor=Y.+Byunauthor=S.+Nimmagaddaauthor=M.+Pullambhatlaauthor=J.+J.+Foxauthor=M.+Castanaresauthor=S.+E+.+Lupoldauthor=J.+W.+Babichauthor=R.+C.+Measeauthor=M.+G.+Pomper&title=Radiohalogenated+prostate-specific+membrane+antigen+%28PSMA%29-based+ureas+as+imaging+agents+for+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Radiohalogenated Prostate-Specific Membrane Antigen (PSMA)-Based Ureas as Imaging Agents for Prostate Cancer</span></div><div class="casAuthors">Chen, Ying; Foss, Catherine A.; Byun, Youngjoo; Nimmagadda, Sridhar; Pullambhatla, Mrudula; Fox, James J.; Castanares, Mark; Lupold, Shawn E.; Babich, John W.; Mease, Ronnie C.; Pomper, Martin G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7933-7943</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To extend our development of new imaging agents targeting the prostate-specific membrane antigen (PSMA), we have used the versatile intermediate 2-[3-(5-amino-1-carboxy-pentyl)-ureido]-pentanedioic acid (Lys-C(O)-Glu), which allows ready incorporation of radiohalogens for single photon emission computed tomog. (SPECT) and positron emission tomog. (PET).  We prepd. 2-[3-[1-carboxy-5-(4-[125I]iodo-benzoylamino)-pentyl]-ureido]-pentanedioic acid ([125I]3), 2-[3-[1-carboxy-5-(4-[18F]fluoro-benzoylamino)-pentyl]-ureido]-pentanedioic acid ([18F]6), and 2-(3-[1-carboxy-5-[(5-[125I]iodo-pyridine-3-carbonyl)-amino]-pentyl]-ureido)-pentanedioic acid ([125I]8) in 65-80% (nondecay-cor.), 30-35% (decay cor.), and 59-75% (nondecay-cor.) radiochem. yields.  Compd. [125I]3 demonstrated 8.8 ± 4.7% injected dose per g (%ID/g) within PSMA+ PC-3 PIP tumor at 30 min postinjection, which persisted, with clear delineation of the tumor by SPECT.  Similar tumor uptake values at early time points were demonstrated for [18F]6 (using PET) and [125I]8.  Because of the many radiohalogenated moieties that can be attached via the ε amino group, the intermediate Lys-C(O)-Glu is an attractive template upon which to develop new imaging agents for prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_c7_c3TRKQ7Vg90H21EOLACvtfcHk0liJyDQZJOLI5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVKlu7bE&md5=cf1e18c253f469491ec6065535be6be1</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm801055h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801055h%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DFoss%26aufirst%3DC.%2BA.%26aulast%3DByun%26aufirst%3DY.%26aulast%3DNimmagadda%26aufirst%3DS.%26aulast%3DPullambhatla%26aufirst%3DM.%26aulast%3DFox%26aufirst%3DJ.%2BJ.%26aulast%3DCastanares%26aufirst%3DM.%26aulast%3DLupold%26aufirst%3DS.%2BE%2B.%26aulast%3DBabich%26aufirst%3DJ.%2BW.%26aulast%3DMease%26aufirst%3DR.%2BC.%26aulast%3DPomper%26aufirst%3DM.%2BG.%26atitle%3DRadiohalogenated%2520prostate-specific%2520membrane%2520antigen%2520%2528PSMA%2529-based%2520ureas%2520as%2520imaging%2520agents%2520for%2520prostate%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7933%26epage%3D7943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm301718c&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm301718c%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-11%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm301718c" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799a45aa8a83cd0","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
